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Abstract 
Abstract 
Secreted or s urface-associated protein s  p l ay an i mportant role i n  the 
immunopathogenesis of Helicobacter pylori infection .  The aim of this study was to 
identify ,  using a genetic approach, H. pylori exported proteins and assess their role in 
the host immune response to infection. As part of this work, an H. pylori expression 
library was constructed and screened with a monoclonal antibody raised to a component 
of outer membrane vesicles from H. pylori, identified and characterised in a separate 
study. The screening strategy identified a locus of the genome containing two genes 
encoding exported proteins. Subsequent expression studies identified the gene product 
detected by the antibody as Lpp20, which encodes a well characterised l ipoprotein from 
H. pylori. In addition , the use of alkaline phosphatase (AP) gene fusion methodology 
enabled the identification of a large number of other H. pylori exported proteins .  
Immunoscreening of a selection of enzymatically active H. pylori AP fusion proteins 
was carried out by Western blot analysis with patient sera and lymphocyte proliferation 
assays using peripheral blood mononuclear cell s  from H. pylori infected individuals .  
These assays identified a novel H. pylori exported antigen which was recognised by 
antibody derived from H. pylori infected individuals .  Southern blot analysis revealed 
that the gene encoding the protein was absent in other Helicobacter species tested and 
sequence analysis of the gene demonstrated that it is highly conserved among H. pylori 
isolates .  In order to obtain pure recombinant protein, the gene encoding the protein was 
cloned and expressed as a Beta-galactosidase (�-gal) fusion in  Escherichia coli and the 
protein purified by affinity chromatography. The size of the recombinant  protein 
released ( 1 8 kDa) was consistent with the calculated molecular mass of the polypeptide 
deduced from the DNA sequence. In Western blot assays, the purified protein was 
recognised by 7 1  % of sera taken from patients infected with H. pylori, but by only 1 6% 
of sera taken from patients with unrelated or with no gastrointestinal disease. These 
results indicated that the 1 8  kDa protei n  from H. pylori was immunogenic and 
expressed in vivo. In other experiments, it was found that oral administration of this 
antigen did not protect mice against H. pylori colonisation following challenge with H. 
pylori. 
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Chapter 1 Introduction 
1 .1  Gastrointestinal disease 
1.1.1 Historical background 
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Ancient  and medieval medical records describe the complications of peptic u lcer 
disease, but the first description of gastric ulceration was not reported until 1 586 by an 
Italian physician (Donati, 1 5 86; cited in Buckley and O'Morain ,  1 998).  The symptoms 
of peptic ulceration were later described in 1 825 and, with the abil i ty to diagnose 
gastrointestinal disease, gastric surgery developed in the late nineteenth century. By the 
start of the twentieth century, the role of gastric acid in the development of ulcer disease 
was well established (Kidd and Modlin, 1998) .  The concept that acid imbalance was 
the primary cause of altered gastric pathology prevailed in most of the early twentieth 
century .  As such, the treatment of peptic ulceration was based almost exclusively on 
the notion of neutralising or inhibiting the secretion of gastric acid, mostly through 
therapy with histamine H2 receptor antagonists and other compounds such as 
prostaglandins, various antacid formulations and proton pump inhibitors . In addition, 
sucralfate, colloidal bismuth and carbenoxolone sodium were used to enhance local 
mucosal resistance without affecting gastric acid. However, in the face of mounting 
evidence that these treatment regimes were at best palliative, many investigators 
realised that peptic ulcer disease was a multifactorial process whose etiology was poorly 
understood. 
The presence of gastric spiral bacteria in the canine stomach was first reported in 1 893, 
and numerous reports describing similar "spirochetes" in the stomach of humans are 
scattered throughout the fol lowing century (reviewed in Kidd and Modlin, 1 998).  As a 
resul t ,  a bacterial origin underlying gastric u lceration had been proposed, but 
demonstration of this was hindered by the problems associated with the isolation and 
culture of pure strains from the stomach and researchers were unable to culture any 
candidate organisms. As such, interest in these spiral bacteria diminished and the 
dictum "no acid, no ulcer" (Shwartz, 1 9 1 0; cited in McNulty , 1 999) remained. The 
initial report implicating a Campylobacter-like organism in the aetiology of human 
gastritis and peptic ulceration (Mat'shall and Warren, 1 984) was thus met with much 
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scepticism. Their discovery , however, soon demanded the attention of researchers 
working in the field of gastroenterology. 
1 .1 .2 The discovery of Helicobacter pylori 
The observation that spiral bacteria were commonly found during microscopic 
evaluation of biopsy samples taken from patients with gastritis initiated a study which 
would eventually redefine the treatment of peptic ulcers . The investigation of over one 
hundred and thirty gastric biopsy samples from gastritis patients confirmed the presence 
of this Campylobacter-like organism and the consistency of the associated histological 
changes, fulfi l ling Koch's first postulate (Goodwin et al. , 1 986) .  However, using 
Campylobac ter  isolation techniques, attempts to culture this bacteria under 
microaerophilic condi tions with a l imited incubation of two days were unsuccessful .  
Serendipity intervened, and the thirty-fifth culture was left to incubate for an extended 
period over the Easter weekend, resulting in the growth of a pure bacterial colonies 
(Mat·shall and Warren, 1 984). 
In order to demonstrate that this gastric bacterium was the etiological agent of human 
gastritis ,  Marshall et al. ( 1 985) and Morris and Nicholson ( 1 987) independently 
satisfied Koch ' s  postulates in two separate experimental human ingestions of the 
bacteria. Fol lowing ingestion of 1 09 colony forming units (CFU),  acute gastritis, 
characterised by polymorphonuclear cell infi ltration, mucus depletion and epithelial cell 
damage, was demonstrated histologically (Marshall et al. , 1 985) .  This newly described 
bacterium was originally named Campylobacter pyloridis, and later Campylobacter 
pylori, as a result of initial morphological similarities to the Campylobacter  bacteria. 
However, this was changed to Helicobacter in 1 989 when the bacteria were recognised 
as a separate genus with the discovery of their unique fatty acid profile and later by 
ribosomal RNA sequencing (Romaniuk et al . ,  1 987) .  The discovery, and subsequent 
studies on this human pathogen, known currently as Helicobacter pylori, revolutionised 
the treatment and diagnosis of gastrointestinal disease. 
2 
1 .2 Helicobacter species 
1.2.1 Classification 
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The Helicobacter group is c lassified in the Proteobacteria, a l arge, diverse division of 
gram-negative bacteria. In a phylogenetic tree derived by maximum likelihood analysis 
of 1 6s subunit rRNA sequences from 253 representative species of bacteria (Olsen et 
al. , 1994), H. pylori was placed in the Epsilon subdivision, which also includes the 
Campylobacter group. Helicobacter pylori was the first characterised member of this 
genus. Morphologically, Helicobacter species range from the gently spiralled H. pylori, 
to the straight rods of H. mustelae. When grown on solid medium, H. pylori assume a 
more rod-like shape and spiral shapes are infrequently observed (Marshall et al. , 1 985) .  
After prolonged culture on solid or in l iquid media, coccoid form tend to predominate 
(Benaissa et al. , 1 996). Coccoid forms are metabolically active, however they cannot 
be cultured in vitro (Dunn et al. , 1 997) and may represent a temporary dormant state. 
Both spiral and coccoid forms have been shown to cause acute gastritis in mice (Wang 
et al. ,  1997) .  Others have demonstrated that adverse changes in DNA, RNA, membrane 
potential and protein synthesis in coccoid forms are consistent with bacterial cell death 
(Kusters et al. ,  1 997). Recent data suggests that the anti genic profiles between the two 
forms differ and may represent an immune evasion tactic (Benaissa et al. , 1996) by the 
bacterium. The significance of these coccoid forms is still under debate. 
The main morphological feature of the Helicobacter genus is the possession of sheathed 
flagella, which are essential for motility (Haas et al. , 1 993)( see also section 1 .4 . 1 ) .  H. 
pylori has four to six unipolar sheathed flagella, each approximately 30 /lm long and 2 .5  
nm in width (Geis et  al . ,  1 989) . The cell wall membrane is smooth in comparison to the 
rugose membrane of Campylobacter species. Most of the Helicobacter species also 
possess a potent urease activity which provides a primary biochemical distinction from 
other oxidase- and catalase-positive spiral organisms (reviewed in Dunn et al. , 1 997) .  
1 .2.2 The H. pylori genome 
The entire H. pylori genome sequence was first published in September 1 997, and 
described the genetic characteristics of H. pylori strain 26695, an isolate from a gastritis 
patient from the United Kingdom, chosen for its toxigenicity and ability to elicit an 
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immune and inflammatory response in  piglets (Tomb et al . ,  1 997) . Later, in February 
1 999, a second H. pylori genome was published describing H. pylori strain J99, isolated 
from a patient with duodenal ulcer from the USA (AIm et al. , 1 999). A comparison of 
these genome sequences revealed that, despite evidence of a large degree of genomic 
and allelic diversity (Taylor et al. , 1 992; Bukanov and Berg, 1 994; Jiang et al. , 1 996), 
the overall genomic organisation ,  gene order and encoded proteins was very similar 
(AIm et al. , 1 999). 
The genome size of H. pylori ranges from l.6 to 1 .75 Mb, with an average G+C content 
of 39% (Tomb et al. , 1 997) .  The genome is circular and encodes approximately 1 ,500 
open reading frames (ORFs) . Sequence analyses of the H. pylori genome have revealed 
that H. pylori has well-developed systems for motility, scavenging iron and for DNA 
restriction and modification (Tomb et al. , 1 997) as well as a complex system of 
enzymes (reviewed in Nilius and Malfertheiner, 1 996) . H. pylori also appears to encode 
a large number of outer membrane proteins and several regions of the genome contain a 
lower percentage of G+C than the rest of the genome, and may represent pathogenicity 
islands (see section 1.4 .2) .  Although providing new insights into the genetic diversity 
of H. pylori (Huynen et al . ,  1 998), the limitation of this raw data is highlighted by the 
fact that approximately one third of the predicted coding sequences are not assigned 
even putative identifications .  In addition, for many of the sequence identifications ,  a 
biological role was assigned on the basis of database matches of less than 50% 
similarity (Owen, 1 998) .  As a result, many elements of pathogenesis still remain 
unclear at the molecular level, and further investigation into both bacterial and host 
factors is required. 
1.3 Helicobacter pylori infection in humans 
1.3.1 Epidemiology 
H. pylori is now recognised as one of the most common human bacterial infections, 
with infection rates of around 50% in developed countries and approaching >90% in 
some developing countries (reviewed in Bardhan, 1 997). There is now much evidence 
to suggest that H. pylori has been part of the normal microbiota of humans and our 
ancestors for millions of years (reviewed in Blaser, 1 998) .  The recent finding of H. 
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pylori antigens in stools from South American mummies about 1 ,700 years old (Correa 
et al . ,  1 998) is consistent with this hypothesis .  The genetic diversity of H. pylori (Go et 
al . ,  1 996), as well as clonal characteristics of H. pylori related to their geographical 
origin (CampbeU et al . ,  1 997) is also consistent with the prolonged presence of H. 
pylori in population groups, and against their recent  spread to humans .  In New 
Zealand, serological studies have found infection rates ranging from 36 - 73% 
depending on  ethnicity . A high seroprevalence of  H. pylori exists in Maori and Pacific 
Island groups, as opposed to European ethnic groups. Ethnicity as a risk factor for 
infection in New Zealand appears to be independent of socio-economic status (Fraser et 
al. , 1 996). 
In concert with other enteric pathogens, childl:.oori represents the phase of maximum 
susceptibility to infection with H. pylori (Cullen et al., 1 993) .  The large differences 
observed between the developing and developed world in the acquisition of H. pylori 
infection (Bardhan, 1 997) , suggest the possibility of an environmental pool of H. pylori 
to which children are exposed in developing countries. However, in contrast to other 
enteric bacteria, the presence of H. pylori in the environment has been difficult to 
demonstrate . Salmonella, Shigella, Vibrio cholerae and more recently, Campylobacter 
jejuni are easily recovered from the environment, including from vectors, sewerage, and 
foodstuffs . Several investigators have attempted to detect H. pylori in water supplies 
both directly and indirectly, but viable H. pylori have not yet been cultured from such 
sources .  H. pylori DNA has been detected in water supplies using the polymerase chain 
reaction (PCR) (Hulten et al. , 1 996) . 
No predominant route of acquisition of H. pylori has been defined. Possibilities include 
oral-oral, fecal-oral and vector transmission (reviewed in Mitchell, 1 999) .  Data in  
support of oral-oral transmission comes from a variety of  studies in which the bacteria 
have been cultured from the mouth (Dunn et al. , 1 997) and detected in saliva and dental 
plaque (Riggio and Lennon, 1 999) using the PCR. There is little data to support the 
transmission via the fecal-oral route, as detection of H. pylori in faeces has proven 
technically difficult, with the exception of one report on the isolation of H. pylori from 
the faeces of children (Thomas et al., 1 992) . The potential for fl ies as vectors for 
enteric disease has been known for decades, and recently the housefly was also shown 
to have the potential for mechanistic transmission of H. pylori (Grubel et al., 1 997). 
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Non-human primates have been shown to be colonised with H. pylori-l ike organisms, 
however, the limited interaction between these animals and humans, makes this an 
unlikely reservoir for human H. pylori. Domestic animals carry gastric Helicobacter­
like organisms (GHLOs) , but most of these have been identified as H. heilmannii 
(Neiger et al . ,  1 998; El-Zaatari et al. , 1 997) . Nevertheless, the identification of H. 
pylori in a colony of domestic cats (Fox et al . ,  1 995) and reports of H. pylori isolated 
from domestic cats suffering from moderate to severe lymphofollicular gastritis (Handt 
et al., 1 995) may have public health implications (see also section 1 .6 . 1 ) .  
1.3.2 Clinical manifestations 
H. pylori infection in humans can lead to a variety of clinical consequences, including 
peptic ulceration, gastric adenocarcinoma and gastric lymphoma. Only a proportion of 
individuals will experience these clinical ly significant disease manifestations .  All  
infected individuals wil l  develop chronic gastriti s ,  usually without any detectable 
adverse symptoms. 
1 .3 .2 .]  Gastritis and peptic ulcer disease 
Primary infection with H. pylori produces an acute gastritis, which is generally 
asymptomatic ,  but may be associated with mild nonspecific upper gastrointestinal 
symptoms. One feature of the acute infection with H. pylori i s  the development of 
hypochlorhydria, which has been observed in volunteers experimentally infected with 
H. pylori (Marshall ,  1 985; Morris and Nicholson, 1 987) ,  and is  accompanied by a 
marked decrease in acid secretion. Despite the persistence of the bacterium, this acute 
hypochlorhydria generall y  resolves within several months. This transient decrease in  
acid secretion is believed to  allow survival of the organism early in the natural history 
of infection (McGowan et al. , 1 996). The normal gastric mucosa contains only a few 
scattered mononuclear cells ,  and lacks lymphoid foll icles and polymorphonuclear 
(PMN) cells (Howden, 1 996) . H. pylori-associated gastritis i s  characterised by an 
abundant inflammatory response (see section 1 .7) and gastric epithelial cell injury. The 
gastric inflammation that results is characterised by a predominance of PMN cells 
infiltrating the gastric antral mucosa. Acute H. pylori infection progresses to a chronic 
gastritis , characterised by an infiltration of monocytes/macrophages, lymphocytes and 
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plasma cells into the l amina propria (Kuipers, 1 997) .  This chronic gastritis often leads 
to atrophic gastritis (Sakagami et al. ,  1 996) ,  which ,  over time, may progress to 
metaplasia, and a decline in the numbers of H. ]JyL)ri infecting the mucosa (McGuigan, 
1 996). 
Other common histopathological findings are a marked reduction or loss of the mucin 
layer and epithelial erosive lesions that range from the focal loss of integrity of a few 
cells to extensive desquamation of the epithelial cell l ayer and exposure of the basal 
membrane to the gastric environment (Ghiara et al . ,  1 995) .  H. pylori infection is 
associated with nearly all duodenal and gastric u lcers formed independently of the 
ingestion of nonsteroidal anti-inflammatory drugs (Blaser, 1 992) .  The estimated l ife­
time risk for peptic ulcer disease in H. pylori infected individuals i s  approximately 1 5% 
(Kuipers , 1 997) . An individual ' s  risk of ulcer disease depends upon the severity of 
gastritis , which is determined by various host and bacteria-related factors. 
Among bacterial factors, diversity among H. pylori strains is believed to contribute to 
the various outcomes of infection. Expression of a vacuolating cytotoxin is more 
common among patients with peptic ulcer disease than among H. pylori-infected 
patients with superficial gastritis alone (Cover et al., 1 990). S imi larly , strains 
harbouring the cag pathogenicity island (cag PAl) are more commonly isolated from 
peptic u lcer patients (Censini et al., 1 996). Gastric epithelial damage induced by a 
vacuolating cyotoxin (VacA) (Telford et al. , 1 994) may result in increased access of 
acid to host tissues or alter the function of gastric parietal cel l s .  In addition,  strains 
possessing the cag PAl are associated with increased epithelial cell IL-8 production and 
increased gastric inflammation (Crabtree et al. , 1 994) leading to further tissue damage 
(see also sections 1 .4.2 and 1 .7. 1 ) . 
Among host factors, most of the evidence focuses on acid production in response to 
infection. Increased acid secretion l imits H. pylori gastritis to the antrum, at the risk of 
duodenal ulcer disease, whereas reduced acid secretion allows a more proximal 
inflammation at the risk of atrophic gastritis, gastric ulcer disease and gastric cancer 
(Kuipers , 1 997) .  The response to infection is determined by host and geographical 
factors including genetic make-up, age at infection, nutritional status and diet (reviewed 
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in Leon-Barua et al. , 1 997). Thus, the outcome of infection, in terms of disease, wil l  
differ both within and between populations, particularly where these are subject to 
widely differing environmental influences (Goldstone et al . ,  1 996). The gastric antrum 
plays  an important role in the regulation of normal gastric secretion (reviewed in 
McGowan et al . ,  1 996). G cells in antral mucosa produce gastrin, which stimulates acid 
secretion and is a growth factor for parietal cells .  D cell s  are also found in the antrum 
and secrete somatostatin which inhibits gastrin release and acid secretion. Individuals 
infected with H. pylori who develop duodenal u lceration have two disturbances of 
gastric function: an increased release of gastrin from the antral mucosa and an 
exaggerated acid response to stimulation by gastriu compared with infected individuals 
without ulceration (McGowan et al. , 1 996). The exaggerated response to gastrin may 
be the result of increased gastrin release from the G cells, possibly in combination with 
a decrease in mucosal somatostatin produced by the D cell s  (Veldhuyzen van zanten 
and Lee, 1 999) . This imbalance leads to an increased duodenal acid load resulting in 
gastric metaplasia in the duodenum that can then be colonised by H. pylori, leading to 
duodenitis and eventually duodenal ulcer (Olbe et al . ,  1 996). 
1 .3 .2 .2 H. pylori associated neoplasia 
Gastric cancer is the second leading cause of cancer worldwide (Forman, 1 998) and is 
the most frequently diagnosed malignancy in Tapan (Pisani et al. ,  1 997) .  An 
epidemiological association between H. pylori and gastric cancer has now been well 
established (reviewed in Goldstone et al. , 1 996 and Queiroz et al . ,  1 999) with infection 
estimated to increase the risk of cancer approximately nine-fold (FOl'man, 1 998) .  
Several retrospective case-control led studies have confirmed a significant  relationship 
between the prevalence of H. pylori antibodies and gastric cancer rates (Forman et al. , 
1 99 1 ;  Parsonnet et ai" 1 99 1 ;  Nomura et al . ,  1 99 1 ;  The Eurogast S tudy Group, 1 993) .  
The natural history of the association between H. pylori and gastric cancer appears to 
involve the acquisition of H. pylori in chi ldhood l eading to l ong term infection 
characterised by chronic gastritis with eventual progression in some individuals to 
atrophic gastritis and gastric mucosal atrophy (Leon-Barua et al . ,  1 997) .  Gastric 
mucosal atrophy is widely considered to be a precursor lesion of the intestinal -type 
gastric cancer (Correa, 1 992), although H. pylori has found to be associated with both 
intestinal and diffuse types of gastric cancer (Hansson et al. , 1 995). Atrophic gastritis is 
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a multifactorial disease. It has been suggested that H. pylori infection, along with 
genetic and environmental factors, including diet and excessive salt intake probably 
combine to exert a long term influence which leads to the progression of gastric 
mucosal atrophy to intestinal metaplasia, dysplasia and finally gastric adenocarcinoma 
(reviewed in Genta and Rugge, 1 999). In addition, chronic H. pylori infection has been 
shown to be responsible for genomic instability in gastric cells, which is generally 
associated with the phenotypic expression of precancerous lesions (Nardone et al . , 
1 999; Solcia et al . ,  1 996), increased apoptosis of epithelial cells (Rudi et al . ,  1 998) and 
increased gas tric cel l  prol iferation (Fan et al. ,  1 996) . The interactions of 
proinflammatory factors and phagocytes leads to the production of a variety of reactive 
oxygen metabolites causing oxidative stress, which also has a proven l ink with 
carcinogenesis (Goldstone et al . ,  1 996) . The accumulated evidence for a role of H. 
pylori infection in gastric cancer led the International Agency for Research on Cancer to 
identify H. pylori as a Class I carcinogen (IARC, 1 994), making H. pylori the first 
bacterial infection recognised as a human carcinogen. 
In addition to the strong statistical association with gastric adenocarcinoma, H. pylori 
infection has been associated with low-grade B cell gastric lymphoma of the mucosa­
associated lymphoid tissue (MALT) (reviewed in Wotherspoon, 1 998  and B ayerdorffer 
et al . ,  1 997) Primary gastric non-Hodgkin ' s  lymphoma comprises 3 -6% of all gastric 
malignant tumours, and are typically high-grade B cell lymphomas, but a significant 
proportion are low grade tumours (Wotherspoon, 1 998) .  Several studies have shown 
that infection with H. pylori i s  associated with the accumulation of MALT and non­
infected individuals rarely have such tissue in their gastric mucosa (Bayerdorffer et al . ,  
1 995 ) .  This lymphoid formation seems to be a universal response to H. pylori 
irrespective of CagA or VacA status (Witherell et al., 1 997). A causal role for H. pylori 
infection in  B cell MALT lymphoma has been well documented and in vitro studies 
have demonstrated that the proliferation of tumor cells in low-grade gastric M ALT 
lymphoma is driven by the presence of the organism and is T cell dependent (Hussell et 
al., 1 993) .  Of particular importance, cl inical studies have shown that, in early lesions, 
eradication of H. pylori can result in tumor regression in 60-92% of cases (Wotherspoon 
et al . ,  1 993 ;  Wotherspoon, 1 998) .  Relapse of the lymphoma has been reported in some 
cases, but this may be associated with recrudescence or reinfection by H. pylori (Stolte 
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1 .3 .2 .3  Extradigestive diseases 
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Several studies have been carried out on the association between H. pylori and a 
miscellany of extradigestive diseases, such as cardiovascular disease (Ellis ,  1 997), 
i mmunological disorders (Gasbarrini et al . ,  1 999) and various other conditions 
i ncluding skin diseases, liver and biliary tract disorders and low growth rate (Raymond 
et al. , 1 994) . Hypochlorhydia resulting from H. pylori infection may also predispose an 
individual to enteric infections, particularly in underdeveloped countries (Mc ColI , 
1 998) .  However, in  many studies the data is confl icting and is complicated by the 
confounding effects of socioeconomic status .  Well designed studies are required to 
clarify the existence of a causal association between H. pylori and other diseases . 
Recent studies have suggested that H. pylori infection may even protect individuals 
from gastroesophageal reflux disease and oesophageal adenocarcinoma (EI-Serag and 
Sonnerberg, 1 998) .  Corpus gastritis has been recently shown to be associated with a 
54% reduction in the risk of reflux oesophagitis (EI-Serag et  al. ,  1 999). 
1 .4 Pathogenesis of H. pylori infection 
H. pylori occupies a unique n iche in the mucus layer overlying the gastric epithelium 
and has adapted to the human stomach mucosa, where it can persist for years or even 
decades by apparently evading the host immune system. H. pylori has to survive amidst 
a strong humoral and cellular immune response and also an extremely hostile 
environment i n  the gastric mucosa. The organism possesses a variety of features 
(reviewed in Labigne and de Reuse, 1 996) which enable it to survive in the stomach, 
and to colonise and persist long-term. 
1.4.1 Colonisation and persistence in the gastric mucosa 
One predominant feature of H. pylori is i ts ability to produce large amounts of the 
enzyme urease, which is an essential determinant of pathogenicity . Involvement of 
urease in the pathogenesis of H. pylori i nfection was first demonstrated by the inability 
of a urease-deficient mutant to colonise the gastric :nucosa of the gnotobiotic piglet and 
mouse (Eaton et al. , 1 99 1 ;  Tsuda et al. , 1 994) . The urease protein of H. pylori is an 
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multimeric enzyme of 600 kDa, composed of two structural subunits (UreA) and 
(UreB) ,  and is located in both the cytoplasm and on the surface of the bacteria (see 
section 1 . 9 .2) .  In addition to the ureA and ureB genes, the entire urease operon of H. 
pylori contains seven accessory genes necessary for the assembly of a functional urease 
enzyme. The high urease activity of H. pylori is responsible for the hydrolysis of urea 
to ammonia and carbon dioxide. Although it is not clear yet how the enzyme acts, the 
ammonia produced by the organism may protect the bacteria and allow its survival in an 
acidic medium by buffering gastric acid or by increasing the local pH of the mucosal 
surface (Clyne et al. , 1 995) .  I t  has also been demonstrated that the high levels of 
ammonia generated by urease activity have toxic effects on cel ls and may break down 
gastric mucous and alter its permeability (Smoot et al., 1 990). 
All gastric Helicobacte r  species are highly motile organisms. Helicobacter species 
exhibit much higher motility in viscous media than any other enteric bacteria such as 
Salmonella or E. coli. Motility has been found to be essential for colonisation of 
intestinal surfaces by many gut pathogens (e .g .  Vibrio cholerae, Salmonella sp .  
Campylobacter jejuni) and H. pylori is no excep[ion. Studies using the gnotobiotic 
piglet as an experimental model have demonstrated that H. pylori relies strongly on its 
high motil i ty to colonise and persist in the epithelium by showing that a nonmotile 
variant of a clinical isolate colonised poorly in contrast to the parental strain (Eaton et 
al . ,  1 996) .  Construction of isogenic flagellar mutants of H. mustelae also demonstrated 
the importance of flagellar motility as a virulence factor for colonisation in the ferret 
stomach (Andrutis et al. ,  1 997) .  The flagellae of H. pylori are unique in that they are 
encased in a membrane-like sheath. The sheath consists of a bilayered membrane that 
contains proteins ,  l ipids and Jipopolysaccharides and closely resembles the outer 
membrane, although differences, especially in fatty acid composition and protein 
patterns exist (Geis et al. , 1 989) . The function of the bacterial flagellar sheath is not 
well understood but it may have a role in flagellum-mediated adhesion to surfaces such 
as gastric epithelial cells .  
H. pylori can interact with gastric epithelial cell s  by attaching to the apical membrane, 
producing an attaching-effacing effect similar to that observed in the small intestine 
with enteropathogenic E. coli (Smoot et al. , 1 993) .  Expression of tissue-specific 
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adhesins is  believed to be necessary for the colonisation of the human gastric epithelium 
by H. pylori. Adherence of H. pylori to the gastric mucosa is a fundamental stage of 
infection and several candidate receptors for H. pylori adhesin proteins have been 
described (reviewed in Logan, 1 996). Like other bacteria which colonise the mucosal 
epithelium, H. pylori adheres to sialic-rich macromolecules that are exposed on the 
mucosal cell membrane and has a specific association with gastric-type epithel ium. 
Several studies have attempted to characterise the haemagglutination (HA) of H. pylori, 
and have identified a 20 kDa surface protein with specificity for a sialic acid receptor 
(Evans et al. , 1 995 ;  Doig et al. ,  1 992) which was later suggested to be a 30 kDa 
flagellar lipoprotein (O'Toole et al. , 1 995) .  A putative Lewis b binding adhesin of H. 
pylori has been identified (lIver et al. ,  1 998) but its importance in mediating attachment 
to the gastric epithelium is still unclear. Once e"tablished in the gastric mucosa, H. 
pylori can then persist and damage the epithelium through a number of viru lence 
determinants. 
1.4.2 Virulence factors 
The discrepancy between the prevalence of infection and occurrence of ulcers may be 
explained by the possible existence of u lcerogenic strains of H. pylori. To date, efforts 
to identify u lcerogenic bacteria have concentrated on those strains which possess the 
vacuolating cytotoxin (vacA) gene (TeIford et al. , 1 994; Phadnis et al. ,  1 994; Schmitt 
and Haas, 1 994) . Approximately 50% of clinical isolates produce active vacuolating 
cytotoxin (Cover et al . ,  1 990) and these isolates appear to correlate with the 
development of ulceration (Tee et al. ,  1 995 ;  Zhang et al. , 1 996) .  Several different  
families of vacA alleles have been identified (Atherton et al. , 1 995) ,  and infection of 
humans with strains containing the type s l m l  vacA alIeles are associated with peptic 
ulceration (Atherton et al. ,  1 997; Rudi et al. , 1 998;  van Doorn et al. ,  1 998;  Donati et al. ,  
1 999) and gastric cancer (Evans et al. , 1 998;  B asso et al . ,  1 998) .  VacA allelic variation 
has been observed in H. pylori isolates from diverse geographical locations (Letley et  
al. , 1 999; Ito et al. , 1 998) .  
H. pylori VacA binds to target cell s  and is slowly internalised (Garner and Cover, 1 996) 
into the cytoplasm, where its biological activity is expressed (de B ernard et al. , 1 998) . 
The interaction of VacA with target cells i s  medhted through high-affinity receptors 
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shown to be necessary for its biological activity (Massari et al . ,  1 998) .  The cytotoxin 
has been shown to be directly responsible for gastric epithelial injury by inducing 
intracellular vacuolation of cell s  (reviewed in Montecucco et  al. , 1 999) and these 
vacuoles are autophagasomal in nature (Harris et al., 1 996). In addition, VacA directly 
inhibits gastric epithelial cell proliferation, one of the main processes involved in gastric 
mucosal healing (Ricci et al. , 1 996) and administration of the purified toxin to mice 
induces gastric mucosal lesions (Telford et al. , 1 994). 
Some H. pylori strains also express a protein of 1 20 kDa, which has been shown to be 
immunogenic in humans infected with H. pylori (Crabtree et al., 1 99 1 ). This antigen is 
expressed by the majority of VacA producing isolates, and consequently the gene was 
designated CagA (cytotoxin-associated gene) (Tummuru et al. , 1 993) but is not required 
for expression of vacuolating toxin activity (Tummuru et al. , 1 994) .  CagA is present in 
88- 1 00% of H. pylori isolates from patients with duodenal u lceration compared with 
50-60% from patients with superficial gastritis alone (Crabtree et al., 1 99 1 ;  Covacci et 
al. , 1 99 3 ;  Cover et  al . ,  1 995) .  CagA+ strains induce higher levels of  cytokine 
production than CagA- strains (Crabtree et al . ,  1 995) but this activity is not due to the 
CagA protein itself, as isogenic cagA- mutants retain the activity (Censini et al. , 1 996) . 
A region upstream of cag A has since been implicated in the enhanced viru lence 
associated with CagA+ strains (Censini et al. , 1 996) . Several characteristics of this 
locus, such as the presence of short repeated sequences and insertion sequences, its 
G+C content (35%) (which is different  to that of the genome (39%» , its prevalence in 
the most virulent strains and its capacity to encode proteins possibly involved in the 
export of virulence determinants (Censini et al., 1 996, see also section 1 .9 .2) has led to 
the consideration that this locus is a so-called pathogenicity island (Hacker et al., 1 997 ; 
Covacci et al . ,  1 997). The locus encodes a region of approximately 40 kilo bases (kb) 
and is referred to as the Cag pathogenicity island (cag PAl) (Censini et al. , 1 996) .  H. 
pylori strains containing the cag PAl are more virulent than those that do not contain it, 
and are more often associated with peptic ulcer (CcllSini et al . ,  1 996) and gastric cancer 
(Blaser et al. , 1 995 ;  Crabtree et al . ,  1 995) although a recent study suggested that the 
presence of the cag PAl cannot reliably predict the outcome of infection (Jenks et al . ,  
1 998). 
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H. pylori isolates have therefore been divided into two categories ; Type I and Type H. 
Type I isolates contain the cag A gene and produce both the CagA and VacA proteins. 
Type H isolates, on the other hand, do not contain the cag A gene and do not produce 
either CagA or VacA (Xiang et al. , 1 995) .  Although some intermediate phenotypes 
exist, Type I strains have been associated with more severe disease . A novel gene, 
recently identified and designated iceA (induced by contact with epithelium) (Peek et 
al., 1998) may also be a major virulent determinant of H. pylori. Although the clinical 
significance of iceA is currently unknown, expression is up-regul ated by contact 
between H. pylori and epithelial cel ls ,  and a recent study confirmed an association 
between iceA and ulcer disease (van Doom et al . ,  1998) .  
1.5 Diagnosis and treatment 
1.5.1 Diagnosis of Helicobacter pylori infection 
It was initially reported in 1 985 that eradication of H. pylori diminished ulcer 
recurrence rates (Goodwin et al. , 1986) . Since then, many advances have been made in 
both the diagnosis and treatment of the bacterium and a variety of tests are now 
available to diagnose H. pylori infection (reviewed in Dunn et al., 1 997) .  B acterial 
culture and histological examination of gastric tissue obtained through endoscopy is the 
gold standard of diagnosis .  Due to the cost and time constraints of culture and 
histology, the urease biopsy test is a quick and inexpensive alternative for diagnosis. 
Noninvasive tests used to diagnose H. pylori infection generally have good sensitivity 
and specificity compared with histological demonstration. Serology has proven to be a 
excellent noninvasive method of diagnosis and a number of accurate enzy me-l inked 
immunosorbent assay tests are available that provide precise and quick diagnosis .  The 
urease breath test (UBT) is recommended for diagnosis after treatment, as serum anti-H. 
pylori antibodies can pers ist for several months fol lowing eradication of the bacterium. 
Urease breath tests are, however, l imited by the avai lab i lity of sophisticated 
instrumentation. PCR may also be useful to diagnose H. pylori with a high degree of 
specificity and sensitivity . PCR has been used to show H. pylori in dental plaques, 
feces and gastric juice (Dunn et al. ,  1997) and can be advantageous in distinguishing 
between reinfection versus recurrence of infection. 
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The publication of the National Institutes of Health Consensus Development 
Conference guidelines on management of H. pylori infection in 1 994 set a precedent 
(NIH, 1 994) . It is now universally accepted that patients with H. pylori infection and 
uncomplicated ulcer disease should receive eradication therapy (Vaira et al. , 1 998) .  
Therapeutic regimens currently used for eradication of H. pylori include both dual and 
triple therapies. Recent evidence suggests that the best treatment regimens include an 
acid-suppressant combined with an antibiotic such as amoxicillin given twice a day for 
two weeks, with or without a second antibiotic (reviewed in Axon, 1 998) .  
Eradication of H. pylori leads to a rapid, complete disappearance of neutrophil s  from 
the gastric mucosa. The number of lymphocytes and plasma cells also decreases, but at 
a much slower rate (Kuipers, 1997) .  The slow disappearance of the mononuclear cell 
infiltrate is paralleled by a reorganisation of the mucosal structure, the reappearance of 
glands, and a slow return to normal acid production. Complete regression of the u lcer 
occurs in approximately 80% of treated individuals .  Eradication of H. pylori leaves the 
patient with about a 2% risk of the ulcer recurring versus at least a 50% chance that the 
u lcer will recur over the next year if H. pylori is not eradicated (Matisko and Thomson ,  
1 995) .  
The increased use of antibiotics in general and the l ack of new compounds in recent 
years has resulted in an increased prevalence of bacterial resistance and treatment 
fai lures with many common infections, and H. pylori infection is no exception. Few 
antibiotics have proven effective in curing H. pylori infection, and the bacteria can 
acquire resistance to these compounds (reviewed in Goodwin, 1 997 and Megraud, 
1998a) .  Resistance to clarithromycin has been found in up to 1 5% of strains in some 
parts of the world, jeopardising its clinical efficacy .  Resistance to metronidazole is 
even more widespread (Megraud, 1 998b) . In addition, antimicrobial therapies continue 
to have a number of l imitations, including poor compliance and adverse side effects. 
The high cost of antimicrobial therapy is also prvhlbitive in many developing countries 
where H. pylori infection is endemic . Immunisation against H. pylori infection may 
therefore be a more viable approach to the management of H. pylori-related diseases 
(Ferrero and Labigne, 1 996) . Of key importance in the development of a vaccine 
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against H. pylori infection is the availability of suitable animal models to test the 
relevant virulence factors for their role in the pathogenesis of infection and to evaluate 
their ability to induce protective immunity for their consideration as candidate vaccine 
components. 
1.6 Helicobacter infection in animals 
1.6.1  Natural infection 
The successful culture of H. pylori stimulated interest in stomach microbiology and in  
the search for a suitable animal model of  Helicobacter infection, numerous studies 
ensued to determine whether gastric ulcer disease occurred naturall y  in animals .  As a 
resul t ,  the genus Helicobacter has expanded rapidly in recent years to include 
organisms that inhabit the gastric mucosa of a number of animal species ranging from 
ferrets to cheetahs (Fox and Lee, 1 996) .  With a few exceptions (see below), the host 
range of naturally occurring H. pylori infection is �estricted to humans and non-human 
primates .  Other species of Helicobacter that tend to be host-specific include H. 
acinonyx, which was originally isolated from captive cheetahs with chronic vomiting 
(Eaton et al. , ] 993) and recently from the gastric mucosa of Sumatran tigers with 
chronic gastritis (Schroder et al. , 1 998) ,  H. mustelae, which naturally infects ferrets 
(Fox et aI. , 1 990) and H. nemestrinae, isolated from the pigtailed macaque (Bronsdon 
and Schoenknecht, 1 988) .  Several species of non-human primates develop chronic 
gastritis in response to natural infection with H. pylori (Dubois et al. , 1 994; Handt et al. ,  
1 997) and are commonly colonised with large gastric organisms given the provisional 
name H. heilmannii (Sol nick et al. ,  1 993) .  H. heilmannii was recently cultured from 
humans (Andersen et al . ,  1 999) and is associated with chronic gastritis, although less 
than 0 .07- 1 .0% of the community are infected with this species (Heilmann and 
Borchard, 1 99 1 ) .  In addi tion, a novel intestinal Helicobacter was recently identified 
from cotton-top Tamarins with chronic colitis and is the first to be identified in New 
World primates (Saunders et al. , 1 999) . 
Domestic pets such as dogs and cats have been found to harbour a variety of spiral 
He licobacte rs in their gastric mucosa (Eaton et a l. , 1 996) .  The main gastric 
Helicobacter species found in these animals are H. heilmannii (also known as H. 
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bizzozeroni) and H. felis (Neiger et al. , 1 998 ,  Eaton et al. , 1 996) but the clinical 
significance and ecology of these species in domestic animals remains unclear (Jalava et 
al. , 1 998 ;  Lecoindre et al . ,  1 997) . In cats and dogs, H. heilmannii has been associated 
with mild to moderate gastritis (Dieterich et al. , 1 998,  Eaton et al . ,  1 996), while others 
have reported little or no gastritis (Non'is et al . ,  1 999). H. heilmannii is also commonly 
found in swine and has been associated with gastric ulcer disease in these animals 
(Queiroz et al., 1 996) . H. canis, implicated in hepatitis in the dog (Fox et al. , 1 996), 
was recently recovered from a kitten with severe diarrhea (Foley et al. ,  1 998) ,  and may 
be of pathological significance. H. pylori infection has been associated with moderate 
to severe gastritis in domestic cats (Handt et al. , 1 995 ,  Fox et aI. , 1 996), but other 
studies have demonstrated that cats are unlikely to be a zoonotic source of H. pylori 
infection in man (EI-Zaatari et al . ,  1 997) . Finally ,  four Helicobacter species (H. 
muridarum, H. rappini, H. hepaticus and H. bilis) have been identified in  the 
gastrointestinal tract of rodents (Mahler et al. , 1 998) and one of these (H. hepaticus) has 
been associated with chronic active hepatitis and liver tumours (Fox et al., 1 996). 
1.6.2 Animal models 
In general , animal models of H. pylori infection have been l imited by their relatively 
poor resemblance to human infections, notably because of the lack of an acute 
neutrophil  response in the mucosa, and peptic ulcers are rarely a consequence of 
infection . Despite this ,  a number of models  exist that have provided valuable 
information on Helicobacter infection and associated pathology (reviewed in  Lee, 
1 998). 
Germ-free piglets are susceptible to colonisation by H. pylori of human origin, and 
colonisation results in a chronic gastritis characterised by lymphocytes and plasma cells 
in the gastric mucosa (Krakowka et al., 1 99 1 ;  Eaton and Krakowka, 1 992). The piglet 
model has been most useful for studies of putative bacterial colonisation factors such as 
urease and flagellum (Eaton et al., 1 996) . Many different species of monkeys have also 
been used to study gastric Helicobacte r  species (Shuto et al. , 1 993 ;  B ronsdon and 
Schoenknecht, 1988) since many are naturally infected with gastric bacteria, including 
H. pylori. Of the species studies, rhesus monkeys appear the most promising because of 
their worldwide availability, moderate size and the large repertoire of immunological 
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reagents avai lable. In addition, the H. pylori-infected rhesus monkey exhibits atrophy, 
microerosions and loss of mucus reminiscent of that seen in humans (Dubois et al. , 
1994) and was recently used for immunisation studies (Dubois et al. ,  1998) .  H. pylori­
induced gastritis has also been successfully induced in specific pathogen free cats (Fox 
et al. , 1995), conventional beagle dogs (Rossi et al., 1999) and guinea pigs (Sturegard et 
al. , 1998 ;  Shomer et al. ,  1998). 
Ferrets are naturally infected with H. mustelae (Fox et al . ,  1990) but there have been no 
previous studies exploring the question of prophylactic vaccination in this model, partly 
due to the almost universal colonisation of ferrets with H. mustelae. In addition, H. 
mustelae i s  genotypically and phenotypicalIy different to H. pylori (MOl'gan et al. , 
199 1 )  and the pattern of colonisation of this organism differs from that observed with 
H. pylori-infected humans (O'Rourke et al . ,  1992) . Despite this, experiments with 
flagellar mutants have provided insights into the importance of motility in colonisation 
(Andrutis et al. , 1997) .  Recent advances have been made in H. pylori research using 
the Mongol ian gerbil as a model (Matsumoto et al., 1997;  Wirth et al . ,  1998) .  This 
small animal model represents one of the few models in which infection reproduces the 
ulceration observed in humans, and more importantly,  it was recently demonstrated that 
long-term infection with H. pylori i n  the Mongol ian gerb i l  i nduces gastric 
adenocarcinoma (Watanabe et al., 1998) . 
Early reports suggested that mice were either not susceptible to colonisation with H. 
pylori or that colonisation was sporadic and not associated with gastritis (Kat'ita et al. , 
199 1 ;  Marchetti et al. , 1 995) .  The discovery that mice were susceptible to infection 
with H. felis and that infection resulted in an activelchronic gastritis that mimicked the 
human pathology (Lee et al. , 1990, 1993) ,  set a precedent for the use of this model in  
numerous studies investigating the pathogcnesi� of  infection, immune response and for 
evaluation of vaccination protocols (see sections 1 .7  and 1 . 8 ) .  The level of gastritis 
appears to be host dependent, with high colonisation rates achieved particularly in 
C57BLl6 mice, resulting in a gastritis resembling the human disease, with some 
neutrophils evident (Mohammadi et al. , 1996). It was recently shown that some strains 
of H. pylori can also be adapted to colonisation of mice (Lee et al. , 1997) and specific 
pathogen free mice (Ferrero et al . ,  1998) .  Use of this standardised model is now 
widespread. The severe gastritis observed in recipient SCID mice also represents an 
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important addition to the growing number of animal models of disease (Eaton et  al. , 
1 999) . Using a variety of the available animal models of Helicobacter infection, the 
feasibil ity of developing both a prophylactic and therapeutic oral vaccine against H. 
pylori infection has been demonstrated. The induction of specific antibodies at mucosal 
sites is most efficiently achieved by local stimulation, therefore an oral vaccine is likely 
to be most effective. An understanding of the immune response to Helicobacter 
infection is an important prerequisite for the development of an effective oral H. pylori 
vaccine and wil l  be discussed in the next section in the context of both human and 
animal results. 
1 .7 The immune response to Helicobacter infection 
H. pylori differs from classical mucosal pathogens in that it does not invade host tissues, 
but rather inhabits a unique niche in the mucus overlaying the gastric epithelium. In 
this ecological niche, the bacteria are protected from the many components of the host' s  
immune system. Despite this ,  the host mounts a vigorous immune response to  H. pylori 
during infection ,  which general ly fai ls to resolve the infection and may in fact 
contribute to disease. The key to understanding these immune responses l ies in the 
complex interplay between the innate and acquired immune systems which combine to 
produce a potent integrated response in an attempt to eliminate the organism. 
1.7.1 Innate immunity 
B acteria entering the gastrointestinal tract can be removed by a number of local 
nonspecific host defense mechanisms. Mucus lining the inner surfaces of the body acts 
as a protective barrier to prevent bacterial adherence to underlying epithelial  cell s  
(Phalipon and S ansonett i ,  1 999) . Bacteria trapped within the mucus can then be 
removed by peristalsis and turnover of epithelial cells and the mucus layer. Bactericidal 
components of body fluids such as acid in the stomach gastric juice are also effective in 
preventing colonisation by microorganisms. However, the virulence factors of H. pylori 
(see section 1 .4) have enabled this bacterium to colonise and persist in  the hostile 
environment of the stomach where it initiates a complex and vigorous host immune 
response. Al though generally ineffective at clearing the infection, the host immune 
response may eliminate H. pylori in some i nstances (Radc1iff et ai. , 1 999). 
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The vertebrate immune response to infection can be separated into two distinct, but 
integrated immune systems; non-specific (innate) and specific (acquired/adaptive) (Lo 
et al. , 1 999) . Both systems play an important role in the defense against Helicobacter 
infection.  Elements of innate immunity include an effective array of host phagocytic 
cell s  such as polymorphonuclear (PMN) neutrophils and macrophages, in addition to 
eosinophils and natural killer cells. Soluble factors such as complement and numerous 
acute phase proteins are also indispensable lines of defense. These factors combined 
enable the host to effectively distinguish between innocuous and potentially noxious 
substances according to their carbohydrate signatures. Recognition of carbohydrate 
structures occurs via receptors on host cell s  such as surface epithel ial cells and the 
effector cells of the innate immune system. The receptor specificity is germline 
encoded and may have evolved because particular carbohydrate structures such as LPS 
are common constituents of bacterial cell walls and have structures distinct from 
eukaryotic cell surfaces (Fearon and Locksley, 1 996). 
Recognition of invading pathogens in this way results in the induction of signals that 
activate the components of the innate immune system. Chronic H. pylori infection is 
characterised by an infiltratration of polymorphol1l.lclear (PMN) and mononuclear cell s  
in to the  epithelium and underlying lamina propria (Figure 1 . 1 ) .  Neutrophils are an 
important component of the inflammatory response induced by H. pylori infection 
(Crabtree et al., 1 993) .  Since H. pylori is a non-invasive bacteria, it has been proposed 
that protein components and secreted products of the bacterium traversing the epithelial 
barrier may, by direct or indirect action on leukocytes, lead to their activation and 
enhanced local migration into mucosal tissue. H. pylori components with chemotactic 
activity for monocytes and neutrophils (Mooney et al . ,  1 99 1 ;  Craig et al. , 1 992 ; Broom 
et al . ,  1992) have been found in the lamina propria of infected patients (Mai et aI. , 
1 992) . Activation of PMNs along with enhanced synthesis of various cytokines and 
increased secretion of reactive and monocytes results in increased expression of the 
surface molecule HLA-DR, oxygen metabolites (ROMs) (Mai et al. ,  1 99 1 ;  Nielsen and 
Anderson, 1 992b) . H. pylori produces antiproteases that confer resistance to proteolytic 
attack by invading neutrophils (Takemura et al. , 1 996). ROMS are highly toxic and can 
cause damage to cellular proteins, carbohydrates and DNA, however, H. pylori appears 
resistant to ROM toxicity, possibly through the production of superoxide dismutase 
(Spiegelhalder et al., 1 993;  Gotz et al. , 1 996). Release of ROMs and other 
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Figure 1 . 1 :  Schematic representation of the host immune response to H. pyLori 
infection. (a) H. pyLori infection leads to the presence of bacteria in the mucus of the 
gastric lumen (b) Upon contact with the epithelium, PAl containing bacteria induce the 
epithelial cells , through signaling pathways, to synthesise and release lL-8 ( c) lL-8 is 
strongly chemotactic for PMN cells which release damaging ROMS and proteases in an 
attempt to kill the bacteria (d) Contact with the epithelium also leads to the release of H. 
pyLori virulence factors ego VacA, which induce epithelial damage (e) H. pyLori antigens 
that cross the epithelial layer are able to activate macrophages to release several pro­
inflammatory cytokines such as lL-8 ,  lL-6, lL- l S and possibly lL- 1 2  (f) lL- 1 2  is 
important for polarising the CD4+ T helper response to a predominant Th 1 phenotype 
(g) H. pylori antigens may also drive an antigen-specific Th 1 response at the site of 
infection (h) Thl cells release pro-inflammatory cytokines such as lFN-y and TNF-a 
which may contribute to the maintenance of gastritis ( i) B cells differentiate into plasma 
cells and produce both local 19G and slgA antibodies at the site of infection (adapted 
from Telford et al.,  1 997). 
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proteolytic enzymes such as myeloperoxidase (Noorgaard et al . ,  1 995) from stimulated 
PMN cells may then contribute to tissue damage characteristic of chronic gastric 
inflammatory diseases (Nielsen and Anderson, 1 992a; Hansen et al. ,  1 999 ; Davies e t  
al . ,  1 994) . This theory is supported by  the finding that H. pylori strains capable of  
activating neutrophils  are found more often in peptic u lcer patients than in  those with 
chronic gastritis (Rautelin et al., 1 993;  Nielsen and Anderson, 1 995) and these strains 
are associated with more severe inflammation (Rautelin et al. , 1 996). In addition, H. 
pylori components induce nitric oxide synthase production by macrophages which may 
also contribute to int1ammation and possibly malignant transformation in the gastric 
mucosa (Wilson et al. , 1 996). 
S timulation of leukocytes also induces the upregulation and activation of integrins,  
which enable the leukocytes to adhere to the endo�helial cells of the vessel wall before 
migrating into tissues (Baggiolini, 1 998). Upregulation of the P2-integrin CD 1 1  blCD 1 8  
glycoprotein complex expressed by activated neutrophils has been shown to be an 
important mediator of neutrophil adhesion to endothelial cel l s  in H. pylori-induced 
inflammation (Y oshida et al. , 1 993;  Enders et al. , 1 995) .  However, others have found 
no difference in the P2-integrin upregulation on neutrophils and monocytes between H. 
pylori strains from ulcer patients and those from asymptomatic patients (Hansen et al. , 
1 999) . The ability of H. pylori products to attract and activate monocytes has been 
attributed to H. pylori products such as neutrophil-activating protein (HP-NAP) (Evans 
et al . ,  1 995) ,  urease (Harris et al. , 1 996), porins (Tufano et al. , 1 994) and LPS (Perez­
Perez et al. , 1 995) .  The LPS of H. pylori, although capable of activating macrophages, 
exhibits much lower biological activity compared to other gram-negative bacteria 
(Perez-Perez et al. , 1 995) and may represent a natural selection for strains that do not 
evoke a detrimental strong int1ammatory response (Kirkland et al. , 1 997) .  S tudies also 
show that H. pylori whole bacteria evoke a strong non-MHC restricted cel lu lar 
cytotoxic response by NK cel ls (Tarkkanen et al. , 1 993) .  Following the recruitment of 
granu locytes and monocytes to the s i te of infection,  proinfl ammatory or 
immunoregulatory cytokines are released from these cel l s .  The release of  these 
cytokines induces the acute phase response, enhancing the microbial functions of the 
host ' s  immune cell s  to H. pylori, resulting in the recruitment of more PMN cel ls and 
monocytes/macrophages (Genta, 1 997) . 
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The local production of cytokines plays an important role in the regulation of the PMN 
cell responses to H. pylori infection. H. pylori urease and recombinant urease is  
capable of activating mucosal macrophages and stimulating them to produce IL- 1 �, lL-
6, IL-8 and tumor necrosis factor-alpha (TNF-a) (Harris et al. , 1 996;  Harris et al. , 
1 998) .  Mucosal biopsies from H. pylori infected patients also show significantly higher 
levels of lL- l �, IL-6, TNF-a and lL-8 (Crabtree et aI. ,  1 99 1 ) .  TNF-a and lL-8 exhibit 
chemtoactic and proinflammatory activities that amplify the recruitment and activation 
of PMN cells (Mai et al., 1 992) as well as T cell chemotaxis. Gastric mucosal tissue 
from H. pylori infected individuals synthesizes IL-8 (Crabtree et al., 1 994) and studies 
using gastric epithelial cell l ines showed upregulation of IL-8 expression in H. pylori­
stimulated cells (Sharma et al. , 1 995) . In addition, l ive bacteria stimulate IL-8 
expression in gastric epithel ial cell s  to a greater degree than do killed bacteria, 
indicating that cellular components produced by live H. pylori are required for the 
induction of cytokine production by the epithelial mucosa (Crowe et al. ,  1 995, Huang et 
al., 1 995) .  
Strain s  of H. pylori that harbour the cag PAl (section 1 .4 .2) (CagA+) induce higher 
levels of IL-8 production (Crabtree et aI. ,  1 995;  Huang et al. ,  1 995;  Yamaoka et aI. ,  
1 996) .  A number o f  H. pylori gene products encoded in this PAl, including the pieB 
gene product, are required for IL-8 expression, since mutations in these genes abrogates 
this IL-8 response (Tummuru et al. , 1 995;  Censini et al. ,  1 996). Recently, the human 
transcription factor, nuclear factor-kappa B (NF-kB) ,  which regulates transcription of 
genes encoding cytokines such as IL- 1 ,  6 ,  8 and TNF-a, was shown to be activated by 
exposure of gastric epithelial cell s  to H. pylori (Munzenmaier et al. ,  1 997; Masamune et 
al. , 1 999) and this correlated with the abi lity of H. pylori to elicit IL-8 induction 
(Sharma et al., 1 998) .  An alternative pathway for IL-8 induction may also occur via H. 
pylori binding to gastric epithelial cells and induction of tyrosine phosphorylation of 
host cell proteins adjacent to the site of bacterial adherence (Segal et al. , 1 997). More 
recently, proteins encoded by genes in the cag PAl were shown to be necessary for NF­
kB activation (Glocker et al. , 1 998) and also tyrosine kinase-dependent transcription of 
IL-8 in gastric epithelial cel ls  CLi et al. , 1 999) . It has been proposed that these PAl 
encoded proteins form a surface structure which acts as the NF-kB-inducing agent 
CGlocker et al. , 1 998) . Indeed, other studies have shown that direct contact of H. pylori 
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with epithelial  cel ls  i s  a possible prerequisite for stimulation of IL-8 secretion and 
requires an intact bacterial membrane conformation (Reider et al., 1 997). 
A consequence of the release of cytokines i s  the i nduction of infl ammation and 
disruption of epithelial cell junctions which favours translocation of the bacteria across 
the mucosal barrier of the stomach (China and Goffaux, 1 999) . Gastritis can occur in 
the absence of T and B cel l s  fol lowing infection of immunodeficient mice w ith 
Helicobacter feUs (Blanchard et al. , 1 995) suggesting that at least some of the changes 
in patients infected with H. pylori result  from these nonspecific infl ammatory 
responses. However, more recent reports have now shown that several mouse strains ,  
i ncluding the strain used in above study , exhibit only mi ld gastritis fol lowing 
Helicobacter infection anyway (Roth et al . ,  1 999; Eaton et aI . ,  1 999) . Nevertheless, 
recent studies suggest that mucosal cytokine responses are responsible for the acute 
infl ammatory response fol lowing infection, and play an important role in preventing 
colonisation by mucosal pathogens (Svanborg et al. , 1 999). During this early phase, the 
immune system attempts to eliminate and control infection using innate i nflammatory 
effector cell s  (Murail le and Leo, 1 998) .  S ignals provided by the components of the 
innate immune system then provide i nstructions to enable the acquired immune 
response to select appropriate antigens and strategies for bacterial el imination (Ogra et 
al., 1 997). 
1.7.2 Acquired immunity 
In addition to phagocytic cel l s ,  the presence of T lymphocytes and plasma cel l s  in the 
inflammatory infi ltrate in H. pylori gastritis indicates that antigen-specific cellu lar and 
antibody-mediated immune mechanisms are important. Acquired or adaptive immunity 
is mediated by T and B lymphocytes. In contrast to those of the innate immune cell s ,  
the specificities of Jymphocyte receptors are generated by somatic mechanisms which 
results in a flexible, almost infinitely adaptable  system (Fearon and Locks1ey, 1 996). 
Recent studies using immunodeficient mice lacking B or T cell s  have demonstrated a 
crucial  role  for the acquired immune response to Helicobacter infection i n  the 
development of gastric epithel ial pathology (Roth et al . ,  1 999; Eaton et al. ,  1 999) . 
Understanding the nature of these responses i s  l ikely to aid i n  the development of an 
effective vaccine against H. pylori infection. 
24 
- ------ - - - - -
Chapter 1 
1 .7 .2 . 1 Cell-mediated immunity 
Intestinal epithelium contain microfold epithelial (M) cel l s  that are speciali sed i n  the 
delivery of material from the lumen to the underlying antigen-presenting cel l s  (APC) .  
Presentation of antigen to T cells occurs within mucosa-associated lymphoid fol licles, 
such as the Peyer' s Patches (PP). Stimulated T and B lymphocytes exit the PP and seed 
other areas of the intestine and mucosal tissues (Kaiserlian, 1 999) . This model implies 
that lymphocytes from PP also seed the stomach, however there is no direct evidence 
that this occurs (Ernst et al. , 1 997) . The mechanism of antigen uptake in the absence of 
PP and M cells  in the gastric mucosa is unknown and it is not clear if gastric T cells 
arise as a result of local expansion or recruitment from other inductive sites such as PP. 
If. pylori infection results in  the development of organised gastric lymphoid fol l icles 
(see section 1 . 3) which decline after eradication of H. pylori, suggesting that specific H. 
pylori antigenic stimulation is required (Hussel et al. ,  1 993) .  Accessory cell s  i n  this 
lymphoid tissue may facilitate antigen delivery from the gastric lumen. The mechanism 
of initial antigen uptake from the gastric lumen i s  not well understood, but could 
involve passive absorption of soluble products, direct epithelial endocytosis of shed 
bacterial antigens or passage of antigen through disrupted epitheli al tight junctions 
(Crabtree, 1 996). 
T lymphocytes can be broadly divided into two general classes which are distinguished 
by the presence of a surface glycoprotein, either CDS or CD4. CDS+ T cel l s ,  or 
cytotoxic T lymphocytes (CTL), recognise epitopes presented on the cell surface by 
major histocompatablility complex (MHC) class I molecules , and recognition results in  
lys is  of the target cell (Whitton, 1 995) .  CD4+ T cells ,  or  T helper (Th) lymphocytes, 
recognise epitopes presented on the surface by MHC class II molecules, and orchestrate 
the immune response by promoting antibody production by B cel ls ,  intracellular kil l ing 
by macrophages and clonal expansion of CTLs (Fearon and Locksley, 1 996) . The 
accumulation of T cells in the gastric mucosa during infection with H. pylori indicates 
that T cells are activated in vivo (Ernst et al. , 1 995) .  Although epithelial cells do not 
normally express HLA-DR (Type II MHC), chronic gastritis is associated with an 
increase in epithelial HLA-DR expression (Valnes t:t al., 1 990) and epithelial cel ls from 
H. pylori infected patients express B7 -2 (Ye et al. , 1 997). The interactions of B7- 1 
(CDSO) or B7-2 (CDS6) on APCs with CD2S on T cells is required for the activation of 
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T helper cell s  (Swain, 1 999). Gastric epithelial cell s  therefore appear to be capable  of 
internalising and processing antigen, as wel l  as stimulating CD4+ T cells (Crowe et al., 
1 996) . IFN-y, which induces the de-novo expression of MHC c lass II and co­
expression of B - 1  (CD80) and B7-2 (CD86) on gastric epithelial cel l s ,  enabling them to 
act as antigen-presenting cell s  (Kaiserlian, 1 999), is known to be produced during H. 
pylori infection (Moss et al. , 1 994; Karttunen et al. , 1 995; Yamaoka et al. , 1 996). 
Peptides presented by MHC class I antigen presenting cel l s  derive from proteins 
synthesised in the cell (endogenous) ,  whereas peptides presented by class I I  APCs 
derive from proteins which have been taken up by the APC, for example,  via 
phagocytosis (exogenous) (Nandi et al. , 1 998) .  As most bacteria, including H. pylori, 
exist and replicate extracellularly, they do not effectively enter the class I pathway, and 
generally fai l  to induce an effective CD8+ T cell response. CD8+ T cell s  are therefore 
most effective in eradicating intracellular infections. CD4+ T helper cell s  play a pivotal 
role in antigen-specific immune responses to H. pylori during i nfection . When 
compared with normal mucosa, H. pylori infected samples have increased numbers of 
predominantly CD4+ T cell s  (Bamford et al . ,  1 998) An increase in CD4+, but not 
CD8+, T cell s  correlates with i ncreasing grades of gastritis and density of colonisation 
(Hatz et al. , 1 996) .  In addition, H. pylori specific CD4+ T lymphocyte c lones have 
been obtained from peripheral blood and gastric biopsies of infected patients (Di 
Tommaso et al. , 1 995; D 'Elios et al. , 1 997) . The T cell s  infi ltrating the l amina propria 
during H. pylori infection are predominantly of the CD45RO+ phenotype, a marker for 
antigen-committed cells, and correlate with enhanced HLA-DR expression on gastric 
epithelial cells (Valnes et al. , 1 990) . 
B y  producing different cytokines ,  CD4+ T helper lymphocytes direct the most 
appropriate counteraction against invading bacteria (Daugel at and Kaufmann, 1 996). 
B ased on experiments in mice, T helper cel l s  can be c lassified into two main types, Th l 
and Th2, according to their cytokine profiles. Although this functional dichotomy may 
not be so c lear-cut in  humans ,  in general Th ! lymphocytes produce IFN-y, TNF-a and 
lL-2, which promote cel l-mediated immune responses, whereas Th2 lymphocytes 
produce IL-4, IL-5 ,  IL-6 and IL- l O  cytokines and are mainly responsible for B cel l  
development and antibody production, including mucosal IgA responses (Lindholm et 
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al. , 1 998) .  Th 1 and Th2 cell s  derive from a common precursor cell (ThO) and their 
differentiation is regulated by cytokines present in the local environment. The 
cytokines necessary for Th 1 or Th2 differentiation are IL- 1 2  and IL-4 respectively 
(Swain,  1 999) .  Therefore, one of the most important mechanisms allowing for direct 
communication between the non-specific and specific immune responses is the local 
production of cytokines or chemokines (Lo et al. , 1 999) . 
Current dogma suggests that ideally mucosal immune responses should select for a Th2 
response, resulting in increased production of secretory immunoglobulin A (sIgA) .  
Paradoxically, during H. pylori infection, Th l responses appear to predominate (Emst e t  
al. , 1 997) .  IFN-y - producing cell s  are increased i n  number during gastritis ,  whereas 
IL-4 - secreting cell s  are not (Karttunen et al. , 1 995) and H. pylori can stimulate the 
production of IFN-y by lymphocytes i solated from gastric tissue (Fan et al . ,  1 994) and 
peripheral b lood (Tarkannen et al. , 1 993) .  T-cell clones isolated from biopsy samples 
taken from H. pylori-infected patients display a cytokine secretion profile typical of Th 1 
cel ls ,  producing IFN-y and TNF-a, but not IL4 or IL5 (Bamford et al. , 1 998 ;  Sommer et 
al. , 1 998 ;  Lindholm et  al . ,  1 998) .  D 'Elios et al. ,  ( 1 997) demonstrated that a large 
proportion of the CD4+ T cell c lones generated from the gastric mucosa of u lcer 
patients were specific for H. pylori antigens and that most of them (80%) exhibited a 
Th l - like cytokine profile, characterised by high levels of IFN-y and TNF-a . In  
contrast, T cell clones from patients with mild gastritis show a more balanced Th l rrhO 
ratio. There was no evidence of a Th2 response in either case. IL- 1 2  is thought to play 
an important role in host responses to bacterial infections by inducing the production of 
IFN-y by natural killer (NK) cells and T cel ls ,  and in association with IFN-y, promoting 
the differentiation of nai've Th cells into the Th 1 phenotype (Murail le and Leo, 1 998) .  
Haeberle et al. ( 1 997) demonstrated that l ive H. pylori selectively stimulated the 
induction of IL- 1 2  and Th 1 cells in vitro and a recent study demonstrated that IL- 1 2  
was increased in H. pylori infected individual s  compared with non-infected patients 
with the same degree of gastritis (Bauditz et al. , 1 999) indicating a pivotal role for this 
cytokine in gastric inflammation. 
The presence of Th l -like cel ls  in the gastric mucosa implies that cell-mediated immune 
responses are i nduced during infection with H. pylori. Given that H. pylori is an 
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extracellular infection, and that the biological niche of the organism is the gastric 
lumen ,  a cell-mediated immune response is unlikely to be protective. This notion is 
supported by the fact that H. pylori infection persists for the life of the host. Excessive 
cell-mediated immune responses in close proximity to the epithelium could perturb the 
function of gastric epithelial cells (Bamford et al. ,  1 998)  and induce chronic 
inflammation through the production of IFN-y, which has been shown to i nduce 
apoptosis in gastric epithelial cells (Fan et al. , 1 998) . Murine studies also show that a 
Th 1 response is associated with gastric pathology (Mohammadi et al. , 1 997; Roth et al . ,  
1 999; Eaton et al. , 1 999) .  Indeed, in vivo neutralisation of IFN-y with an anti-IFN-y 
monoclonal antibody significantly reduces gastritis in H. felts infected mice 
(Mohammadi et  al. , 1 996) (see also section 1 .8) .  
In  contrast to reports supporting the induction of cell-mediated immune (CM!) 
responses by H. pylori, early studies indicated that H. pylori may even suppress CMI 
responses, by down-regu lating Th 1 responses and enhancing the Th2 response 
(reviewed in Fan et al. , 1 996) . Predominant Th2 responses have previously been 
associated with persistence of chronic infections (Daugelat and Kaufmann, 1 996), and 
is consistent with H. pylori being a "slow" bacterial pathogen (Blaser, 1 993) .  In vitro 
studies have suggested that H. pylori possesses some immunosuppressive actions, 
which may enable the bacteria to either evade bacterial clearance or to avoid excessive 
inflammation-mediated damage to the host (Fan et al . , 1 996) . Reports have 
demonstrated that H. pylori inhibits mitogen-induced proliferation of peripheral blood 
mononuclear cell s  (PBMCs) (Knipp et al. , 1 993; Birkholz et al. , 1 993) . H. pylori whole 
cell preparations induce lower proliferative responses by PBMCs from H. pylori 
infected versus non-infected patients (Karttunen et al. , 1 99 1 ,  1 995; Fan et al. ,  1 994; 
Sharma et al . ,  1 994; di Tommaso et al. , 1 995 ;  Chmiela et al. , 1 996). 
Increased levels of IL- l O  have also been reported in H. pylori infected mucosa (Bodger 
et al. ,  1 997; Yamaoka et al. ,  1 997 ; Bauditz et al. ,  1 999). IL- l O  is a potent inhibitor of 
phagocyte and lymphocyte responses and is produced by a variety of human cells, 
particularly activated macrophages (Henderson m;d Wilson, 1 995) .  Decreased IFN-y 
production by blood and gastric lymphocytes in H. pylori infected compared to non­
infected individuals has also been demonstrated (Fan et al. , 1 994), in  addition to 
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i ncreased IL-6 in supernatants from cultured PBMCs (Fan et al. , 1 996) and gastric 
tissue (Crabtree et al . ,  1 99 1 ) . H. pylori may also i!lterfere with protective immunity by 
acting on APCs through the release of VacA, which has recently been show to impair 
antigen processing and therefore subsequent stimulation of CD4+ T cells (Molinari et 
al. , 1 998 ) .  This immune down-regulation may l imit tissue damage caused by 
inflammation, but may also contribute to the fai lure of the immune response to clear the 
infection (Bodger and Crabtree, 1 998).  
1 .7 .2 .2  Antibody-mediated immunity 
Although a Th 1 response predominates ,  humoral immunity also plays a role i n  the 
immune defense against H. pylori infection. Gastric T cell  clones express helper 
function for B cell proliferation and immunoglobulin secretion that is antigen-dependent 
(D'Elios et al . ,  1 997). A study examining gastric mucosal humoral responses found H. 
pylori specific B cells in  infected but not non-infected individuals (Mattsson et al. , 
1 998) .  H. pylori specific IgA and IgM antibodies are detectable in gastric juice (Sobala 
et al. , 1 99 1 )  and there is local production of H. pylori specific IgG and IgA (Crabtree et 
al. , 1 99 1 ) . IgA is the predominant humoral effector at mucosal surfaces and can 
mediate host defenses within luminal secretions, the epithelium and the lamina propria 
(Bouvet and Fischetti ,  1 999).  In the mucosa, IgA molecules are predominantly 
produced as dimers, which are bound to secretory component (SC) and transported in 
endocytotic vesicles to the apical side of epithelial cell s .  Subsequent proteolytic 
c leavage of SC results in the release of secretory IgA (s-IgA) (Corthesy and 
Kraehenbuhl ,  1 999). Conflicting results regarding the presence of SC in the healthy 
stomach have been publ ished, but an association between gastritis and increased 
expression of SC by gastric epithel ial cells has been reported (Ahlstedt et al. , 1 999). 
Mucosal IgA is l ikely to be important in inhibiting antigen uptake, blocking bacterial 
adherence and motil ity of the organism, and also in toxin neutralisation (Russell et al. , 
1 999). 
Gastric IgA antibodies can inhibit the vacuolation of epithelial cells induced by the 
cytotoxin in vitro (Figura and Crabtree, 1 994) . In a study of the gastric mucosal IgA 
response to H. pylori infection, IgA antibodies were found to recognise several H. 
pylori antigens, in  particular the 1 20 kDa antigen later described as the cytotoxin-
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associated protein (CagA) (Crabtree et al. , 1 99 1 ) . Nevertheless, H. pylori infection can 
persist for the l ife of the host, indicating that IgA-related defense mechanisms are not 
effective in eradicating H. pylori infection. In a study of IgA-deficient individuals, l ack 
of sIgA did not seem to have any major effect on the establ ishment of infection, arguing 
against a pivotal role of IgA in defense of H. pylori infection (Bogstedt et al . ,  1 996).  In 
addition, a more recent study found no difference in SC expression or IgA positive cel l s  
between H. pylori asymptomatic and u lcer patients, implying that l ocal sIgA does not 
influence the outcome of infection (AhlstedL ef al . ,  1 999) .  Under physiological 
conditions, IgA has poor or no complement activating activity (Russe l l  et al. , 1 999), but 
complement activation has recently been suggested as being important in H. pylori 
gastritis perhaps mediated through mucosal IgG antibodies (Berstad et al. ,  1 997) .  
Chronic infection with H. pylori i s  also associated with the development of  specific 
local and systemic IgG antibody responses to the bacterium (Tinnert et  al. , 1 997) . 
Serum IgG antibodies are important components of the humoral response of the host to 
H. pylori infection. Serum IgG antibodies from H. pylori infected individuals enhances 
complement-mediated phagocytosis of H. pylori by PMN cells (Tos! and Czinn, 1 990) . 
Immunohistochemistry has demonstrated in situ coating of H. pylori l in ing the 
epithel ium with host antibodies (Wyatt et al. ,  1 986)  and activated complement 
components (Berstad et  al. , 1 997), however the role of such antibodies in vivo is  unclear 
(Wyatt et al. , 1 986).  Early in vitro studies suggested that H. pylori can activate the 
c lassic pathway of complement, even in the absence of antibody (Bernatowska et al. , 
1 989) .  The presence of activated C3b on H. pylori in the gastric mucosa indicates 
complement activation, but whether this involves the c lassical or alternative pathway 
has yet to be determined. The presence of antibody-coated H. pylori (Wyatt et al. , 
1 986) and the possible involvement of LPS in the initiation of the alternative pathway 
(Kuby, 1 997),  suggests that both complement activation pathways may be involved i n  
H. pylori associated gastritis .  Whether complement activation is involved in host 
defense mechanisms or whether it mediates the tissue damage associated with gastritis 
remains unclear (Ferrero et al. ,  1 997). Complement activation may contribute to the 
neutrophi l ic response in the gastric mucosa as the presence of activated C3b i s  
significantly related to neutrophil infi ltration in vivo (Berstad e t  al . ,  1 997) .  Urease also 
exhibits immunomodulatory functions by inhibiting opsonisation of H. pylori in  the 
presence of low concentrations of H. pylori specific antibodies (Rokita et al . ,  1 998) .  
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1 .7 .2 .3 Autoimmunity 
In addition to a specific local humoral response to the bacterium, infection with H. 
pylori also results in a humoral response against autoantigens. An autoimmune 
response has long been postulated to play a role in gastritis (reviewed in Appelmelk et 
al., 1 997). Serum samples from most infected patients specifically cross-react with the 
gastric mucosa, but not with other tissues (Negrini et al. ,  1 99 1 ) . In addition, an H. 
pylori specific monoclonal antibody shown to be cross reactive with both human and 
murine gastric mucosa caused stomach pathology in mice (Negrini et al., 1 996). The 
O-polysaccharide chains of LPS from some H. pylori strains exhibit mimicry of Lewis x 
and Lewis y blood group antigens (Wang et al. , 1 999) found in the gastric mucosa 
(Appelmelk et al. , 1 996). The expression of Lewis antigens by H. pylori can induce an 
immune response when antibodies recognise gastric glycoprotein targets, thus causing 
autoimmune inflammation (Monteiro et  al. , 1 998) .  This autoimmune mechanism is 
thought to lead to cell injury and contribute to gastritis (Appelmelk et al. , 1 997). Wirth 
et al. , ( 1 997) have suggested that the relative expression of Lewis  x and Lewis y 
corresponds to the host Lewis phenotype, indicating selection for host-adapted strains. 
By analogy with mycobacterial and chlamydial heat shock proteins (HSPs) ,  H. pylori 
HSPs may also contribute to gastric injury by stimulating T cell s  that cross react with 
similar determinants on the endogenous HSPs from stressed host cell s .  Antibodies 
against the heat shock protein HspB, found in infected patients, display cross-reactivity 
with the human homologue heat shock protein (Hsp60) (Kansau and Labigne, 1 996). A 
potential role of HspB in the development of gastritis was also suggested in a study in 
which a monoclonal antibody raised against HspB also reacted with gastric epithelial 
cell s ,  suggesting the presence of a common epitope (Yamaguchi et al. , 1 997). Binding 
of T cells to MHC class Il, B - l fB-7 and autoantigen presented by gastric epithelial cell s  
in  H. pylori gastritis, could lead to the activation and differentiation of the autoreactive 
B cells detected in H. pylori infected patients (Faller et al. , 1 997; reviewed in Kirchner 
et al. ,  1 998) .  
1 .8 Vaccination against H. pylori infection 
The feasibility of a prophylactic vaccination against Helicobacter infection was initially 
demonstrated by experiments in  which administration of H. pylori sonicates, together 
with mucosal adjuvant cholera toxin (CT) induced the production of specific serum and 
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gastrointestinal IgG and IgA (Czinn and Nedrud, 1 99 1 ) .  Subsequent studies 
demonstrated that administration of H. felis sonicate given concurrently with CT 
protects mice against experimental infection with H. felis (Chen et al. ,  1 992, 1 993 ;  Lee 
and Chen, 1 994) and protection was long-term (Radcliff et al. ,  1 996). In addition, the 
feasibi l i ty of a therapeutic immunisation against H. felis infection in mice was 
establ ished w hen whole cell sonicate (Doidge et al. ,  1 994) or urease B subunit 
(Corthesy-Theulaz et al., 1 995) ,  along with CT, was found to eradicate the bacteria in 
50% of animals experimentally infected with H. felis. More recently ,  therapeutic 
immunisation with recombinant VacA or CagA against H. pylori infection in mice was 
demonstrated (Ghiara et al., ] 997) . H. pylori ure?se alone is wel l  tolerated in humans 
(Kreiss et al. , 1 996) and administration of urease and E. coli heat-l abile toxin (LT) to 
infected volunteers significantly decreases bacterial load but with no cure of infection. 
Therapeutic immunisation against H. mustelae in naturally infected ferrets has also been 
demonstrated (Cuenca et al. ,  1 996) . 
There is now much data available to support the development of a vaccine against H. 
pylori infection , and significant advances have been made in  the identification of 
protective antigens, experimental adjuvants, delivery vehicles and the optimal route of 
administration. Only the most relevant advances in vaccine development are described 
below, as it is beyond the scope of this thesis to review al l  of the l i terature related to this 
topic, and a number of recent reviews are avail able (Blanchard et al. ,  1 999; Rijpkema, 
1 999;  Vyas and S ihorkar, 1 999 ;  Kleanthous et al . ,  1 998 ) .  The mechanisms of 
protective immunity are discussed in more detail .  
A number of purified or recombinant H. pylori antigens including the urease B subunit 
(Ferrero et al . ,  1 994; Michetti et al . ,  1 994), VacA (Marchetti et al. , 1 995) ,  catalase 
(Radc1iff et al. , 1 997) and GroES homo log (Fen'ero et al . ,  1 995) ,  have been shown to 
have protective properties in murine (Mm'chetti et al . ,  1 995) and non human primate 
(Dubois  et al. , 1 998)  models  of H. pylori infection.  Oral immunisation with a 
combination of recombinant HspA and urease in mice achieved l OO% protection 
against challenge with H. felis (Ferrero et al., 1 995) .  The administration of H. pylori 
antigens for protective immunisation requires a mucosal adjuvant such as CT or LT 
(reviewed in E lson and Dertzbaugh, 1 999), but the toxicity of these precludes their use 
in humans.  Recently, oral (Marchetti et al., 1 998) and intranasal (Kleanthous et al. , 
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1 998) immunisation with purified H. pylori antigens (native and recombinant VacA, 
urease and CagA) co-administered with a non-toxic mutant of LT protected mice 
against H. pylori infection. Corthesy-Theulaz et al. , ( 1 998) have used an attenuated 
strain of Salmonella typhimurium expressing H. pylori urease A and B subunits to 
achieve protective immunity against challenge with H. pylori in mice, and may 
represent an alternative approach to mucosal adjuvants. Systemic vaccination of mice 
with H. pylori antigens ,  using aluminum hydroxide as an adjuvant, protected mice 
against challenge with H. pylori (Nedrud et al., 1 999) demonstrating that an effective 
adjuvant already approved for use in humans can be used. 
The induction of protective immunity against invading pathogens requues the 
stimulation of a specific type of immune response. As discussed above, the type of 
immune response mounted is dependent upon the local cytokine environment and the 
nature of the T-cel l  repertoire (Th l ffh2) induced. During infection with H. pylori, Th l 
cell s  predominate (see section 1 .7 .2) .  Studies using the H felis mouse model have also 
demonstrated the induction of Th 1 phenotype in mice infected with H. felis 
(Mohammadi et  al. , 1 996). In contrast, mice immunised against H. felis appear to 
develop a Th2-type response (Mohammadi et al . ,  1 997 ; Saldinger et al . , 1 998 ;  van 
Doom et al . ,  1 999). Observations supporting a role for Th2 based immunity to 
Helicobacter infection are consistent with the known activities of the mucosal adjuvants 
such as CT and LT used in the vaccination protocols (Blanchard et al . ,  1 999) . 
IgA responses have been shown to be selected by cytokines produced by Th2 cel ls .  A 
shift in  the T -cell response from Th 1 to Th2 in H. pylori infection may thus favor the 
development of IgA responses and protective immunity. Mucosal IgA antibodies may 
p lay a rol e  in protective immune mechanisms fol lowing immunisation against 
Helicobacter infection. Researchers have found increased levels of IgA concentrations 
in the secretions of immunised mice (Pappo et al . , 1 995) ,  but few studies have 
correl ated this with protection . Support for a role  of IgA in protection comes from 
evidence that IgA antibodies recognising urease are sufficient to provide protection in 
animal models (Lee et al . ,  1 995 ; B lanchard et  al. , 1 995) .  However, the mucosal IgA 
antibodies that occur in response to natural and experimental infection appear to be 
incapab le  of e l iminating such infections (see section 1 .4 . 2 . 2) .  Indeed, in some 
instances,  the induction of protective immune responses in mice does not always 
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correlate with the production of mucosal IgA antibodies (Pappo et al. , 1 995;  Ferrero et 
al. , 1 995) and studies using the H. felis mouse model show that IgA deficient mice can 
be protectively immunised (Nedrud et al., 1 996) . Blanchard et al., ( 1 999) found that 
immunisation induced the production of local antibodies with antigenic specificities 
different from those induced by natural infection, suggesting that specificity, rather than 
the magnitude of antibody may be important. 
Recent work using the Rhesus monkey as a model of H. pylori infection has also 
suggested that neither serum nor secretory 19A plays a protective role against infection 
(Dubois et al. , 1 998) ,  and has led to investigations i nto the role of IgG, which i s  
generall y  neglected i n  mucosal immunity . Previous work has demonstrated that 
administration of IgG is sufficient to confer passive protection against G1 infections 
(Robbins et al., 1 995). Support for a role of IgG in protective immunity comes from the 
recent finding that oral immunisation of mice with H. pylori sonicate or recombinant 
antigens,  along with CT, results in the induction of specific IgG-secreting cells in the 
gastric mucosa. The proliferation of such antibody-secreting cells correlated with both 
the presence of 19G in gastric secretions and protection against H. felis infection 
(Ferrero et  al., 1 997) .  In addition, the administration of the GroES homolog of H. 
pylori increased the production of specific anti-Ho pylori IgG 1 in  mice and concurrently 
protected them against experimental H. felis infection (Ferrero et al . ,  1 995) . A recent 
study investigating the role  of IFN-y in H. pylori infection concluded that this cytokine 
was not essential for protective immunity and pl ayed a more important role in the 
induction of gastric inflammation (Sawai et al . ,  1 999) .  Their data indicated that the 
protective immunity induced in mice by oral immunisation was based on humoral 
immunity, specifically serum IgG. 
On the other hand, the observation that Th2-type cell s  can reduce the H. feUs burden 
when adoptively transferred into unimmunised recipients (Mohammadi et al. , 1 997) and 
the recent finding that MHC deficiency exacerbates H. pylori infection (Pappo et al. , 
1 999) imp licates a role for cell-mediated immune responses in contro l l ing the 
magnitude of infection. In addition, experiments in /-LMT antibody deficient mice have 
revealed that protective immunity can be achieved in the absence of any antibody 
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(Ermak et al. , 1 998 ) .  Thus, the mechanism by which protective immuni ty to 
Helicobacter infection is mediated remains to be established. 
It is worth noting that other species of animals appear less amenable than mice to 
protection by vaccination, for example, oral vaccination in species such as p iglets 
(Eaton et  aI. ,  1 998)  tends to suppress infection but not completely prevent i t .  
Differences in the efficacy of vaccination against Helicobacter infection in other species 
is l ikely to be due to variability in vaccination protocols, host and bacterial factors 
(Dubois et aI. , 1 999). The identification H. pylori proteins and characterisation of their 
involvement in the immune response to infection is critical to developing an effective 
vaccine. The next section describes the mechanisms by which a gram-negative 
bacterium such as H. pylori may secrete virulence factors that interact with immune 
cells, and reviews some of the current knowledge on H. pylori exported proteins .  
1 .9 Secretion of bacterial virulence factors 
1.9.1 Bacterial secretion systems 
Secreted or surface-exposed bacterial proteins ha're long been known to play central 
roles in bacterial-host interactions. Proteins secreted by gram-negative bacteria, must 
pass through a number of compartments before they are expelled i nto the extracellular 
mil ieu.  Gram-negative bacteria have an outer membrane situated above a thin 
peptidoglycan layer. Sandwiched between the outer membrane and the i nner membrane 
cytoplasmic membrane) ,  is a concentrated gel-l ike matrix (the perip lasm) i n  the 
perip lasmic space (Beveridge, 1 999) . Proteins synthesised in the cytoplasm at 
ribosomes must be targeted to the right compartment in order to fulfi l l  their specific 
function. Three general secretion pathways have been described in gram-negative 
bacteria that export bacterial proteins (Figure 1 .2) ,  as well as a fourth pathway for group 
of bacterial proteins that mediate their own transport. 
1 .9 . 1 . 1  Type I secretion 
In the Type I system, the protein is secreted in a one-step mechanism in which the 
protein crosses directly from the cytoplasm to the cell surface. Proteins transported by 
this system lack c lassic signal sequences and require three or four accessory molecules 
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that form a transmembrane channel through which the secreted prote in moves. The 
type I secretory machinery consists of a homologue of an ABC tran porter bel ieved to 
be involved in providing the energy required for translocation. The rest of the apparatus 
includes an outer membrane component and a dimeric protein spann ing the inner and 
outer membrane which belongs to a fami ly of molecules referred to as membrane fusion 
proteins (Lory, 1 998) .  The genes that encode these accessory molecules are usually 
found clustered with those that encode the secreted molecu le. The carboxyl-terminal 
reg ion of proteins secreted by this system contains the information necessary for 
secretion (Finlay and Falkow, 1 997). 
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�I TYPE IV I 
c 
SecB c 
N
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Figure 1 .2 :  Schematic overv iew of the Type I ,  I I ,  II and IV secretion systems for 
protein export in Gram-negative bacteria. The General Secretory Pathway (Type IJ) 
uses protein encoded s ignal peptides to d irect export across the inner membrane, 
fol lowed by cleavage of the signal sequence. Translocation across the outer membrane 
occurs in a second step via one of the main terminal branch (MTB) pathways.  OM: 
outer membrane; PP: periplasm; IM: inner membrane. See text for further detai ls. 
Th i s  system i s  exempl ified by the HlyA hemolysin of E. coli, an important v iru lence 
factor in E. coli extraintestinal infections. HlyA has an unprocessed export s ignal at its 
extreme C terminus spec ifical ly within the last 48 amino acids (China and Goffaux, 
1 999) . H lyA is secreted through the inner and outer membrane via an ol igomeric 
complex composed of a large ATP-binding cassette (ABC) transporter (HlyB) and 
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accessory factor (H lyD) and an additional outer membrane factor (ToIC) (Figure l .2) .  
H lyB is  assumed to be central to substrate recognition .  The structure of the membrane 
translocator, and the generation of energy from A TP together with proton motive force, 
drives protein translocation. HlyD is suggested to be the membrane fusion protein as it 
may bring the protein in contact with the outer membrane channel .  TolC forms a porin­
l ike channel that creates a periplasmic bridge to the energized inner membrane 
components of the translocation complex (China and Goffaux, 1 999) . 
1 . 9 . 1 . 2 Type II secretion - the General Secretory Pathway 
The Type II secretion system is  generall y  described as the c lassical system, general 
secretory pathway (GSP) or the sec-dependent secretion system. Type II secreted 
proteins use the GSP to reach the periplasm and then traverse the outer membrane 
through specialised secretory machinery consisting of at least 1 2  different components .  
This l atter step i s  an extension of the GSP and is often referred to as the terminal 
branch. The type II secretion system is  the major export pathway in most gram­
negative bacteria (Finlay and Falkow, 1 997). 
Proteins  transported by the GSP are distinguished from other proteins by the presence 
of a signal sequence. S ignal sequences are characterised by a long, hydrophobic region 
(H domain) that is usually preceded by one or more positively charged residues in a 
short, generally hydrophi l ic region (the N domain) .  The C domain i s  usuall y  less 
hydrophobic and contains the signals that are recognised by  the signal peptidases 
(Perlman and Halvorson, 1 983 ) .  The N region has been suggested to bind the 
negatively charged surface of the l ipid bilayer of the membrane while the positive 
charges rare equired to orient the signal sequence of the secretory protein (or the stop­
transfer signal of membrane proteins) correctly within the l ipid l ayer (von Heijne, 
1 990) . The H domain is the hydrophobic core of a signal sequence and varies in length 
from 7 to 1 5  amino acids. It is the most important part of the signal sequence and i s  
responsible for positioning the C domain within reach of  the signal peptidase (von 
Heijne, 1 998) .  The s ignal peptidase site i s  the onl y  part of the signal sequence that 
contains primary sequence specificity . S ignal sequences are exclusively amino 
terminal, and although they all have essential ly  similar structural features, they can be 
divided into three types .  The standard signal peptide as described above has three 
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domains with a cleavage site usually preceded by an Ala-X-Ala amino acid sequence, 
which is cleaved by signal peptidase I (Perlman and Halvorson, 1 983) .  A small number 
of bacterial l ipoprotein signal peptides are proces�ed by signal peptidase II rather than 
signal peptidase 1. A well-conserved consensus sequence Leu-Ala-(Gly, Ala)-Cys, 
defines the signal peptidase II cleavage site. Lipoprotein signal sequences lack a polar 
C-region, and are therefore usually shorter, and have more hydrophobic amino acids in 
the H region due to the nature of the cleavage site (von Heijne, 1 990) . Final ly,  type IV 
cleavage signal peptides are considered not to have a C domain since they are cleaved 
between the N and H domains (Pugsley 1 993) .  
The E. coli Sec translocation machinery i s  an enzyme complex consisting of several 
i ntegral membrane proteins and a peripheral bound ATPase . The core of this 
multisubunit enzyme is formed by the integral membrane proteins SecY, SecE and 
SecG, together with the peripherally bound SecA and are termed translocase (see Figure 
1 .2 ) .  Additional ly, there are two membrane proteins, SecD and SecF, that are not 
essential for protein translocation but stabilise SecA in its active conformation. This 
Sec system is collectively responsible for the translocation of precursor protein across 
the cytoplasmic membrane and the insertion of i ntegral membrane proteins i nto the 
membrane (Schatz and Beckwith, 1 990). The first step in Type II secretion involves the 
targeting of the presecretory protein (preprotein) to the translocon in the cytoplasmic 
membrane.  The targeting  of the preprotein to the Sec apparatus for translocation is 
accomplished by several pathways of which the signal recognition particle (SRP)- and 
SecB-dependent targeting  routes are the best studied. The choice of pathway i s  
probably governed by the preprotein' s  signal sequence, by  sequence motifs within the 
mature region of the precursor, and by the competition between folding and binding to 
SecB (Schatz and Dobberstein ,  1 996). 
SecB-dependent targeting 
SecB i s  a molecular chaperone that plays a dedicated role in guiding many precursor 
proteins to the cytoplasmic membrane. Although other chaperones such as GroEL 
DnaK and Dna] are capable of maintaining a preprotein in a translocation-competent 
state in vitro (Langer et al . ,  1 992), they fail to stimulate the translocation. This suggests 
that they can substitute for SecB in the translocation reaction with regard to interaction 
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with the preprotein ,  but cannot properly target the preprotein to the translocase. The 
processing of the SecB-independent precursor of alkaline phosphatase is disturbed in  
cells lacking DnaK or DnaJ, and it has been suggested that these chaperones play a 
more general role in the targeting of SecB-independent precursor proteins (Wild et  al. , 
1 996). Although there are some conflicting opinions, it is generally believed that SecB 
binds the preprotein at the mature domain and that the signal sequence, although not 
directly involved in this binding, slows the folding process of the mature domain ,  
allowing SecB to  recognise only those proteins destined for translocation (Driessen et  
al. , 1 998) .  SecB binding keeps preproteins in a translocation competent state and 
targets them to the SecA subunit of the membrane-bound translocase. The receptor for 
SecB at the membrane is SecA, and the binding site on SecA for SecB is located at the 
carboxyl terminus and is conserved among the bacterial SecA proteins .  Upon 
in teraction of SecB with SecA, SecB releases the precursor protein ,  which is 
subsequently transferred to SecA (Fekkes and Driessen, 1 999) . SecA binding of ATP 
then induces a conformational modification of SecA leading to its insertion into the 
inner membrane.  The A TP hydrolysis induces the return to the initial conformation and 
l iberation of the preprotein. This cycle is then repeated leading to a deeper insertion of 
SecA into the membrnae. Repeated cycles of SecA preprotein association, ATP­
binding and hydrolysis ,  and SecA-preprotein  dissociation result in the stepwise 
translocation of the entire preprotein across the membrane (Driessen et al. , 1 998). 
SRP-dependent targeting 
Some proteins are exported independently of SecB , although interaction with the rest of 
the Sec export apparatus is required. Among these are alkaline phosphatase, ribose­
binding protein, �-lactamase and the outer membrane lipoprotein (Wild et al. , 1 992). In 
this system, proteins are targeted to the translocon by a signal-recognition particle 
(SRP) and SRP receptor. Targeting occurs cotranslationally with the proteins stil l  
attached to the ribosome. Directly after the signal sequence emerges from the ribosome, 
the nascent chain is bound by SRP. The E. coli SRP recognises and binds its substrates 
due to the presence of a highly hydrophobic signal :;equence. This interaction results in  
a pause i n  the translation of the nascent chain and the ribosome-bound complex is then 
targeted to the SRP receptor. The interaction between SRP and its receptor releases 
SRP from the ribosome and the signal sequence. Subsequently the translation arrest is 
39 
Chapter 1 
relieved, the ribosome binds the membrane-embedded translocon and the preprotein i s  
threaded across or  into the membrane by chain elongation. The SRP of  E. coli i s  
comprised a 4 .5S RNA molecule and a homologue of  the 54 kDa eukaryotic SRP 
protein subunit called Ffh (fifty-four homologue) . In E. coli, the SRP receptor, FtsY, is 
peripherally associated with the membrane and a membrane-bound FtsH homolog has 
been identified in H. pylori which may be involved in folding and assembly of proteins 
into and through the membrane (Ge and Taylor, 1 996) . At the membrane, SRP is 
released from the preprotein in a GTP-dependent manner. The preprotein, or integral 
membrane protein,  is subsequently transferred to the translocase, which consists of the 
Sec apparatus (Fekkes and Driessen, 1 999) and is exported across the membrane as 
described above. 
Once a protein has traversed the inner membrane into the periplasm, a second step is 
then required to export the protein into or across the outer membrane if  required. This 
is most often achieved by the main terminal branch (MTB) of the GSP, which is used 
for the export of a wide variety of extracellular proteins, and requires at least 1 4  
accessory proteins i n  order to be functional (Pugsley et al . ,  1 997) .  One representative 
of the MTB is the pullulanase (PuIA) secretion pathway of Klebsiella oxytoca which 
has been extensively studied (Pugsley, 1 993) .  Despite this, l ittle tangible progress has 
been made towards identifying MTB components that determine secretion specificity or 
which form the putative channel through which secreted proteins cross the outer 
membrane. It is generally accepted that once they reach the periplasm, secreted proteins 
adopt tertiary and even quaternary structure before they are recognised by the 
components of the MTB and transported across the membrane.  This secretion­
competent conformation may provide the signal required for MTB secretion or may 
present secretion sequence signals in a way that is recognised by the transport system 
(Pugsley et al. , 1 997) .  
In addition to the MTB, a well characterised chaperone/usher assembly pathway is 
required for the assembly of over 30 adhesive organelles in  a wide range of Gram­
negative pathogenic bacteria (Thanassi et al. ,  1 998).  In particular, the assembly of P­
pili by this pathway has enabled the investigation of the molecular mechanisms 
involved in the translocation of these proteins across the outer membrane (OM). The 
process involves a periplasmic chaperone (PapD) that binds to the pilus subunits as they 
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enter the periplasm, capping their interactive surfaces. These chaperone-subunit 
complexes are targeted to the OM usher assembly sites. The usher (PapC) is needed for 
the translocation of the subunits across the OM and is thought to form a pore via their 
largely � -sheet secondary structure, which is typical of bacterial OM pore-forming 
proteins .  The next chaperone-subunit complex to reach the usher causes the 
displacement of the chaperone which results in  the exposure of the subunit interactive 
surface allowing it to interact with the incoming subunit. Subunit-subunit interactions 
at the usher lead to the formation of l inear pilus fibers which are then translocated 
through the pore and form into a final helical formation on the outside of the cell 
(Thanassi et al. ,  1 998). Unlike the MTB secretion system, the chaperone/usher pathway 
requires only two helper proteins and appears to be energy-dependent. 
1.9. 1 .3 Type III secretion 
Like the type I secretion pathway, type In secretion is independent of the sec system. 
Type III secretion systems, which are found in various gram-negative organisms, are 
specialised for the export of virulence factors delivered directly to host cells (Anderson 
and Schneewind, 1 999). Each of the pathways comprises a complex apparatus of more 
than 20 proteins that assembles into a highly regulated channel through the inner and 
outer membranes (Henderson et al. , 1 998). Interestingly, many of the inner membrane 
proteins are homologous to components of the flagellar biosynthesis apparatus of both 
Gram-negative and Gram-positive bacteria (Finlay and Falkow, 1 997). This homology 
suggests that the two systems are functionally related.  The flagel lum transport 
machinery was thought to have a dedicated role in organelle biogenesis, but a recent 
study demonstrated that it is also required for the transport of proteins to the 
extracellular environment in Yersinia enterocolitica (Young et aI. ,  1 999) . Type III 
secretion systems have been characterised for a number of gram-negative bacteria 
including Yersinia, Salmonella, Shigella and enteropathogenic E. coli, i n  addition to 
unrelated plant pathogens (Galan and Collmer, 1 999) . Genes required for the synthesis 
and assembly of type III machines are typically clustered. Transfer of such a gene 
cluster is thought to transform otherwise nonpathogenic species into virulent organisms 
(Anderson and Schneewind, 1 999) . Indeed, the genes encoding several type III  
secretion systems often reside on pathogenicity is lands, discrete segments of DNA that 
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encode virulence traits and often appear to have a foreign origin (Mescas and Strauss 
1 996). 
Type III secretion systems have three distinguishing features :  the absence in the 
secreted proteins of a cleavable signal peptide that is characteristic of proteins secreted 
via the GSP; the requirement for customised accessory proteins for many of the secreted 
proteins and a widespread requirement for host cell contact for ful l  activation of the 
secretory pathway (Galan and Collmer, 1 999) . Thus, type III secretion appears to be 
triggered when a pathogen comes in close contact with host cell s  such as macrophages 
or epithelial cell s  and many proteins secreted by the Type III system are i njected 
directly into the cytoplasm of eukaryotic cells .  The effector molecules released act to 
alter host cell function, which facilitates the pathogen' s  abi li ty to survive (China and 
Goffaux, 1 999).  The best studied model is the Y op system of Yesinia .  Upon 
macrophage contact, yesiniae activate the type III secretion machinery to inject a set of 
virulence factors into the eukaryotic cell .  These polypeptides, named Yersinia outer 
proteins (Y ops) i nterfere with host cellular processes such as actin polymerisation and 
s ignal transduction cascades, thereby preventing phagocytosi s  and kil ling  by 
macrophages (Lee and Schneewind, 1 999). For a more detailed description of type III 
secretion systems, a number of recent reviews are available (Mescas and Strauss, 1 996; 
Galan and Collmer, 1 999; Anderson and Schneewind, 1 999;  Lee and Schneewind, 
1 999; Hueck, 1 998).  
1 .9 . 1 .4 The autotransporters 
Secreted proteins that mediate their own transport out of bacteria belong to a fourth 
class of secretion system. Like the type Il secretion system, these proteins use a sec­
dependent pathway and cleavage of a classic signal sequence to translocate across the 
inner membrane. Their translocation across the outer membrane, however, is unique in 
that the protein moiety mediating export is contained within the precursor of the 
secreted protein i tself, hence the nickname "autotransporters" . The term "type IV 
secretion" has been proposed for these autotransporter proteins (Henderson et al. , 1 998 ;  
Hueck, 1 998) ,  but wil l  not be used in the context of this review, as  a fifth secretion 
system is also referred to as Type IV (see section 1 .9 . 1 .5) .  The autotransporter system 
was first described for the IgA 1 proteases of Neisseria gonorrhoeae but a number of 
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other autotransporter proteins have been recently postulated, including the VacA protein 
of H. pylori (see section 1 .9.2) and Hsr of H. mustelae (O'Toole et al. ,  1 994). 
Following translocation across the inner membrane via the general secretory pathway, 
passage through the outer membrane is mediated by the protein' s  carboxy-terminal 
domain and no energy coupling or accessory proteins are known to be required for this 
translocation process. As such, three distinct domains can be identified for nearly al l  
autotransporter molecules :  an amino-terminal leader peptide, the surface-localised 
"mature" protein (a or passenger domain) and a carboxyl-terminal domain (�-domain) 
that mediates secretion through the outer membrane. The amino-terminal peptide 
domain in most autotransporters contains at least some characteristics of the 
prototypical sec-dependent signal sequence described above (section 1 .  9 . 1 .2) although 
they commonly contain unusually long signal peptides, consisting of at least 47 amino 
acids, the function of which has not be determined (Henderson et al. ,  1 998) .  Following 
passage across the inner membrane, the autotransporter protein exists as a periplasmic 
intermediate, but it is unclear how they survive the periplasmic phase without extensive 
degradation by periplasmic proteases. It is possible that they complex with chaperones, 
or exist in a protease-protected configuration or that the inner and outer membrane 
translocation is temporarily coupled so that the periplasmic intermediate is short-lived. 
It is widely believed that the �-domain of the autotransporter protein spontaneously 
inserts into the outer membrane in a characteristic �-barrel configuration. A �-barrel is 
a complex protein structure composed of multiple amphipathic � -sheets . The 
amphipathic primary structure permits the establishment of a molecular pore through 
which the passenger domain ,  still attached to the �-barrel ,  is  translocated to the cell 
surface. The polyprotein may then remain intact as a large protein with a membrane­
bound carboxyl-terminal domain and an amino-terminal domain extending into the 
external milieu as is thought to be the case for Hsr of H. mustelae (O'Toole et al. , 
1 994) .  Alternatively, the protein may be cleaved by an outer membrane protease, with 
the passenger domain remaining in contact with the surface via noncovalent interactions 
or released into the external milieu, the latter being the case for the IgA 1 protease. 
Some autotransporters are even capable of autoprocessing via their serine protease 
active sites (Henderson et al. ,  1 998) .  
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1 .9. 1 .5 Type IV secretion 
Controversy surrounds the classification of this type of transport system, which is the 
least well characterised and comprises only three members so far. The information that 
fol lows is taken from two reviews that refer to this class of transport system as the Type 
IV system (Burns, 1 999; Lory, 1 998),  despite the overwhelming bias i n  the literature 
towards the autotransporters being classified as type IV. The prototype member of the 
type IV transporter family is the VirB system of Agrobacterium tumefaciens that 
exports a large, single-stranded DNA, known as T-DNA, across the bacterial 
membranes and into plant cells ,  where the T-DNA integrates into the plant genome. 
The virB locus consists of 1 1  genes, ten of which (virB2-virBll)  are critical for DNA 
transfer. A similar system of type IV secretion was recently identified in Bordetella 
pertussis and was the first type IV system shown to solely transport proteins. The B. 
pertussis secretion apparatus (Ptl system) consists of nine proteins required for the 
secretion of the multisubunit pertussis toxin (Lory, 1 998) .  Additional type IV 
homologues were recently discovered in other pathogenic bacteria including H. pylori 
(see section 1 .9 .2) and Legionella pneumophila (Miller and Cossart, 1 999). 
Currently,  l ittle is known about the series of events that occur during this type of 
transport process. The finding that many of the VirB protein are found in both the inner 
and outer membrane fractions is consistent with the idea that the VirB proteins form a 
transport complex that spans both membranes (Burns, 1 999).  However, it i s  not yet 
known i f  transport occurs as a one-step process across both bacterial membranes 
simultaneously or as a two step process as with type II secretion. There is evidence to 
suggest that different members of the type IV secretion family differ in this regard. For 
instance, it has been postulated that the VirB system utilises a one-step process whereby 
proteins and associated DNA cross both bacterial membrane through a channel formed 
by the VirB proteins .  The Pt! system, despite the strong homology between its proteins 
and that of the VirB system, is suggested to utilise a two-step process .  Each of the 
individual subunits of the pertussis toxin that �ue transported by this system are 
synthesised with their own signal sequence, suggesting that they may cross the 
membrane in a sec- l ike system. Further investigations may elucidate the exact 
mechanisms behind this unusual secretion system. 
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1.9.2 Secretion of H. pylori proteins 
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There is accumulating evidence to suggest that surface or secreted proteins of H. pylori 
play a pivotal role in the organism' s ability to colonise, persist and more importantly, 
promote an inflammatory response within its host (Doig and Trust, 1 994) .  There is 
mounting evidence to suggest that stimulation of inflammatory cytokines, in particular 
IL-8, by H. pylori is due to the release of soluble bacterial extracellular factors or direct 
contact of the bacterial cell with host cells (Mai et al . ,  1 99 1 ;  Huang et al. , 1 995). Data 
also shows that H. pylori can directly injure gastric epithelial cells by the secretion of 
enzymes and by the elaboration of toxins.  Exposure to soluble bacterial proteins leads 
to cell injury, which results in growth inhibition and may lead to cell death, possibly 
through apoptosis (Smoot, 1 997) .  
Despite this ,  the mechanisms b y  which H. pylori releases or secretes its virulence 
factors are not yet well understood. To date, the secretion systems used to export many 
of the surface or secreted proteins identified in H. pylori remain theoretical. Sequencing 
of the entire H. pylori genome has revealed that it contains the basic mechanisms of 
secretion similar to those of E. coli and H. inJluenzae. However, some important 
difference were reported, notably the absence of an orthologue of the secretory 
chaperone, SecB (Tomb et al. , 1 997).  In addition to the SecA-dependent secretory 
pathway, H. pylori appears to contain two specialised export systems, one associated 
with the cag pathogenicity island (see below) and the flagellar export pathway common 
to gram-negative bacteria reviewed elsewhere (Porwollik et al. , 1 999) .  Approximately 
24% of the ORF ' s  annotated from the H. pylori genome were predicted to contain a 
signal peptide SignalP analysis (Tomb et al. , 1 997) and may encode for exported 
proteins secreted by the GSP. H. pylori also contains a large family of outer membrane 
proteins (OMP' s) (Owen, 1 998) that are thought to play a role in anti genic variation 
(Marais et al. , 1 999), for example, the B abA outer membrane adhesin (Ilver et al. , 
1 998) and Lewis antigens (Appelmelk et al. , 1 998) .  Although a clear homologue of 
SecB has not been found, it is to be expected that a protein with a similar function 
exists, as in gram-positive bacteria that lack SecB . A role for the Dnak and DnaJ 
proteins in the viability and protein export process of cells lacking SecB has been 
demonstrated (Wild et al., 1 992) . 
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Several virulence factors have been described for H. pylori, many of which are secreted 
or associated with the outer membrane. These include the vacuolating cytotoxin 
(VacA) an 87 kDa extracellular protein. The vac A gene itself encodes a precursor 
protein of 1 39 .6  kDa, consisting of a 33 -amino acid signal sequence, the 87 kDa 
cytotoxin and a 50 kDa C-terminal domain (Schmitt and Haas, 1 994) . It is the first 
known protein to be actively secreted into the extracellular space and is believed to be 
secreted via a mechanism similar to that found in Type IV secretion systems ( see 
section 1 .9 . 1 .4) .  VacA is probably specifically secreted into the extracellular space by a 
mechanism analogous to that used for the secretion of IgA protease from Neisseria 
gonorrhoeae (Jose et al. , 1 995) .  This mechanism would involve the transport of a 
VacA protoxin across the inner bacterial membrane via the sec-mediated pathway, 
fol lowed by transport across the outer membrane via a channel formed by the C­
terminus of VacA. It is also possible that VacA activity is  under the control of a 
secretion apparatus encoded in a second unidentified PAl (Covacci et  al. , 1 997) .  
Detection of VacA accumulation in the periplasm has ruled out type I and IH secretion 
pathways, while providing evidence for a two-step pathway where the N-terminal leader 
sequence of the 1 39 kDa protoxin is cleaved (Fiocca et al. , 1 999). 
The CagA gene is  one of many putative viru lence genes encoded by a 40 kb 
pathogenicity island (PAl) recently identified in H. pylori (Censini et al . ,  1 996) The 
cag PAl appears to encode a number of homologues of proteins involved in protein 
secretion ,  including flagellum assembly,  proteases,  translocases and permeases .  
Although the functions of these proteins have not been well defined, they possess 
features similar to components of bacterial type H, type HI and most notably Type V 
secretion systems (Covacci et aI. , 1 997) .  It has been suggested that the H. pylori eag 
pathogenicity island encodes a novel secretion system for the delivery of bacterial 
constituents directly into host cells. These secreted products may interact directly with 
the epithelium to trigger a cascade of events that leads to epithelial cell  damage . 
Alternatively, these secreted proteins could interact with immune cells that i n  turn 
liberate cytokines causing the observed effect indirectly (Mobley,  1 997).  It i s  known 
that the VirB4/PtlC homolog of H. pylori, pieB,  plays a role in the induction of 
proinflammatory interleukin-8 expression in gastric epithelial cells (see section 1 .7 . 1 ) ,  
since mutations i n  p ieB markedly reduce the ability o f  the bacteria to induce IL-8 
expression (Tummuru et al. ,  1 995).  Evidence suggests that other components of the 
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P AI are involved in the induction of IL8 and research has focussed on the potential 
toxic factors exported by this region (Tummuru et al . ,  1 995 ; Censini et al. , 1 996; 
GIocker et al. ,  1 998) and their role in immunopathogenesis .  
In addition, various other secreted or surface-located proteins involved in  motil i ty 
(Suerbaum et al. , 1 994) , adhesion (Clyne and Drumm, 1 996) and iron uptake (Dhaenens 
et al. , 1 997) have been identified .  Progress in identify ing  secreted or membrane 
proteins using standard biochemical techniques has been hampered by the presence of 
the high copy assemblies of cytoplasmic proteins. H. pylori appears unique in that three 
proteins, urease, HspB (a homolog of the GROEL family of heat-shock proteins) ,  and 
superoxide dismutase (SOD), are associated with the outer membrane whereas they are 
found exclusively within the cytoplasm in other bacteria (Phadnis, 1 996; Dunn et al. , 
1 997) .  These normally intrinsic cytoplasmic proteins become associated with the 
bacterial surface in a novel manner, not yet fully understood. These cytoplasmic 
proteins may be released by bacterial autolysis and become adsorbed to the surface of 
intact bacteria due to the unique characteristics of the outer membrane (Phadnis et al. , 
1 996;  Cao et  al. ,  1 998) .  Such "altruistic lysis" appears to be essential in  our 
understanding of the pathogenesis of H. pylori and may explain how vaccines against a 
cytoplasmic protein such as urease can be effective against Helicobacter sp in animal 
models. Indeed, it was recently demonstrated that the release of urease by altruistic 
lysis is essential for the survival of H. pylori in an acid environment (Krishnamurthy et 
al. , 1 998) .  It may also explain how the integral membrane proteins of H. pylori can 
evade immune detection and persist in spite of a humoral and cellular immune response 
and how this noninvasive bacterium can present virulence factors and immunogens to 
the immune system (Dunn et al. ,  1 997). 
One method of ascertaining the location of a protein within a bacterium is to determine 
its localisation index. The localisation index is an expression of secretion efficiency. 
Cytoplasmic proteins should ,  by definition ,  have a local isation index of zero . 
Differentiation between antigens that are actively secreted from the cell and intracellular 
antigens released during the autolytic process during culture has met with considerable 
difficulty in the past, although these two groups are functionally quite distinct. The use 
of cytoplasmic marker proteins with simultaneous quantification of these and other 
individual proteins has been essential in defining these groups of proteins in other 
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bacteria (Harboe et al., 1 992) . Using a similar technique, some H. pylori proteins have 
been shown to become associated with the outer membrane by a novel programmed 
release mechanism (Vanet and Labigne, 1 998) rather than autolysis. 
1 .9 .2 . 1 Outer membrane vesicles and H. pylori 
A unique feature of gram-negative bacteria is the discharge from their surface of outer 
membrane vesicles (OMVs) during bacterial growth. As these vesicles are being 
extruded from the surface, they entrap some of the underlying periplasm so that they are 
actually small particles of gram-negative cell wall .  They possess OMPs, LPS, 
phospholipids, and periplasmic constituents and are released by virtually all gram­
negative bacteria (reviewed in Beveridge, 1 999) . 
The pathogenicity of a variety of gram-negative bacterial pathogens relies, at least in 
part, on their ability to secrete a number of virulence factors into the environment 
surrounding their targeted tissue. OMVs could provide an alternative route for the 
delivery of virulence factors. H. pylori releases OMVs during growth in vitro and in 
vivo and these vesicles contain VacA (Fiocca et al., 1 999) . It has been observed that H. 
pylori vesicles bind to epithelial cells in vitro as well as to the gastric mucosal surface in 
vivo (Fiocca et al. ,  1 999) and may represent a vehicle whereby H. pylori virulence 
factors are delivered to the gastric mucosa. S ince H. pylori rarely enter intact epithelial 
cel ls ,  it has remained poorly understood how infection with H. pylori results in a 
vigorous local and systemic immune response. The data indicates that H. pylori 
vesicles frequently enter the endocytic pathway of epithelial cells .  Antigens that are 
released from these vesicles may traverse the gastric epithelial  monolayer and 
ultimately reach the lamina propria via a process involving transcytosis. (Fiocca et al. , 
1 999). 
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1 .10 Aims of  the Thesis 
Chapter 1 
The objective of the present study was to identify,  using alkaline phosphatase (AP) gene 
fusion technology, novel H. pylori sequences directing protein export and to evaluate 
the antigenicity of the fusion proteins using using blood samples taken from H. pylori 
infected patients . In order to identify exported proteins that are potentially 
immunogenic during H. pylori infection, two approaches were employed to screen the 
H. pylori AP fusion proteins generated,  ( 1 )  Western blot screening of the fusion 
proteins using patient sera, (2) lymphocyte proliferation assays using peripheral blood 
mononuclear cells from H. pylori infected patients. It was expected that this strategy 
would generate a number of immunogenic proteins which could then be further 
characterised and tested for their ability to induce protective immunity in a mouse 
model of infection. The specific aims of the thesis were to: 
1 .  Construct a Helicobacter pylori genomic l ibrary in the shuttle plasmid vector, 
pJEM 1 1 , and identify H. pylori gene sequences encoding exported proteins. 
2 .  Screen the H. pylori alkaline phosphatase fusion proteins generated from the 
pJEM 1 1  l ibrary with patient sera and test for their ability to induce proliferation of 
peripheral blood lymphocytes. 
3 .  Construct an expression library of H. pylori genomic DNA in the Lambda Zap 
vector to obtain the ful l  gene sequence of any exported proteins identified from the 
pJEM l 1 library (this was done prior to the release of the H. pylori genome sequence). 
4 .  Clone and express selected genes, identified by the immunological screening, to 
obtain purified recombinant protein for further immunological characterisation. 
5. Test recombinant proteins in a mouse model of H. pylori infection for their ability to 
induce protective immunity. 
6. Identify the gene encoding an anti genic outer membrane vesicle component by 
screening the H. pylori expression library with a monoclonal antibody raised to this 
antigen (This formed part of a collaborative project with the Christchurch School of 
Medicine, New Zealand) . 
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Chapter 2 General Materials and Methods 
2.1 Bacterial strains and plasmids 
2.1.1  Bacterial strains 
The bacterial strains used in this study are detailed in Table 2. 1 :  
Table 2.1 :  Bacterial strains used in this study 
Strain 
E. coli Dl-I l OB 
E. coli XLI-blue 
E. coli BL2 1 (DE3 )  
H. pylori 1 7874 
H. pylori NZCH I 
H. pylori M U005 
H. pylori M U007 
H. pylori MU008 
H. pylori M U0 1 5  
H. pylori MUO 1 6  
H. pylori MU038 
H. pvlori M U064 
H. pylori MU09 1 
H. lelis 
H. mustelae 4298 
Genotype/Phenotype 
F'mcrA.1( mrr-hsdRM5-mcrBClf80 o/lacZ.1M I 5 .11acX74 
deoR recA I endA ] araDJ39 .1(ara, leu)7697 ga/U galK A­
'j!sL nllpG 
recA ] endA ! gyrA 96 thi- ! hsdR J 7  supE44 relA] lac[F' 
proAB lacN Z.1M] 5 TnlO (tetf) 1 
hsd5 gal (Aclts857 ind! 5al117 nin5 lacUV5-T7 gene ] )  
H .  pylori type strain,  Cag NlYac N (Type I ), identical to 
NCTC 1 1 637 
Cag A+ Vac A+ 
Cl inical isolate, Auckland. Cag+lYaeN (Type I) 
Cl i n ical isolate, Auckland. Cag+1Y acN (Type I) 
Clin ical isolatc, Auckland, CagA-;Vack (Type 1 1 )  
Clin ical isolate, Auckland, CagklYack (Type 1 1 )  
Clinical isolate, Auckland, Cag+lYacA+ (Type J) 
Clinical isolate, Auckland, CagklYack (Type 11) 
Clinical isolate, Auckland, Cag+lYacA+ (Type I)  
Cl i n ical isolate, Auckland, CagklYack (Type 1 1 )  
Cat cl ini cal isolate 
Laboratory passagecl strain 
SourcefReference 
Sambrook et al. ( 1 989) 
Sambrook et al. ( 1 989) 
Sambrook et al. ( 1 989) 
Culture collection, U niversity of 
Gothenburg, Sweden. 
Otago U niversity, NZ 
Campbell et al.  ( 1 997) 
Campbel\ et al. ( 1 997) 
Campbell el al. ( 1 997) 
Campbell et al. ( 1 997) 
Campbell el al. ( 1 997) 
Campbell et al. ( 1 997) 
Campbell et al. ( 1 997) 
Campbell el al. ( 1 997) 
P.W.O'Toole, 
P.W.O'Toole* 
* originally obtained from J.G .Fox, Massacusetts Institute of Technology, Ma, USA. 
All E. coli strains were obtained from commercial suppliers. All Helicohacter species 
and H. pylori isolates were kindly supplied by P.W.O'Toole, Massey U niversity, NZ, 
with the exception of clinical isolate NZCH 1 ,  which was originally obtained from 
Professor V .S .  Chadwick, Otago University, NZ. 
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2.1.2 Plasmids and phagemids 
The plasmids used in this study and their relevant characteristics are detailed in Table 
2 .2 .  The mycobacterial shuttle vector, pJEM 1 1 , was kindly supplied by Brigitte 
Gicquel, Unite de Genetique Mycobacterienne, Pasteur Institute, Paris ,  France. All  
other E. coli expression vectors and phagemids were obtained from commercial 
sources. 
Plasmid 
pBK-CMV 
pJEM l 1 
pJHp l -294 
pJHp20 
pXa l 
PXa- 1 085 
PPROEX HTb 
pPRO- 1 456 
pPRO- 1 457 
PGEX-6P-3 
PGEX- 1 456 
PGEX- 1 457 
Table 2.2: Plasmids used in this study 
Description 
Phagemid vector (P1ac ,f 1  ori,COlE I Ofi'S V  40ofi,Kanf) 
E. coli - mycobacterial shuttle vector containing a truncated phoA 
gene, Kanr 
pJEM 1 1  contain ing 0.2-2 kb fragments from Helicobacter pylori 
NZC H I  
pJEM 1 1  contain ing a 1 . 1  k b  H.pylori fragment contain ing the ORF 
H P I 085 
Expression vector (Plac; f l ori : ) 
pXa I vector containing the 20/ 1 -20/2 PCR ampl i fication product 
Expession vector (Ptre, lad'!, fl ",i" Amp', pBR322 ori) 
pPROEX HTb contain ing the 1 456/B- 1 4561E PCR product 
PPROEX HTb containing the 1 457/B- 1 567/E PCR product 
Expression vector (Ptae, lad'!, f 1 ori" Amp', pBR322 ori) 
PGEX-6P-3 contain i ng the 1 456/B- 14561E PCR product 
PGEX-6P-3 conta in ing the I 457/B - 1 4571E PCR product 
2.2 Bacterial growth conditions 
Source I Reference 
Stratagene 
Lim et al. , 1 995 
This study 
This study 
Boehringer Mannheim 
This work 
L i fe Technologies 
This study 
This study 
Pharmacia B iotech 
This study 
This study 
E. coli strains were routinely grown in Luria Bertani (LB) broth or on LB plates (l % 
(w/v) tryptone, 0 .5% (w/v) yeast extract (Difco), 0 .5% (w/v) NaCI, pH 7 .0) at 37°C 
under aerobic conditions (Mil ler, 1 972) . All  l iquid cultures w ere aerated at 
approximately 200 rpm. Helicobacter cultures were routinely grown on Columbia agar 
base (Oxoid) supplemented with 5 %  sheep b100d. Plates were incubated under 
microaerophillic conditions consisting of 5% oxygen, 1 0% carbon dioxide and 85% 
nitrogen. Plates were incubated for approximately 4 to 5 days a t  35°C. Recombinant E. 
5 1  
----------- � -� � �� ���� -� -�------�-� 
coli were grown overnight at 37°C in 5 ml of the appropriate media containing the 
appropriate antibiotic (Sigma, St. Louis). For medium term storage, plates were kept at 
4°C . For long term storage of bacteria, l iquid cultures were grown overnight, mixed 
with 1 5 %  (v/v) glycerol and stored at -70°C. 
Table 2.3: Media supplements and antibiotics 
Supplement Stock concentration (mglml) Final concentration (/-lglml) 
Ampici l l i n  1 00 1 00 
Kanamycin 20 30 
BelP 40 25 
IPTG* 240 25 
X-gal* 20 20 
* for plating the recombinant libraries in E. coli DH l OB and E. coli XLI blue. 
2.3 DNA extractions 
2.3.1 Isolation of plasmid DNA from E. coli 
Plasmids were isolated from E. coli by the alkaline lysis mInI-prep method as 
previously described (Ish-Horowicz and Burke, 1 98 1 ) . B riefly, E. coli was grown 
overnight under standard conditions and the bacterial cells harvested by centrifugation. 
The cells were resuspended in buffer I (50 mM glucose, 25 mM Tris-CI, 1 0  mM EDTA) 
followed by the addition of lysis buffer Il (0.2 M NaOH, 1 % SDS) and incubated on 
ice . Following the addition of ice-cold buffer III (5 M K- acetate, glacial acetic acid), 
the precipitated protein, SDS and chromosomal DNA were removed by centrifugation. 
The supernatant containing the plasmid DNA was then extracted twice with phenol­
chloroform followed by ethanol precipitation. Alternatively, plasmid DNA was 
prepared using either the QIAprep-spin Plasmid Miniprep Kit (QIAGEN, Hildon, 
Germany) or B RESAspin Plasmid Mini Kit (Bresatec, Australia). 
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2.3.2 Isolation of genomic DNA from Helicobacter species 
Chapter 2 
The Helicobacter species and strains used in this study are listed in  Table 2 . 1 . 1  For 
DNA extraction, the organisms were grown under standard conditions and the cells 
harvested from two media plates into 1 .5 ml TE buffer. Cells were pelleted by 
centrifugation at 2,000 rpm for 1 0  mins ,  washed once with TE buffer and resuspended 
in 800 III of TE buffer. To this suspension, 1 00 III of 1 0  mg/ml lysozyme was added 
and the tube incubated in a 37°C waterbath for 30 mins. After the addition of 1 00 III of 
1 0% SDS,  the tube was incubated for a further 30 mins at 37°C. Incubation was 
increased to 56°C for 1 hour after the addition of 5 III of 1 0  mg/ml Proteinase K.  The 
DNA was extracted twice with phenol :chloroform:isoamyl alcohol (25 :24 :  1 )  to remove 
contaminating protein and ethanol precipitated at -75°C for 1 hour. The DNA was then 
resuspended in 1 00 III of distilled water. DNA concentrations were measured using a 
GeneQuant (Pharmacia) at 260 nm. 
2.4 DNA manipulations 
2.4.1 Ethanol precipitation of DNA 
DNA was routinely precipitated by the addition of 2.5 volumes of 95% (v/v) ethanol 
and 0 . 1 volume of 3 M Na-acetate (pH 5.2) .  The solution was then put at -20°C for at 
least 30 minutes .  The DNA was pelleted by centrifugation at 1 4,000 rpm for 30 mins, 
washed with 70% ethanol and the pellet vacuum dried in a Speed Vac (SC I OO, Savant) . 
DNA was resuspended in either TE buffer or distill.::d water. 
2.4.2 Electrophoresis 
Agarose gel s  were prepared in I x  TBE or TAE buffer, usually at a concentration of 1 %  
agarose (Life Technologies) . The agarose was dissolved by heating the solution in a 
microwave and following cooling, ethidium bromide was added to a final concentration 
of 1 0  Ilg/ml . Gels were poured and electrophoresis was performed using B ioRad 
equipment according to the manufacturer' s  instructions. Samples were loaded with 0.2 
volumes of loading buffer ( 0.25% (w/v) bromophenol blue, 30% (v/v) glycerol, 0 .25% 
(w/v) xylene cyanol) and run alongside the appropriate DNA marker. TBE or TAE 
buffer ( I x) were used as the running buffer and the DNA fragments were separated by 
electrophoresis with a limiting current of 80 mA for small gels, or 1 00 mA for large 
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gels. The molecular size of the DNA fragments was estimated by comparison with one 
of the following DNA markers : <pX 1 74 RF DNA / Hae III fragments, Lambda DNA / 
Hind III fragments and 1 kb ladder (GIBCO BRL,  Life Technologies) .  The gels were 
exposed to UV light and photographed using a Polaroid camera with Polaroid 667 film. 
2.4.3 Cloning procedures 
2.4.3 . 1 Digestion of DNA with restriction enzymes 
A typical restriction enzyme digest was performed in a final volume of 50 III containing 
0.2 1 Ilg of target DNA. Enzymes were purchased from Boehringer Mannheim unless 
otherwise stated. The appropriate enzyme buffer was added to a final of I x  along with 
1 -2 units of the enzyme. One unit of enzyme was defined as the amount required to 
digest 1 Ilg of DNA to completion in one hour in the recommended buffer at the 
recommended temperature. Reactions were generally performed at 37°C for one to two 
hours and the reaction stopped by the addition of 1 0  mM EDTA (pH 8 .0).  
2.4.3 .2  Ligation of DNA into plasmid vectors 
In general , ligations were performed using fragments with noncomplementary protuding 
termini generated by digestion two different restriction enzymes. Approximately 1 00 
ng of vector DNA was added to an equimolar amount of insert DNA in a 20 III volume. 
Ligase buffer ( I x) and T4 DNA Ligase C l  unit) were added to the DNA and the reaction 
incubated at l OoC for 5 min - 1 hour. Since ligation of blunt-ended fragments i s  
comparatively inefficient, these concentrations of  both the DNA termini and DNA 
ligase were increased and the reaction carried out at 250C overnight. DNA Polymerase 
I (Klenow Fragment) was used to fil l  in recessed 3 '  termin i  created by digestion of 
DNA with restriction enzymes to achieve blunt ends according to standard procedures 
(Sambrook et al. ,  1 989) .  Where fragments of DNA carrying identical termini were to 
be cloned into linearised plasmid DNA bearing compatable ends, the vector was treated 
by standard procedures using calf intestinal alkaline phosphatase (ClAP) to remove the 
5 '  phosphate group and prevent self-ligation using standard procedures (Sambrook et 
al. ,  1 989). 
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2.5 Transformations 
2.5.1 Preparation of competent cells 
2 
For preparation of competent cells,  E. coli cultures were grown to log phase and 
repeatedly exposed to calcium, which renders the cells amenable to uptake of DNA, as 
follows. A single colony of the E. coli was innoculated into 5 ml of LB media and 
grown overnight at 37°C with moderate shaking (250 rpm) . Four millilitres of the 
culture was sub-innoculated into 400 ml of media in a sterile flask and grown at 37°C 
with shaking to an OD600 of 0.3 - 0.75.  The cells were then centrifuged for 1 0  mins at 
5000 rpm at 4oC.  The supernatant was poured off and the cells gently resuspended in 4 
ml ice-cold 0. 1 M CaCl2 solution. The cells were centrifuged a further 1 0  mins at 5000 
rpm at 4°C and the pellet gently resuspended in another 4 ml 0 . 1 M CaC12 and 
incubated on ice for approximately 1 5  minutes.  Following a final centrifugation of 1 0  
mins at 5000 rpm at 4°C, the cells were resuspended i n  2 ml 0 . 1 M CaCI2, 20% 
glycerol, aliquoted and stored at -70°C. For the preparation of electrocompetent E. coli 
cells,  the above procedure was adjusted to include ice-cold distilled water in place of 
CaCI2• 
2.5.2 Transformation of E. coli 
Competent E. coli cells were transformed with either l O ng of purified plasmid or 
approximately 1 00 ng of the ligation mix by heat-shock at 42°C for 90 secs using 
standard procedures (Sambrook et al. , 1 989) .  E. coli ElectroMAX DH I 0B cells 
(Gm CO B RL, Life Technologies, Inc . )  and E. coli XLI -blue cells (Stratagene) were 
transformed with purified plasmid DNA or the l igation mix by electroporation 
according to the manufacturer's instructions .  Al l  ligation mixes were dialysed for 1 0  
mins using 0.025 IlM pore filter discs (Millipore Corporation, Bedford, MA) prior to 
electroporation. The following electroporation conditions were used with the Bio-Rad 
Gene Pulser apparatus (Bio-Rad Laboratories, Richmond, CA): cells with a 0 .2  cm 
electrode gap, 2 .5  kV, 25 IlF capacitance, and 200 ohms resistance. Transformed E. 
coli were incubated in 1 ml LB broth at 370C for approximately 1 hour prior to plating 
on LB plates containing the appropriate antibiotic . 
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2.6 Polymerase chain reaction 
2.6.1 Primer design 
Oligonucleotide primers were generally designed based on published sequences .  
Several factors were taken into consideration when designing primers for PCR or 
sequencing reactions .  Except in the case where restriction enzyme sites were to be 
incorporated, all primers were 1 00% specific for the template, with no sequence 
mismatches. The Amplify version 1 .2 software program was used to check for 
alternative hybridisation sites present in the template and the possibility of primer-dimer 
formation. In addition, primers were assessed for the presence of secondary structures .  
All  primers were designed to be of an adequate length to give good specificity and 
melting temperatures,  usually between 20 and 30 base pairs . For primers shorter than 
20 base pairs, the melting temperature (Tm) was calculated according to the formula 
Tm = 2°C[A+ T] + 4°C[G+C] . An average G+C content around 50% was maintained 
where possible .  Oligonucleotide primers were designed with the aid of the 
GeneWorks™ software . Primers were synthesi sed by Life Technologies and 
resuspended in disti lled water to a final concentration of 1 00 �M. To determine the 
volume of water (mls) in which to dissolve the oligonucleotide, the following formula 
was used: 
Total OD (Absorbance at 260nm) 
[ (EM) x Molar Concentration Required ] 
where EM is the molar extinction coefficent. 
2.6.2 peR conditions 
Standard PCR reactions were carried out using Taq DNA polymerase unless otherwise 
stated according to the manufacturer's instructions, in the presence of 1 .5 mM MgCb in 
a 50 �l volume. The fol lowing cycling parameters were typical for a standard PCR: 
95°C for 2 min, followed by 30 cycles of 95°C for 30 sec, 60°C for 30 sec, and 72°C 
for 60 sec , with an extended elongation step (72°C for 5 min) for the final cycle. 
Amplification reactions were carried out in  a Perkin Elmer 9600 PCR machine using 
0.2 ml thin-walled PCR tubes (Life Technologies) .  The PCR amplification products 
were analysed by electrophoresis on agarose gelS (see 2 .4 .2) .  PCR products were 
purified directly using a PCR purification kit (Boehringer Mannheim) or alternatively, if 
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more than one band was observed, were purified from the agarose gel using a gel 
purification kit (Qiagen, Aus). Procedures for DNA template preparation, preparation 
of the PCR mix and PCR cycling were all carried out in designated separate laboratories 
to reduce the risk of contamination. 
2.7 DNA sequencing 
2.7.1 Manual sequencing 
Manual sequencing was performed using Life Technologies Sequencing gel 
electrophoresis apparatus Model S2 according to the manufacturer' s instructions.  
Standard 6% polyacrylamide/urea sequencing gels were prepared as follows.  Fifteen 
millilitres of a 40% acrylamide solution (BioRad) was added to I x  TBE along with 50 g 
urea in a final volume of 1 00 ml. The solution was degassed under vacuum before the 
polymerising agents ( l  % ammonium sulphate, 1 5  III TEMED) were added. The gel 
was poured at a 450 angle to minimise air bubbles. Following polymerisation, the gel 
sandwich was secured to the apparatus and pre-electrophoresed for 1 5  mins prior to 
loading samples. 
Plasmid DNA templates to be sequenced were prepared using the Qiagen plasmid kit, 
followed by ethanol precipitation and PCR products purifed using a B reatec DNA 
purification Kit (Bresatec , Aus) .  For determination of the complete sequence, four 
reactions, one for each nucleotide (dG,dA,dT,dC) were carried out .  Each reaction 
contained the DNA template ( 1 - 1 00 fmol) , the sequencing primer (20 IlM ) with [a33p] 
for direct label incorporation, Taq DNA polymerase, each deoxynucleoside triphosphate 
(dGTP, dATP, dTTP, dCTP) and one of the four dideoxynucleoside triphosphates 
(ddNTPs) . The cycling protocol consisted of a denaturation step at 95°C, annealing 
step of 55 70°C depending on the sequencing primer, and an extension/termination 
step at 72°C. The extension step is terminated by the incorporation of a ddNTP. Three 
microlitres of the labelled products were electrophoresed at 1 ,500- 1 ,900 volts/30-45 
mA/60 Watts for 3-6 hours. The gel was then transferred to Whatman paper, dried and 
exposed to X-ray film followed by autoradiography to visualise the products. 
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2.7.2 Automated sequencing 
Automated sequencing was carried out by Massey University DNA Analysis Service 
(MUSeq) .  This service provides automated DNA sequencing on an ABI Prism 377 
DNA Sequencer (Perkin Elmer) . The reactions were performed using a Dye Terminator 
Cycle Sequencing Ready Reaction Kit. This kit uses dye labelled dideoxynucleotides in 
which a specific fluorescent dye is covalently attached to each base. Products can then 
be visualised as fluorescent colour coded bands that are collected and interpreted by 
computer software. 
2.7.3 Sequence analyses 
DNA and protein databases were searched to identify similarities between the insert 
DNA and previously identified sequences. Databases used for sequence similarity 
searches included the National Centre for Biotechnology Information (NCBI) BLAST 
server (http://www. ncbi .nlm.nih.govlindex.html) (Altschul et al . ,  1 990) and European 
B ioinformatics Institute FASTA server (http://www.ebi.ac .uk/ebi home. html) . The 
BLAST + BEAUTY algorithm (Worley et al. , 1 995) was also used to search databases 
for sequence similarities and structural motifs. Following the release of two entire 
H.pylori genome sequences (Tomb et al., 1 997, AIm et al. , 1 999), the H.pylori genome 
d atabases (http : //www . tigr. org/tdb/mdb/hpdb/hpdb. html and http://www .astra­
boston.comlhpylori/) . were searched to identify sequence similarities with the annotated 
H. pylori open reading frames (ORF's) . The GeneWorks programme (release 2.45, 
Intell iGenetics ,  Inc. Cal ifornia) was used for sequence analyses. In addition, the 
ExPASy Molecular Biology Server (http://expasy.hcuge.ch), S ignalP World Wide Web 
P re d i c t i o n  S e r v e r  (http://www.cbs.dtu.dk/servers/SignaIP/) . P S O R T  I I  
(http://psort.nibb.ac.jp/) (Nielsen et al. , 1 997) and Promoter Prediction (http://www­
hgc . lbl.gov/projects/promoter.html) (Reese et al . ,  1 996) were utilised in the analysis of 
H. pylori export proteins. 
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2.8 DNA hybridisations 
2.8.1 Isolation and labelling of DNA probe 
2 .8 . 1 . 1  Radioactive probes 
Chapter 2 
DNA fragments to be used as probes in Southern b lot experiments were routinely 
purified from agarose gels. Following electrophoresis, the DNA fragments were eluted 
from a 1 % low melting point agarose gel using a GELase kit (Epicentre Technologies 
Corporation, Madison, Wisconsin).  DNA fragments were labelled with [a-32P]-dCTP 
using the RTS RadPrime DNA labelling system (GIBCO B RL,  Life Technologies) .  
This system is  based upon the random primer labelling method and produces probes 
with specific activities of greater than 1 09 cpm/j.lg. The nick-translated DNA fragments 
were separated from unincorporated radiolabelled nucleotides using a NICK column 
(Pharmacia B iotech,  Uppsala, Sweden) .  Following equilibration of the column with 
buffer ( l 0 mM Tris-HCI (pH 7 .5 ) ,  1 mM EDTA), 50 j.ll of the sample was added, 
washed with 400 j.ll of buffer, and eluted with a further 400 j.ll of buffer solution. The 
fraction containing the radiolabelled probe was either used immediately or stored at 
--20oC until required. 
2 .8 . 1 .2 Digoxigenin probes 
As an alternative to radioactive labeling, the DIG nonradioactive nucleic acid labeling 
and detection system was used in Southern blotting (Boehringer Mannheim) . DNA 
fragments were routinely extracted with phenol:chloroform prior to labeling. DNA was 
labeled with didoxigenin using the standard random primed DNA reaction .  In this 
reaction, one digoxigenin molecule is incorporated in every 20 - 25 nucleotides and 
yields a minimum of 250 ng of digoxigenin-Iabded probe from 1 j.lg of DNA template 
in 1 hour. B riefly, the DNA to be labeled was denatured by boiling for 1 0  mins 
followed by the addition of 4 j.ll of DIG-High Prime (Boehringer Mannheim). The 
reaction was incubated at 37°C overnight and stopped by the addtion of EDT A.  The 
yield of DIG-Iabeled probe was quantitated by the spot test in which a side by side 
comparison of the DIG-labeled probe with a DIG-labeled control i s  carried out. A 
serial dilution of the labeled probe and control sample were spotted onto the membrane 
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and colorimetrically detected according to the manufacturer' s  instructions (Boehringer 
Mannheim). 
2.8.2 Southern blot analysis 
2.8 .2 . 1 Radioactive Southern blotting 
DNA fragments were size-fractionated on 1 .0% agarose gels by electrophoresis ,  
incubated in denaturation (*) solution followed by neutralisation solution (#9 for 1 5  mins.  
The DNA was b lotted onto nylon membrane (Hybond-N, Amersham International, 
U . K. )  by capil lary transfer using standard procedures (Sambrook et  al. , 1 989) .  The 
DNA was fixed to the nylon membranes by exposure to UV irradiation for 3 . 5  mins. 
Hybridisation was carried out using Rapid-hyb buffer (Amersham) as recommended by 
the manufacturer. Unless stated otherwise, the membranes were incubated at 65°C for 2 
hrs in the rapid hybridisation buffer containing 50- 1 00 JlI of [a 32P]-labeUed probe. 
Washes were carried out in 2 x SSC (Appendix x) ,  0. 1 % SDS at RT for 1 0  min ,  
fol lowed by  1 x SSC,  0. 1 % SDS a t  65°C for 2 x 15  min .  To  re-use Southern blots, the 
membranes were incubated at 45°C for 30 min in 0.4 M NaOH and then transferred to a 
solution containing 0 . 1 x SSC,  0 . 1 % SDS,  0 .2  M Tris-HCl pH 7 . 5  for 30  min . 
Autoradiographs were prepared by exposure to X-ray film ( Kodak X-Omat AR) at -
75°C for at least 1 6  hrs in the presence of a single intensifying screen. 
2 .8 .2 .2 DIG Southern blotting 
Membranes were prepared as above and prehybridised i n  DIG Easy Hyb buffer 
(Boehringer Mannheim) at 42°C for 2 hours. Following prehybridisation, the blot was 
hybridised with 25 ng probe I ml hybridisation solution overnight at 42°C followed by 
washing twice in 0.5xSSC, 0. 1 % SDS at 68°C. The membranes were then incubated in 
blocking solution for 30 - 60 mins and developed using the anti-DIG antibody 
conjugated to alkaline phosphatase dilutied 1 :  1 0,000 according to the manufacturer' s 
instructions. The blots were developed by either colorimetric or chemi1uminescent 
detection using NBT/BCIP or CSPD substrate respectively. After 5 mins incubation in 
CSPD substrate, the membrane was exposed to X-ray film and developed for 1 5  - 20 
mins.  
* Denaturation solution : 0 .5 M NaOH, 1 .5 M NaCl 
# Neutralisation solution: 1 M Tris-HCl, 1 .5 M NaCI, pH 7 .5  
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2.9 Protein preparations 
2.9.1 Preparation of E.coli lysate 
Chapter 2 
Recombinant E. coli clones were grown in LB culture medium supplemented with 30  
/l.g/ml kanamycin a t  37°C on  an  orbital shaker for approximately 16  hrs .  Cultures were 
inoculated 1 :  1 00 into 25 ml of fresh medium and grown to mid-log phase. The cells 
were washed twice with 25 mM Tris-HCI,  2 mM MgCb (pH 7 .0) buffer by 
centrifugation at 3000 x g for 10 min at 4°C, and re suspended in 5 .0 ml of wash buffer. 
Cell s were sonicated on ice for 3 x 1 min at 30  sec intervals using an XL-2020 
Sonicator (Heat Systems Inc . ,  Fanningdale, NY) with microtip on setting 3 . 5 .  The 
cells were incubated on ice for 1 0  mins in the presence of approximately 200 units of 
DNase I (BRL, Life Technologies, Auckland) after which was added 1 mM PMSF and 
2 .5  mM EDT A (pH 8) .  Insoluble cellular debris was removed by centrifugation at 
1 4,000 rpm for 1 0  min at 4°C in a microfuge and the supernatants collected. A non­
recombinant E. coli DH 1 OB lysate control sample was prepared according to the above 
protocol from a 25 ml culture in the absence of kanamycin. 
2.9.2 Preparation of a H. pylori lysate 
H. pylori was grown under the appropriate conditions on blood agar plates and lysate 
samples prepared from cells scraped from the solid media. Colonies were scraped from 
plates in a 1 .5 ml volume of TE (pH 8) using a glass rod. The cells were pelleted in a 
microfuge and the sllpernatants (extracellular wash samples) removed. The H. pylori 
cells  were washed twice with TE (pH 8) and resuspended in 5 ml of TE. Cell lysates 
were then prepared by sonication as described in section 2.9. 1 .  
2.10 Protein analysis 
2.10.1 Estimation of protein concentration 
Protein concentrations were estimated in duplicate using the BCA Protein Estimation 
Assay (Pierce, Rockford) according to the manufacturer's instructions. The BCA assay 
is based upon a colour change resulting from a complex formed between bicinchoninic 
acid and Cu+ l ,  which is produced when Cu+2 is reduced by protein in an alkaline 
environment. Briefly, protein samples were diluted in I ml dH20, to which was added 1 
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ml of premixed colour reagent (Pierce) and the sample incubated at 37°C for 30 mins .  
A set of bovine serum albumin (BSA) protein slaLjards was also prepared in the same 
manner. Protein was estimated by reading the absorbances at 562 nm and comparing to 
a standard curve generated by the known standards. Purified recombinant protein was 
determined by reading the abosrbance at 280 nm and the amount calculated according to 
the individual molar coefficient. 
2.10.2 Polyacrylamide gel electrophoresis (PAGE) 
Protein separation was carried out on SDS polyacrylamide gels (SDS-PAGE) using 
BioRad mini-gel electrophoresis apparatus according to the manufacturer' s  instructions. 
The resolving PAGE gels were prepared with 1 .5 M Tris pH 8 .8  with a 5% stacking gel 
prepared with 0.5 M Tris pH 6 .8 .  The electrophoresis buffer consisted of 1 92 mM 
glycine, 25 mM Tris and 0.03% SDS (Laemmli ,  1 970) . Kaleidoscope prestained 
proteins were used as size standards (B ioRad Laboratories,  Auckland) . Following 
electrophoresis, proteins were visualised by staining with Coomassie Brilliant B lue R-
250. For Coomassie staining, the gels was first incubated in fixing solution (40% 
methanol, 1 0% acetic acid), followed by staining with 0.25% (w/v) coomassie powder 
in fixing solution. Once the protein bands were visualised, the gel was de stained in 
10% ethanol , 5% acetic acid. 
2.10.3 Western blotting 
For Western blotting experiments, protein samples were run on an SDS-polyacrylamide 
gel and transferred onto PVDF membrane (NENTM Life Sciences Products, USA) using 
a mini-Transblot apparatus (B io-Rad Laboratories, Auckland). Firstly, the SDS-PAGE 
gel was equilibrated by soaking in blotting buffer (48 mM Tris, 39 mM Glycine, SDS, 
20% methanol , pH 9.2) twice for 10 minutes with shaking. Ten sheets of filter paper 
cut to the size of gel were also soaked in blotting buffer twice for 1 0  minutes .  PVDF 
membrane was pre-wetted in methanol according to the manu facturer ' s  instructions 
prior to equilibration in blotting buffer. Five sheets of the presoaked fil ter paper was 
placed on the anode, fol lowed by the membrane and finally the PAGE gel , ensuring 
there were no air bubbles. The remaining filter paper was used to cover the gel and the 
cathode placed on top. Membranes were blotted for 30 -60 mins at 20V (using B ioRad 
power pack Model 20012 .0). Kaleidoscope molecular weight standards (BioRad) were 
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run on gels alongside protein samples. Following blotting, the membranes were 
incubated in a 2% milk powder solution in PBS / 0. 1 % tween-20 (PBS-T) for 2 hrs at 
RT to block sites without bound protein .  Membranes were incubated with the 
appropriate primary antibody diluted in PBS-T at RT for 1 -2 hours. Following washing 
with PBS -T, membranes were incubated with the corresponding secondary antibody 
conjugated to alkaline phosphatase conjugate at RT for 1 hr. Following incubation, the 
membranes were washed twice with PBS-T and once with substrate buffer ( 1 00 mM 
Tris / 1 00 mM NaCI / 10 mM MgCI2) .  Protein lands detected by the antibody were 
visualised by the addition of 50 )l g/ml XP and 0.0 1 %  nitro-blue tetrazolium as 
substrates (Sigma, St. Louis). 
Alternatively, to increase the sensitivity, Western blots were developed US1l1g a 
Chemiluminescence Western blotting kit (Boehringer Mannheim) . Membranes were 
developed as for colorimetric detection with the foll owing modifications : Tris buffered 
saline pH 7 .5  (TBS) was routinely used as the washing buffer and membranes were 
incubated in 1 % blocking solution. Following incubation with the primary antibody, 
blots were developed using a POD-Iabeled secondary antibody at 40 mU/ml. Protein 
bands were detected by a 60 sec incubation in detection solution (Boehringer 
Man nheim) followed by short exposures to X-ray film according to the manufacturer' s 
instructions . 
2.1 1  Patient serum 
2.1 1 . 1  Patient details 
Sera was collected from thirty-five patients at the Wakefield Gastroenterology Centre, 
Wellington . Of the total thirty-five patients , twenty -three were determined to be 
infected with H. pylori. Infection was diagnosed by either CLO test (C), urease breath 
test (UBT) and/or by testing for anti-H. pylori antibodies in serum (Quikview Kit) .  
Control sera was obtained from twelve asympto:n?tic volunteers who were determined 
to be H .  pylori negative by Quikview and CLOtest. For a description of patient details 
see Table 2.4.  Blood samples (5- 1 0  ml) were collected into a Vacu-tainer (Becton­
Dickinson) and left to clot for approximately 2 hrs after which the serum was collected 
by centrifugation at 3 ,000 rpm for 1 5  - 20 mins. This study was approved by the 
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Wellington Ethics  Committee, Central Regional Health Authority, New Zealand. 
Patient anonymity and confidentiality were maintained. 
2.1 1.2 Removal of E. coli antibodies 
Crude sera and ascites f1uid often contains IgG components that bind to E. coli proteins 
and may cause cross-reactivity. Adsorbing the sera with E. coli protein  can i nhibit or 
remove the anti - E. coli IgG's ,  and nonspecific binding may be decreased. E. coli 
antibodies were removed from sera samples using reverse affinity chromatography. 
The method immobilises E. coli proteins onto an agarose column to which the primary 
antibody preparation (sera) is applied directly for the removal of E. coli reactive 
antibodies .  The column was packed with E. coli lysate slurry according to the 
manufacturer's instructions (Pierce, Rockford, Illinois, USA). The column was then 
equilibrated with 1 0  ml of TBS pH 7 .6, and 1 00 f.ll of serum in 1 ml TBS applied to the 
column . Fractions were eluted by adding 1 ml of TBS and after reading the absorbance 
at A2so, fractions containing the highest amount of protein were pooled and diluted 
1 : 200 for Western blotting. 
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Table 2.4: Patient data for sera used in this study 
Serum Number Age Gender HP Status 
PSOO I 60 M N/C 
PS003 32 M PIU 
PSOO5 45 M N/C 
PSOO6 72 M PIU 
PSOO7 38  F N/C 
PSOO8 47 F PIU 
PSOO9 47 F PIU 
PSO I O  44 F PlC 
PSO l 4  :13 F P/C,U 
PSO l 7  74 M PlC 
PSO l 8  49 F PlC 
PS0 1 9  42 M P/Q 
PS023 28 F N/C 
PS025 64 M PlC 
PS027 69 M PlC 
PS028 49 M PlC 
PS033 66 M P/Q 
PS036 57 F N/C,Q 
PS038 57 F N/C,Q 
PS039 67 M P/C,Q 
PS040 29 F PlC 
PS045 63 M PlC 
PS046 68 M PlC 
PS048 39 M PlC 
PS062 63 M P/C,Q 
PS064 49 M P/Q 
PS066 42 M P/Q 
PS068 55 F N/Q 
PS069 33 F N/Q 
PS070 55 M P/Q 
PS07 1 48 F N/Q 
PS072 25 F N/Q 
PS073 47 F N/Q 
PS074 32 M N/Q 
PS075 3 1  F N/Q 
PS076 40 M P/Q 
HP Status:  N:  H. pylori negative, P: H. pylori positive 
C: Clotest (biopsy urease test) ;  U: urease test using C 14;  Q: QuikView (fingerprick 
whole blood test) . 
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Chapter 3 Development of an H elicobacter pylori Expression 
Library for the Identification of H. pylori Genes Encoding 
Immunogenic Proteins 
3. 1 Abstract 
Characterisation of the humoral immune response to Helicobacter pylori infection in 
humans has faci litated the investigation of the host response to bacterial virulence 
factors and the development of serological tests that are both sensitive and specific in 
the diagnosis of the infection. This study describes a preliminary investigation into the 
recognition of H. pylori antigens by sera taken from H. pylori-infected and non-infected 
patients. A c linical isolate of H. pylori was used as the source of antigen. This strain 
was demonstrated to be a Type I H. pylori strain on the basis of production of both the 
vacuolating cytotoxin and cytotoxin-associated protein .  Differential screening of H. 
pylori total cel l  protein against sera from H. pylori infected and non-infected patients 
showed that a number of H. pylori proteins were recognised by antibodies present only 
in the infected patient sera. In other experiments, the H. pylori isolate was used as the 
source of DNA for construction of a H. pylori genomic expression l ibrary in the 
bacteriophage, Lambda. Screening of the l ibrary with gene probes derived from 
previously characterised H. pylori genes identified the urease B subunit and flagel l in A 
subunit genes and immunoscreening of the l ibrary with a monoclonal antibody enabled 
the identification of a gene encoding an outer membrane vesicle antigen of H. pylori. 
3.2 Introduction 
Since its discovery over a decade ago in 1 982, Helicobacter pylori has been the subject 
of extensive research aimed at improving diagnosis and control of the infection, and the 
identification of H. pylori antigens remains critical to this challenge . Initial studies 
investigating the protein profi les of H. pylori strains using SDS-PAGE, demonstrated 
that there was a high degree of conservation between strains (Perez-Perez et al. , 1 987) .  
This is in contrast to the high degree of variability in anti-H. pylori antibody patterns 
reported in the l iterature (Karczewsa et al. ,  1 996; Karvar et aI. , 1 997; Nilsson et al. , 
1 997 ; B l anchard et al. , 1 999) , which probably reflects differences in host and bacterial 
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factors. Antibodies against various H. pylori proteins can be detected in patient sera 
(Aucher et al . ,  1 998)  but the identity of many of these proteins  remains to be 
established. Immunodominant proteins of H. pylori that have been well-characterized 
include the urease subunits (Ferrero et al. , 1 994) ,  the vacuolating cytotoxin (VacA)  and 
cytotoxin-associated protein (CagA) (Covacci et aI. , 1 99 1 ) ,  proteins involved in flagella 
structure (Luke and Penn, 1 995) and other surface-associated antigens (Guruge et al. , 
1 990) . 
Cytotoxic strains expressing the CagA antigen and the vacuolating cytotoxin (VacA) 
are associated with a more severe disease (van Doom et al. ,  1 998) and both of these 
antigens elicit a specific antibody response during infection. S tudies of infected patient 
responses to H. pylori antigens have shown that several immunodominant antigens, 
including CagA, are not recognised by non-infected patients (Crabtree et al., 1 994) and 
are therefore useful for diagnosis. Many of the diagnostic tests for H. pylori infection 
involve enzyme-linked immunoabsorbant assays (ELISA) using a variety of antigenic 
preparations. The specificity of these tests is often hampered by cross-reactivity (van 
Zwet and Megraud, 1 998) .  Thus ,  the identification of specific major antigens is  
fundamental for the development of improved diagnostic tests. Immunoblotting 
techniques also used for the diagnosis of H. pylori i nfection in  humans are 
recommended when the outcome of the ELISA is equivocal (Nil sson et al. , 1 997). 
Like other gram-negative bacteria, H. pylori shed part of their outer membrane as 
vesicles under certain growth conditions (reviewed in Beveridge, 1 999). Immunisation 
with H. felis outer membrane vesicles (OMVs) and cholera toxin (CT) as an adj uvant, 
can protect mice against subsequent challenge with H. feUs (Keen an et aI. ,  1 997). 
Moreover, protection correlates with an antibody response to an 1 8  kDa H. felis outer 
membrane component (Keenan et al., 1 995) .  Immunisation of mice with H. pylori 
OMVs and CT also elicits a serum IgG response to a similar s ize outer membrane 
antigen from H. pylori (Keenan et al. , 1 998). A monoclonal antibody raised against the 
this OMV antigen from H. pylori (Keenan et al. , 1 998) was made available as part of 
the present study . 
This study describes a prel iminary investigation into the sero logical response to 
antigens derived from a H. pylori New Zealand cl inical isolate (NZCH l )  (Mooney et  
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al. ,  1 99 1 ) . This H. pylori strain was shown to be cagA+ vacA+ by Southern b lotting, 
and the phenotypic expression of these gene products confirmed by Western b lot 
analysis of protein prepared from cel l  lysates of H. pylori. A genomic l ibrary of H. 
pylori NZCH 1 was constructed in the expression vector Lambda Zap (Stratagene) and 
the expression l ibrary was screened with the monoc1onal antibody as part of a 
coll aborative project. This identified the antigen as Lpp20, a previously characterised 
lipoprotein from H. pylori (Kostryznska et al. ,  1 994), recently shown to be a protective 
antigen in a murine model of H. pylori infection (Hocking et al. ,  1 999). 
3.3 Materials and Methods 
3.3.1 Construction of a H. pylori expression library 
3 . 3 . 1 . 1  Digestions and Ligations 
A cl inical H. pylori isolate, designated NZCH 1 ,  originall y  isolated from a patient 
undergoing upper gastrointestinal endoscopy (Mooney et al., 1 99 1 ) ,  was chosen as the 
source of genomic DNA for construction of the H. pylori expression l ibrary. Five 
micro l itres of the Lambda ZAP vector (Statagene) was digested with 1 0  units of Barn 
HI and dephosphorylated with calf intestinal alkaline phosphatase (ClAP) . After the 
addition of 5 mM EDTA, 0 .5% SDS and 50 f.1g/ml Proteinase K, the vector was 
incubated at 56°C for 30 mins . Prior to the l igation, the vector was extracted three 
times with phenol :chloroform and ethanol precipitated (Chapter 2 .4 . 1 ) .  Approximately 
5 f.1g of genomic DNA isolated from H. pylori NZCH l ,  (Chapter 2 .3 .3 )  was partially 
digested with Sau 3A (0.3 units) for 10 mins at 37°C. Following electrophoresis, DNA 
fragments between 2 and 10 kilobase pairs (kbp) were excised from a 1 % low melting 
point agarose and purified using GELase (Epicentre Technologies) according to the 
manufacturer' s instructions. The H. pylori DNA fragments were ligated into the Barn 
HI site of Lambda Zap at 4°C for 48 hrs. 
3 . 3 . 1 .2 Packaging of the l igation 
The recombinant Lambda were packaged u S1l1g a MaxPlax Packaging Extract 
(Epicentre Technologies, Wisconsin) according to the manufacturer's instructions. Five 
microIitres of the l igation mix was added to 50 f.11 of packaging extract and incubated at 
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RT for 2 hours. Following the addition of 500 �l of phage buffer ( 10 mM Tris-HCl (pH 
8 .3) ,  1 00 mM NaCl , 1 0  mM MgCI2) and 20 III of chloroform, the packaged phage ( 1  Ill )  
were used t o  transfect E. coli XL i -blue (OD600 0.5) by incubating the cel ls with the 
phage at 37°C for 30 mins. The phage were plated by pouring the cel ls onto an LB 
plate after the addition of 3 ml of melted top agar containing 1 0  mM MgS04, 2 .5  mM 
IPTG and 4 mg/ml X-Gal for determination of the number of recombinant Lambda 
particles. Plates were incubated overnight at 37°C. In addition, serial dilutions of the 
packaged phage were made and used to transfect E. coli XLI-blue as above to determine 
the titer of plaque-forming units (PFU) per milli litre. 
3 . 3 . 1 . 3 Amplification of l ibrary 
A culture of E. coli XLI-blue was grown to an OD600 of 1 .0 in LB broth supplemented 
with 0 .2% maltose and 1 0  mM MgS04. Aliquots of the packaged phage were mixed 
with 600 III of host cells at an OD600 of 0.5 and incubated at 37°C for 1 5  mins. Five ml 
of melted top agar was added to each al iquot of infected bacteria and poured over LB 
agar, and the plates incubated at 37°C for 6 8 hours. The plates were then overlayed 
with 8 ml of SM buffer (0. 1 M NaCl, 1 0  mM MgS04.H20, 50 mM Tris-Cl (pH 7 .5) , 2% 
gelatin) and stored at 4°C overnight to allow the phage to diffuse into the buffer. The 
bacteriophage suspension was recovered from the plates , pooled and chloroform added 
to a 5%  final concentration. After thorough mixing, the suspension was incubated at 
RT for 1 5  mins, and the cel l debris removed by centrifugation. Chloroform was added 
" 
to the supernatant to a final 0.3% and 7% of dimethylsufoxide was added before storing 
at -70°C. 
3.3.2 Immunoscreening 
3 .3 .2 . 1 Immunoscreening of H. pylori protein with patient sera 
Lysate protein was prepared from H. pylori Royal Perth Hospital strain 1 3487 (NZRM 
Accession No. 2925, Type Strain NCTC 1 1 637) and H. pylori NZCH 1 and quantitated 
as previously described (Chapter 2 .9) .  For immunoscreening, 50 Ilg of H. pylori 1 1 637 
protein was electrophoresed in quadruplicate alongside a protein marker on a 1 0% SDS­
polyacrylamide gel and blotted onto PVDF membrane as described in Chapter 2 . 1 0. 
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Following incubation in blocking solution at RT for 2 hrs, the membrane was divided 
into two and incubated with sera from either an infected (PS025) or uninfected (PSOOI )  
patient. Sera was collected as described (Chapter 2 . 1 1 ) and used at a dilution of 1 :200. 
For patient detail s  refer to Table 2 .3 .  Membranes were incubated in sera overnight at 
4°C prior to washing with PBS-T. Following the washes, the b lots were incubated with 
anti-human IgG conjugated to horseradish peroxidase (POD) (Boehringer Mannheim) 
diluted 1 : 5 ,000 for 30 mins at RT and developed by autoradiography by exposure to X­
ray film for 1 min as described in Chapter 2 . 1 1 . The positions of the immunoreactive 
bands revealed by the patient' s sera were assessed with a calibrating curve constructed 
by plotting the distances of migration of the protein standards visible on the membrane. 
3 . 3 .2 .2  Immunoscreening of the H. pylori expression library for an 1 8  kDa antigen 
Two microl i tres of packaged phage from the amplified Lambda l ibrary was used to 
transfect E. coli XL I -blue (OD600 0.5) by incubating the cells with the phage at 37°C 
for 30 mins. The phage were p lated by pouring the cel l s  onto a LB plate after the 
addition of 3 ml of melted top agar containing 0.2% maltose and 1 0  mM MgS04• 
Assuming a genome size of 1 ,667,867 bp and an average insert of 5,000 bp, then the 
number of independent recombinant p laques that must be recovered in the Lambda 
vector in order to have a 99% probablility of detecting a single gene is 1 ,47 1 (Sambrook 
et al . ,  1 989) .  Discs of Hybond-C extra hybridisation transfer membrane (Amersham) 
were soaked in l a  mM IPTG and placed onto the rlates fol lowing overnight incubation 
at 37°C. The plates were left to incubate at 37°C for a further 6 hours to al low for 
induction of any �-galactosidase fusion proteins, and then placed at 4°C overnight. The 
membranes were removed and placed into 2 % blocking solution at room temperature 
for Western blot development. The membranes were incubated in blocking solution for 
2 hrs at RT fol lowed by incubation in a monoclonal antibody raised to an H. pylori 1 8  
kDa antigen di luted 1 :  100 for 2 hours at RT. Foll owing washing with PBS-T, 
membranes were incubated with the goat anti-mouse IgG alkaline phosphatase 
conjugate (S igma, St .  Louis) at a dilution of 1 :  1 ,000 at RT for 1 hr. The membranes 
were washed with PBS-T and positive plaques detected by the antibody were visualised 
by the addition of the substrates BCIP and NBT as described (Chapter 2 . l 0.3) .  
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3.3.3 Polymerase chain reaction 
The polymerase chain reaction was used to ampl ify the urease B subunit (ure B) ,  
flagel l in subunit A (jla A), vacuolating gene (vac A) and cytotox in-associated gene (cag 
A). H. pylori genomic DNA was i solated from H. pylori type strain 1 7874 (Chapter 
2.2.3) and 1 00 ng used as a template in the PCR. The oligonucleotide primers are listed 
in the fol lowing table: 
Table 3. 1 :  Oligonucleotide primers designed to amplify H. pylori gene sequences 
H. pylori Olilgonucleotide Sequence (5'-3') Product Reference 
gene (forward primer) (reverse primer) Size 
ure B AAAAGATCTAAGGAGTAAGAAATGAAAAAGATT 1 742 bp This study 
AAAGAATTCTAGAAAATGCTAAAGAGTTGC 
jla A ATGGCTTTTCAGGTCAATAC 1 499 bp Bukanov et al. 
GCTTAAGATATTTTGTTGAAC ' ( 1 994) 
vac A GCTTCTCTTACCACCAATGC 1 1 60 bp Xiang et al. 
TGTCAGGGTTGTTCACCATG ( 1 995) 
cagA AGTAAGGAGAAACAATGA 1 350 bp Xiang et al. 
AATAAGCCTTAGAGTCTTTTTGGAAATC ( 1 995) 
The PCR products were amplified using Taq DNA polymerase (Boehringer Mannheim) 
under standard conditions (Chapter 2 .6) The PCR reaction cons isted of an initial 
denaturation step of 5 mins at 95°C, followed by 25 cycles of denaturation at 95°C for 
30 secs, anneal ing at 55°C for 30 secs and an extension step at 72°C for 40 secs. 
Products were v isual ised on a 1 .0% TBE agarose gel as previously described (Chapter 
2.4.2) .  
3.3.4 Southern blotting 
3.3 .4. 1 Southern blot of H. pvlori genomic DNA 
Genomic DNA from H. pylori NZC H 1  and H. pylori 1 7874 was i solated (Chapter 
2.4. 1 )  and 5 /J.g digested with Hind III at 37°C for one hour. Digested fragments were 
electrophoresed on a 1 % agarose gel and transferred to Hybond nylon membrane 
7 1  
(Amersham) by capil lary action as previously described (Chapter 2 .8 .2) .  The cag A and 
vac A genes were amplified by PCR as described above and purified from a 1 % T AE 
agarose gel using a B resac lean purification kit (Bresatec, Aus) . The purified PCR 
product from the cag A gene was then DIG-labelled and quantitated (see Chapter 2 .8 . 1 )  
and 2 5  n g  probe per m l  hyridisation solution used in the Southern blot experiments. 
Fol lowing prehybridisation, membranes were hybridised overnight at 42°C and 
developed with anti-DIG antibody conjugated to alkaline phosphatse (Chapter 2 .8 .2) .  
The vac A gene was radiolabel led with 32p[dCTP] and 50 III of l abelled probe used in 
the Southern blot and the results visualised by autoradiography as previously described 
(Chapter 2 .8 .2 . 1 ) .  
3 . 3 .4 .2 Plaque hybridisation of the H. pylori expression library 
Five microlitres of phage stock was diluted in 995 �Ll of phage buffer and 1 00 III 
aliquots added to E. coli XLI-blue (OD600 0.6) and incubated for 20 mins at 37°C before 
p lating onto LB media as described above (3 . 3 . 3 .2) .  The resultant p laques were 
transferred to nylon disc membranes in duplicate as fol lows. The plates were incubated 
overnight at 3TC and chilled for 2 hours at 4°C. The plaques were then transferred onto 
Hybond-N+ Nucleic Acid Transfer Membrane discs for 2 minutes. The membranes 
were then denatured by submerging in denaturation solution ( 1 . 5 M NaCl ,  0 .5  M 
N aOH) for 2 minutes and then neutralised by submerging the membrane in  
neutralisation solution ( 1. 5  M NaCl,  0 . 5  M Tris-HCl (pH 8 .0» . The DNA was fixed by 
exposure to DV l ight for 2 minutes. The 1 742 bp ureB and 1 499 bp flaA PCR product 
was generated using the appropriate primers as described above (3 .3 .4), radiolabelled 
with 32p[dCTP] and used in the hybridisation reaction at 65°C as described elsewhere in 
Chapter 2 . 8 . 2 .  Positive p laques detected by the probe were visual ised by 
autoradiography. 
3.3.5 Analysis of Lambda phage 
3 . 3 . 5 . 1 Storage of  plaques 
Positive p laques, detected by autoradiography or colorimetric development, were 
selected by aligning the membrane with the original plate. Corresponding plaques were 
taken as plugs of agar and transferred to 500 III of S M  buffer containing 20 III of 
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chloroform. The suspension was then vortexed to release the phage particles and stored 
at 4°C. 
3 . 3 . 5 .2  Conversion of positive plaques to phagemids 
The in vivo excision and recircul isation of the c loned insert to form a phagemid 
containing the H. pylori insert was carried out by co-infecting the phage stock with E. 
coli XLI -b lue and Ex Assist helper phage (> 1 x l  06pfu/ml )  according to the 
manufacturer's instructions. The phage stock (250 �l) was added to 200 �l of XLI-blue 
cell s  (OD60o 1 .0) along with 1 �l of ExAssist helper phage and incubated at 37°C for 1 5  
mins . After the addition of 3 ml LB broth, the mixture was incubated a further 2 hrs at 
37°C and then heated to 700C for 1 5  mins .  Following centrifugation at 4,000 g for 1 5  
mins, the supernatant was collected and stored at 4oC. To plate the excised phagemids, 
10 III of phage supernatant was added to 200 III of E. coli XL OR cell s  (OD6oo 1 .0) and 
incubated at 37°C for 1 5  mins. Fol lowing the addition of 300 III of LB broth, the cells 
were incubated a further 45 mins at 370C and 200 III p lated onto LB plates containing 
50 Ilg/ml of kanamycin. 
3 . 3 . 5 . 3  Sequence analysis of phagemid inserts 
The cloned insert contained within the lambda vector from the positive p laques was 
excised in vivo and recircularised to form a phagemid containing the c loned insert as 
described above. Phagemid DNA was prepared from E. coli XLOR using the B resatec 
Plasmid Isolation Ki t (Bresatec ,  Austral ia) .  The H. pylori DNA inserts i n  the 
phagemids were analysed by sequencing across the c loning junctions using the 
universal primers T3 and T7. Sequencing was carried out by Massey University DNA 
Analysis Service. The DNA sequences generated were compared to the published 
TIGR sequence of H. pylori strain 26695 and the genes encoded in each phagemid 
identified. 
3.3.6 Cloning and expression of recombinant H. pylori genes 
3 .3 .6. 1 Cloning of HP ORFs into expression vectors 
Oligonucleotide primers were designed to amplify ORFs HP 1 456 and HP 1 457 based on 
the sequence from the published genome sequence (Tomb et al. , 1 997). The primers 
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were designed to amplify the ORF devoid of its signal sequence, with a Barn HI site 
incorporated into the 5 ' end and a Eco RI si te at the 3 '  end. Primers were designed as 
described in Chapter 2 .6 ,  and tested for thei r  suitabi l i ty in the PCR reaction using 
Amplify version 1 .2 .  The primer sequences ,  with the incorporated restriction s ite 
shaded, are l isted in Table 3 .2. Genomic DNA prepared from H. pylori 1 7874 was used 
as the template in the PCR. The PCR products were ampl ified using Pwo Taq 
polymerase (Boehringer Mannheim),  a high fidel i ty Taq polymerase with 3 '  -5 ' 
exonuclease (proofreading) activity that amplifies DNA with tenfold greater accuracy 
than common Taq polymerase. PCR products were amplified under standard conditions 
Table 3.2: Oligonucleotide primers designed to amplify HP1 456 and HP 1 457 
Primer Name Oligonucleotide sequence (5'-3') Reference 
(forward primer) (reverse primer) 
HP 1 456/8 CTTTAGGATCCGTGGGTTGCTGAAG This study 
HP 1 456/E TATTTGAATTCAAAACATACGCTTA This study 
HP 1 45 7/8 TCGTAGGATCCAGCCATGCC This study 
HP 1 457/£ AAGGCGAATTCTTAAAACCCT This study 
(Chapter 2 .6) .  The PCR reaction was as described in section 3 .3 .4, with an adjusted 
annealing temperature of 60oC. Products were visualised on a 1 % T AE agarose gel and 
purified using QIAGEN gel purification kit (QIAGEN, Aus) . Purified products were 
then digested with the restriction enzymes Barn HI and Eco RI and cloned into the Barn 
HI- Eco RI sites of the expression vectors, pPROex HTb (Life Technologies) and 
pGEX-6P-3 (Pharmacia Biotech) (Figure 3 . 1 ) . Recombinant p lasmids were purified 
and transformed into E. coli for expression studies. All  c loning and transformation 
techniques were carried out using standard procedures (Chapter 2 .4 & 2.5) .  
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, �  , , 
- -pGEX 
lacY' ptac Glutath ione S-transferase MCS Amp 
- - .. -pPRO 
lacP 
Spacer Protease 
MCS ptrc H i S'  region cleavage Amp 
site 
Figure 3. 1 :  Schematic representation of cloning of HP 1 456 and HP l 457 into two 
expression vectors, pGEX-6P-3 and pPROEX HTb showing the major features of each 
vector. Numbers at the 5 '  and 3 '  end refer to the position of the amplified fragments on 
the publ ished genome (Tomb et al. , 1 997) . 
3 .3 .6 .2  Expression of the recombinant proteins in E. coli 
Maximum expression of the recombinant proteins was determined by induction trials 
with varying amounts of isopropy l-I3-8-thiogalactopyranoside (IPTG) over a time 
course of 1 hour and overnight induction. IPTG was added into the culture medium 
once the E. coli cells had reached mid-log growth phase (OD600=0.5- 1 .0) . Following 
induction, the cells were harvested by centrifugation at 1 4,000 rpm and resuspended in 
20 mM Tris pH 8,  1 0  mM MgC12• Total protein was electrophoresed on SDS-PAGE 
gels and stained with Coomassie as previously described (Chapter 2 . 1 0) .  For Western 
blotting, the separated protein was transferred to PVDF membrane and developed as 
described in section 3 . 3 . 3 .2 ,  using the monoclonal antibody to the 1 8  kDa antigen as the 
primary antibody, with a one hour incubation at RT. 
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3.4 Results 
3.4.1  Differential immunoscreening of H. pylori total protein 
Chapter 3 
The Helicobacter pylori type strain NCTC 1 1 637 was grown under condi tions 
described previously (Chapter 2.2) .  Smal l  transparent g lassy colonies were observed 
after 72 hours of i ncubation. The bacterial  ce l l s  compri sing the colonies were 
confirmed to be Gram negative and subsequently tested for urease activity. Fol lowing 
innoculation of test agar with the bacteria, a pH change, indicated by the development 
of a pink color, was observed after 1 0  mins. Total H. pylori protein was prepared from 
pooled colonies and separated by SDS-PAGE. The protein profi les of the H. pylori type 
strain (NCTC 1 1 637) and c l inical  isolate NZCH l were compared by Coomassie 
staining.  Both isol ates showed very s imi lar protein profi les ,  with major bands 
conserved. The strongest bands corresponded to apparent molecular weights (mw) of 
approximately 1 5 , 20, 25, 55 ,  60, 66 and 90 kDa, with a number of minor protein bands 
observed, particularly in the range between 45 and 87 kDa (Figure 3 .2) .  The sera from 
H. pylori NCTC 
1 1 637 
1 5 1 0  
H. pylori 
NZCH I 
5 I I 5 M I  M2 (Da) 
200,000 
1 1 6,250 
97,400 
66,200 
45,000 
2 1 ,500 
1 4,400 
6,500 
Figure 3.2: Comparison of protein profiles from a H. pylori type strain NCTC 1 1 637 
and the human cl inical i solate (NZCH l )  used in this study. Lysate protein (5 , 1 0, 15 or 
20 J..ll volumes) was prepared as previously described (Chapter 2. 1 0) and separated by 
electrophoresis on a 1 0% SDS-PAGE gel. Following electrophoresis, the proteins were 
visual ised by Coomassie blue stain alongside two protein standard markers. M l :  
Kaleidoscope marker (BIORAD); M2: BIORAD broad range marker. Arrows refer to 
positions of major protein bands common between the two strains. 
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an H. pylori-infected and non-infected patient was used in immunoblot experiments to 
probe total protein. Eight reactive bands in the molecular weight range of 25 1 50 kDa 
were observed in a l l  subjects irrespective of H. pylori status .  A number of 
immunoreactive bands in the molecular weight range of 1 4  - 1 28 kDa were found only 
in patients with positive H. pylori status (Figure 3 .3 ) .  The immundominant proteins 
detected only by the infected patient sera were of apparent molecular weight (mw) 1 30, 
90, 75, 55 , 50, 42, 36, 35 , 25 and 14 kDa. The protein bands at 1 30 kDa and 90 kDa are 
consistent with the sizes of the CagA and VacA proteins. The results of this screen 
indicated that there are a number of H. pylori antigens that only antibodies from 
infected patients recognise, and therefore may be involved in the pathogenesis of 
infection. 
2 3 
(a) .--_____ -, 
206 
44.4 -
33.0 -
1 9.0 _ 
2 3 
Figure 3.3 : Autoradiograph of Western blot analysis of H. pylori NZCH 1 lysate protein 
screened with sera from an H. pylori sero-positive (a) and sero-negative (b) patient. 
Lane 1 ,  Kaleidoscope standard marker; l ane 2 and 3, H. pylori lysate protein .  Numbers 
on the left refer to molecular weight (mw) size markers (kDa) . Arrows refer to the 
unique protein bands detected by the sero-positive patient sera. 
3.4.2 Analysis of H. pylori NZCHl genotype and phenotype for use in a H. pylori 
gene expression library 
Type I strains of H. pylori contain the genes vacA and cagA, and produce a vacuolating 
cytotoxin (VacA). The majority of ulcerogenic strains of H. pylori have been found to 
contain these genes, although combinations of this genotype/phenotype exist (Xiang et  
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al. , 1 995) .  To confirm H. pylori NZCHl was a Type I strain, the genes encoding the 
VacA and CagA proteins were amplified by PCR from genomic DNA isolated from the 
H. pylori clinical isolate NZCH 1 and the type strain NCTC 1 1 637 using publ ished 
primers as described above (3 .3 .4) . The PCR reaction yielded the expected products of 
1 350 bp (cagA) and 1 1 60 bp (vacA) (Figure 3 .4 ( l a) and (2a)) .  The PCR products were 
either DIG-labelled or 32p[dCTPJ-labelled and used as probes in a Southern blot against 
Hind III digested genomic DNA. The results of these blots confirmed the presence of 
these two genes in the genomic DNA of H. pylori isolate NZCH l (see Figure 3 .4) . 
(la) (2a) 
� 1 350 bp cag A gene � 1 1 60 bp vac A gene fragment amplified by fragment amplified by PCR and PCR and DIG labelled 32p[ dCTP] labelled 
(lb) (le) (2b) (2e) 
1 2 2 1 2 3 2 3 
Figure 3.4: Southern blot experiments to detect the cag A ( 1 )  and vac A (2) genes in H. 
pylori genomic DNA. l a  and 2a: Agarose gel of PCR product amplified from the cag A 
and vac A genes from H. pylori 1 7874 genomic DNA; I b  and 2b: Agarose gel of H. 
pylori genomic DNA digested with the restriction enzyme Hind III and separated on a 
1 % agarose gel ; l c  and 2c:  Autoradiograph of Southern blot. ( 1 )  genomic DNA was 
probed with DIG-labelled cag A gene product; lane 1 ,  H. pylori NZCHI ;  lane 2,  DNA 
marker. (2) genomic DNA was probed with 32P[dCTP]-labelled vac A gene product; 
l ane 1 ,  DNA marker; l ane 2, H. pylori 1 7874, lane 3, H. pylori NZCH l .  
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In addition, a Western b lot was performed on total protein from H. pylori isolate 
NZCH 1 using a polyclonal antibody raised against the VacA and CagA proteins. 
Lysate protein was prepared from both the c linical isolate (NZCH 1 )  and H. pylori type 
strain 1 7874. An E. coli lysate sample was used as a negative contro l .  The blot was 
probed with anti-VacA ( 1 : 5000) or anti-CagA ( 1 : 5000) antibodies (kindly supplied by 
P .W.O'Toole, Massey University) and detected using colorimetric development (see 
Chapter 2 . 1 0.3) .  The presence of the CagA protein was detected as a band > 1 20 - 1 28 
kDa and the VacA at approximately 87 kDa, (Figure 3 .5) providing further confirmation 
of a Type I phenotype. This result demonstrated that the strain expresses both the 
cytotoxin and cytotoxin-associated protein when cultured in vitro. 
(a) 2 3 4 5 
84 -
:: VacA 
(b) 
r-------------------------� 
.-
.- CagA 
Figure 3.5: Western blots of H. pylori and E. coli lysate protein screened with (a) anti­
VacA antibody and (b) anti-CagA antibody. Lane 1 ,  Kaleidoscope marker; l anes 2 and 
3 ,  H. pylori NZCH l lysate protein; lane 4, H. pylori 1 1 636 lysate protein ; l ane 5 ,  E. coli 
DH 1 OB lysate protein .  Positive protein bands were detected by co lorimetric 
development. 
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3.4.3 Construction of a genomic H. pylori expression library 
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An H. pylori expression l ibrary was constructed using the Lambda Zap Express vector 
(Statagene) . A color assay was used to determine the ratio of recombinants to non­
recombinants by plating the l ibrary on IPTG and X-Gal . Non-insert background 
plaques, in  which there is a functional lacZ gene generate a blue colour when p lated on 
these substrates .  In total, there were approximately 50 b lue p laques for every 1 000 
c lear p laques, indicating that 95% of the l ibrary was recombinant .  Titering of the 
packaged phage generated the fol lowing plaque numbers : 
Dilution 1 0-1 1 0-3 1 0-5 1 0-6 
�; r 
\',v« <,· ",;,,,' c,"" " "' '3�i'»''X'N()'Wb''''\;'0,,'''''('''�\:'''\?'''N'�''''''�' '�_''�©�¥'\�m�"""""' ',&'''�*Bi",,,·).i'�W�"\'''''''��''$»{�.'lt?{:''*W''�.f''"'F�'%"'«'��WA%W"�\*.t"""�*,":tS.'��'\'$:H«\x"'�W''2''&W�,�,-".g.�4('J:R"'\''''�''��B,*�M 
No. plaques confluent 900- 1 000 80 9 
U sing these figures, the titer was calculated to be 1 . 1  x 1 08 pfu/�g 
3.4.4 Southern blot screening of the H. pylori expression library for H. pylori 
genes 
To gain an indication that the expression l ibrary was representative of the H. pylori 
genome, the l ibrary was screened for two known H, pylori genes. Genomic DNA from 
H. pylori 1 7874 was used as a template to PCR amplify the H. pylori genes encoding 
the urease B subunit and flage ll in A subunit (section 3 . 3 . 5 ) .  The PCR generated the 
expected products of 1 742 bp for the ureB gene and 1 499 bp for the flaA gene (Figure 
3 . 6(a)) and sequencing of the PCR products confirmed these sequences. The resu ltant 
PCR products were purified and radiolabelled for use as a probe in screening the 
Lambda l ibrary. Assuming a genome size of 1 ,667,876 bp and an average insert of 
5 ,000 bp, then the number of independent recombinant p laques that must be recovered 
in the Lambda vector to have a 99% probabi lity of detecting a single gene is 1 ,47 1 
( Sambrook et al. ,  1 989) . The recombinant phage were p lated at a density of 1 ,000 pfu 
per p late for screening, and fol l owing three hours exposure, 40-50 strong positive 
signals were detected on each membrane. An example of this screening is s hown in 
Figure 3 .6 (b) .  Three positive plaques for the urease gene were selected and converted 
to phagemids. Phagemid DNA was prepared and digested with the restriction enzymes 
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Pst I and Hind In to excise the insert, and separated on an agarose gel fol lowed by 
transfer to membrane for Southern blot screening.  The original radio labelled PCR 
product was used as a probe against the Southern blot and the presence of this gene was 
confirmed by a positive signal with the corresponding phagemids (data not shown).  
This screening indicated that the H. pylori genome was representative and suitable for 
screening for immunoreactive antigens .  
(h) 
M l  M2 2 
� I 742bp lire B 
I 499bpfla A 1 "P[dCTP] 
labelled 
Figure 3.6: Southern blot screening of 
the H. pylori expression l ibrary. (a) 
Agarose gel of PCR products amplified 
from the flaA and ureB genes from H. 
pylori 1 7874. (b) Autoradiograph of 
Southern blot fol lowing screening of the 
expression l ibrary w ith radiolabelled 
ureB sequence after three hours 
exposure. 
3.4.5 Plaque immunoblotting of the H. pylori expression l ibrary using a 
monocIonal antibody raised against the immunogenic 18 kDa protein 
The 1 8  kDa antigen is a component of an outer membrane vesicle preparation from H. 
pylori. A monoclonal antibody specific for this antigen was made available for this 
study (Keenan et al., 1 998) . Immunoscreening of the expression l ibrary was performed 
as described i n  the materials and methods (3 .3 .3 .2) . The H. pylori expression library 
was transferred to Hybond-C extra membrane discs and screened with the monoclonal 
antibody raised to the 1 8  kDa H. pylori outer membrane protein. Eight strongly positive 
plaques were selected and their reactivity confirmed with secondary screening. An 
example of this is presented in Figure 3 .7 .  The H. pylori DNA from each of the eight 
8 1  
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phage was then excised and recirculised to form a phagemid containing the H. pylori 
insert DNA as described in the materials and methods (3 .3 .6 .2) .  
Figure 3.7 : Secondary screening of the H. pylori Lambda l ibrary with a monoclonal 
antibody raised to an 1 8  kDa antigen from membrane vesicles of H. pylori. Positive 
plaques were detected on the membrane by colorimetric development. 
3 .4.5 . 1  Sequence analysis of phagemid inserts 
Restriction digests of the selected positive phagemids revealed that six contained an 
identical insert of approximately 2 kb while the remaining two contained inserts of 
approximately 2 .5 kb (data not shown) .  Sequence analysis of these phagemid inserts 
revealed that they all mapped to the same region of the H. pylori genome. The locus is 
diagrammatically represented in Figure 3 .8  and encompasses the promoter and start 
5 ' --�--------------�. 
T3 promoter MCS LacZ � + 1  
_ •. 
" 
- - - " ,  Bam HI " 
" 
. - -
ATG ATG 
HP 1 45 8  HP 1 457 HP 1 456 
T7 promoter 
� ... 
TTG 
HP 1 45 5  
3 '  pBK-CMV 
vector 
H. pylori 
insert 
Figure 3.8: Schematic representation of the H. pylori insert sequence from a positive 
phagemid fol lowing screening with an 1 8  kDa monoclonal antibody . Met: start 
methionine of �-galactosidase (�-gal) ; MCS:  multiple c loning site. HP numbers refer to 
the number of the ORF designated in the published genome (Tomb et al. , 1 997) . 
codons of three genes (HP 1 455,  HP 1 456 and HP1 457) . Only two of these three genes 
(HP 1 456 and HP 1 457) contained a putative signal sequence, and was therefore a 
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candidate to encode an outer vesicle membrane protein. HP 1 456 and HP 1 457,  when 
translated from the putative cleavage point produce proteins of approximately 1 9 . 1 1 
kDa and 23.3 1 kDa . Although the predicted size of the gene product indicated that the 
HP 1 456 ORF was l ikely to encode the 1 8  kDa antigen detected by the antibody, further 
experiments were required to confirm this. S ince HP 1 455 did not appear to contain a 
signal sequence, and encoded a smaller protein of 1 4  kDa, this gene was not included in 
the fol lowing experiments. 
3 .4.6 Identification of an immunogenic 1 8  kDa antigen 
To investigate which ORF (HP 1 456 or HP 1 457) was encoding the 1 8  kDa antigen, the 
ORFs of each were cloned and the protein expressed as a recombinant fusion protein. 
Oligonucleotide primers were designed to amplify a truncated ORF devoid of the signal 
sequence. PCR was carried out as described (Section 3 .3 .6) and the expected PCR 
products were purified from an agarose gel , digested with the appropriate restriction 
enzymes and cloned into the compatible sites of the expression vectors pPROEX HTb 
(Life Technologies ,  USA) and pGEX-6P-3 (Pharmacia Biotech , USA) (see Figure 3 . 1 ) .  
Expression of the recombinant fusion protein was induced by the addition of 0.5 and 
1 mM IPTG and analysed by SDS-PAGE at various time intervals. The induction trial 
for HP 1 457 - His6 is shown in Figure 3 .9 and was similar for HP 1 456 - His6. 
I hour 4hours overnight 
0.5 1 1  1 1  1 .0 0.5 1 .0 0.5 1 .0 mM IPTG 
� HP 1 457· 
His6 
Figure 3.9: Expression of HP 1 457 in pPROEX HTb resu lting in a 27. 8  kDa fusion 
protein consisting of HP 1 457 and a six Histidine tag (6 .8 kDa) for affinity purification. 
Expression of the recombinant protein was induced with both 0.5 mM and 1 mM IPTG 
and the cells harvested at time intervals  fol lowing 1 hour, 4 hours and overnight 
induction. Twenty microlitres of resuspended cells from the uninduced, 1 hour and 4 
hour induction were electrophoresed on a 1 2 . 5% SDS-PAGE gel along with 1 0  III of 
overnight sample and stained with Coomassie. 
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Expression of HP ] 456 and HP 1 457 in pPROex HTb resulted in the production of a 
fusion prote in of 23 .6  kDa and 27.8 kDa respectively, with the N-terminal signal 
sequence replaced with a string of six Histid ines, a spacer region and rTEV protease 
cleavage site (Figure 3 . 1 0  (a) ) . Similarly ,  induction of expression in pGEX-6P-3 
resu lted in a fusion protein of 42.8  kDa for HP 1 456 and 47.0 kDa for HP 1 457 (Figure 
3 . ] 0 (a) ) with the N-terminal being replaced by Glutath ione S-transferase and a 
recognition site for the protease PreScission TM.. Total protein was prepared from 
cultures of cells contain ing each construct and separated on 1 2 .5% SDS-PAGE gel and 
transferred to PVDF for Western with the monoc1onal antibody to the 1 8  kDa antigen. 
(a) M 2 :1 4 
2 1 7 -
1 26 -
73 -
.- 47.0 
43.5 -
.- 42.8  
3 1 .6 - .- 27.8 
.- 23.6 
(b) M 2 :1 4 
2 1 7  
1 26 
73 
.-
43.5 -
3 1 .6 -
Figure 3 . 1 0: Identification of HP 1 456  with an anti- I 8  kDa monoc1onal antibody . (a) 
Coomassie stained gel . H. pylori proteins HP 1 456 and HP 1 457 were expressed as 
fusion prote ins as both Histidine tagged prote ins  and GST tagged protein , and 
electrophoresed on a 1 5% SDS-PAGE gel. (b) Western blot. Proteins were transferred 
to PVDF membrane and screened with a monoc1onal antibody. M, Kaleidoscope 
marker (B IORAD); lane ] ,  H P 1 456-His; lane 2, HP ] 457-His; lane 3 ,  HP I 457-GST; 
lane 4, HP 1 456-GST. 
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A posi tive reaction was seen with both HP 1 456 fusion proteins, but no reaction was 
observed with either HP1 457 proteins, confirming that the HP 1 456 ORF encodes the 1 8  
kDa antigen (Figure 3 . 1 1  (b) ) .  
3.5 Discussion 
H. pylori possesses a number of antigens that i nduce an immune response in infected 
patients (Andersen et al. , 1 995) .  The initial characterisation of H. pylori protein 
profi les and the serological response to these was performed primarily to assess the 
feasibility of using sera as a screening tool to identify H. pylori antigens. Early reports 
on whole-cell profiles of H. pylori showed that the bacterium constitutes a relatively 
homogeneous species (Perez-Perez and B laser, 1 987) .  SDS-PAGE analysis of protein 
profi les from different H. pylori strains have demonstrates a number of common major 
bands. Seven major bands of molecular weights (mw) 62,000, 56,000, 53,000, 48 ,000, 
44,000, 29,000 and 26,000 are consistently present among strains ,  with considerable 
variation among the minor bands (Perez-Perez and B laseI', J 987; Dunn, 1 993) .  There 
also appears to be a high degree of conservation among outer membrane proteins 
(OMPs) of H. pylori, with major bands being found at 6 1 , 54, 46, 40, 30 and 1 9  kDa 
(Drouet et al. , 1 991) .  More recent studies have divided H. pylori antigens into three 
major groups based on their molecular weight (Karvar et al. , 1 997) . The Iow molecular 
mass proteins (LMMPs) include the 30 kDa urease antigen (UreA) ,  while the high­
molecular mass proteins (HMMPs) include the 87 kDa vacuolating cytotoxin (VacA) 
and the 1 28 kDa cytotoxin-associated protein (CagA) (Karvar et al. ,  1 997) 
The two H. pylori strains examined in this study showed consistent results with the 
earl ier reports on H. pylori anti genic profiles, with some variations on the estimated 
molecular weights . The major bands seen at 20 and 25 kDa may correspond to the 1 9  
kDa outer membrane protein (Drouet et al. ,  1 99 1 )  and the species specific  26 kDa 
antigen (O'Toole et al., 1 99 1 )  previously described. Hawtin et al. ( 1 990) demonstrated 
that two major bands at 28 - 3 1  and 62 - 66 kDa correspond to the two urease subunits, 
while the 54 kDa hspB heat shock protein homolog (Suerbaum et al. , 1 994) is probably 
represented by the band at approximately 55 kDa. Other variable proteins around 40 -
53 kDa may include flagellin, catalase and other unidentified proteins. The variations 
in size observed between different studies can be affected by the type of gel used, for 
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example, the urease subunit migrates at 66 or 62 kDa depending on whether a gradient 
or non gradient gel is used (Dunn, 1 993). 
Protein profi les show apparent consistency among H. pylori strains, but the individual ' s 
humoral immune response to these antigens can vary widely . In addition, several 
important antigens of H. pylori, detected by immunoblot techniques, are not recognised 
as major proteins in gels in which proteins are detected by Coomassie blue or S ilver 
stain (Dunn, 1 993) .  This study demonstrated that human serum contained antibodies 
that reacted with a number of antigens from our cl inical strain .  Consistent with others, 
the results showed that a large number of immunreactive proteins were detected by 
patient sera from the H. pylori infected individual . Western b lot assays detecting IgG 
antibodies to H. pylori antigens have consistently reported up to 1 3  immunodominant 
bands ranging from 1 5  to 1 50 kDa, in  addition to a large number of minor bands 
(Drouet et al., 1 99 1 ;  Andersen and Espersen, 1 992). Some of these immunodominant 
proteins have since been identified (Macchia et al. , 1 993 ;  Crabtree et al. , 1 99 1 ;  Cover et 
al., 1 990; Dunn et al. , 1 992), but many remain uncharacterised. 
Sera from infected patients tested by Western blotting generally reveal 1 - 1 5  bands while 
sera from non-infected patients react with 0-5 bands (Andersen and Espersen, 1 992; 
Aucher et al . ,  1 998) .  This is also observed in the serological response to Helicobacter 
sp. in dogs, in which samples from uninfected dogs had fewer immunoreactive bands 
(5- 1 2  median=8) than samples from infected dogs ( 1 2- 1 8  median= 1 6) (Strauss-Ayali et 
al., 1 999). Further characterisation of the serological response to Helicobacter antigens 
revealed that sera from positive patients gave a strong antibody response to the three 
main clusters of proteins encompassing the low, medium and high MMPs (Nilsson et 
al. , 1 997), whereas sera from H. pylori negative patients reacted mostly with only the 
M MMPs. The immunoblot result for the negative patient sera in this study was 
consistent with this and probably reflects the finding that these medium-sized proteins, 
in  the range 43 - 66 kDa, are responsible for cross-reactivity with other antigens such as 
f1agellin and heat shock proteins from other bacterial species (Ni lsson et aI. , 1 997). 
Using Southern blotting, the cagA and vacA genes in were detected in the H. pylori 
cl inical strain used for the l ibrary constructions described in this thesis .  Compared to 
the type strain (H. pylori 1 1 637), the cl inical isolate demonstrated more than one band 
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on Southern blot and is most l ikely due to an additional Hind III site i n  the sequence. 
Differences in restriction-fragment sizes and in probe hybridisation patterns is common 
among H. pylori isolates, and has been interpreted to mean that H. pylori strains are 
highly diverse in their genomic organisation and gene order (Jiang et al . ,  1 996) .  Any 
two independent c linical isolates are readily distinguishable by PCR-based random 
amplified polymorphic DNA (RAPD) fingerprinting (Bukanov and Berg, 1 994) .  
Comparisons o f  the two published genomes (Tomb e t  al . ,  1 997;  AIm e t  al. , 1 999) 
revealed that the overall genomic organisation was in fact quite similar, and that 
differences observed in sizes of Not I fragments between the two strains was mainly due 
to silent nucleotide variation within genes (AIm et al . ,  1 999). 
The diversity at the genome level does not appear to affect the organism's  abi l ity to 
colonise the host, but can have important phenotypic consequences . Al l  H. pylori 
isolates contain a vacA homolog, but only about 50% of isolates produce detectable 
vacuolating activity . This is due to allelic mosaicism in the H. pylori vacA gene such 
that each gene has one of two different signal sequences (s l (s l a, s l b) and s2) and also 
one of two alternative sequences in the middle region of the gene (m l and m2) .  The 
significance of this is that s I  m 1 VacA is highly active, while s2 m2 VacA is inactive. 
Western blotting confirmed that the cytotoxin was being produced by both the clinical 
strain NZCH l and the type strain used in this study . H. pylori strains producing 
cytotoxin  activity have been found to be more closely associated with more severe 
clinical disease (Van Doorn et al. ,  1 998) ,  and this association is reflected in VacA allele 
variety (Atherton et al., 1 997). For these reasons, the VacA+CagA+ phenotype of the 
H. pylori strain for construction of the library was important, since type I strains are 
perhaps more l ikely to contain genes that encode products involved in the immune 
response to infection. 
Western blotting also confirmed the production of the CagA protein, indicating that this 
strain contained the cag PAJ, also associated with more severe disease (Jenks et  al. , 
1 998) .  The difference in size observed in the CagA protein between the two H. pylori 
strains used in this study also reflects variabi lity at the genetic level. Using SDS­
PAGE, the CagA protein band varies between 1 20 and 1 40 kDa, probably due to a 
variable region that exists within the cag A gene. Repetitions of 1 5- to 99- base 
nucleotide sequences and variation in the number of codons result in CagA proteins 
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which vary i n  both size and amino acid sequence (Rudi et al. , 1 998) .  It i s  currently 
unclear whether these differences effect the c linical outcome of H. pylori infection, but 
it has been suggested that the size variations observed may affect antigenic properties of 
CagA and thereby alter the host ' s immune system' s abi lity to recognise the antigen 
(Rudi et al. , 1 998) .  Indeed, as discussed above, the serological profiles of H. pylori­
positive patients tend to be quite diverse, possibly reflecting the genetic diversity of H. 
pylori worldwide. The polymorphism of the antibody response to H. pylori has been 
suspected to reflect either an evolution of the immune response or an antigenic shift of 
the infecting strain,  which is also suspected to be correlated to a predisposition for more 
severe disease (Aucher et al . ,  1 998) .  
The H. pylori expression library constructed in this study formed the basis of a 
collaborative project designed to identify the gene encoding an outer membrane vesicle 
antigen originally described by Keenan et al. , ( 1 998) ,  by immunoscreening with a 
monoclonal antibody raised to this protein. The monoclonal antibody used for this 
screening the l ibrary was shown to map to one region of the genome. Further 
experiments confirmed that the gene encoding a conserved 20 kDa l ipoprotein ( lpp20) 
(Kostryznska et al . ,  1 994) was the antigen detected by the antibody. Lipoproteins are 
major antigens in a number of bacterial pathogens, and Lpp20 has been shown to be an 
immunodominant H. pylori antigen (Cao et al. , 1 998;  Kostryznska et al. , 1 994; Hocking 
et al. , 1 999) . Moreover, it is l ikely that the immunoreactive species-specific 1 9  kDa 
outer membrane protein in an earlier study is Lpp20 (Drouet et al., 1 99 1 ) .  In addition, 
the report by Kostryznska et al. ( 1 994) describes the purification of this protein from 
outer membrane vesicles spontaneously released during growth, also described i n  the 
study by Keenan et al. , ( 1 998) . Antibodies to this antigen were not detected in patient 
sera, however, leading the authors to conclude that the protein  was e ither 
nonimmunogenic or nonantigenically cross-reactive. In addition, the Lpp20 antigen 
appears to be conserved and does not cross react with closely related species of 
Helicobacter, Campylobacter or a diverse range of other bacteria (Drouet et al. , 1 99 1 ;  
Kostryznska et al. , 1 994) . 
Extracellular membranous vesicles are thought to represent an important mechanism for 
the release and delivery of virulence factors and antigens to host tissues . Budding of 
outer membrane vesicles of H. pylori has recently been proposed as a specific secretion 
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pathway to deliver antigens to the gastric mucosa (Fiocca et al. , 1 999) and investigation 
of other components of H. pylori OMV s, in addition to Ipp20, may be worthwhile. 
Recently this antigen has been shown to protect against H. pylori infection in a murine 
model along with a number of other surface or secreted proteins (Hocking et al. , 1 999). 
It is possible that other components of H. pylori outer membrane vesicles and exported 
proteins may be useful for inclusion in a subunit vaccine against H. pylori infection. 
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Chapter 4 Identification of H. pylori DNA Sequences 
Encoding Exported Proteins 
4.1 Abstract 
Bacterial secreted or membrane-associated proteins often play a role in the pathogenesis 
of infection and are potentially useful candidates for vaccine development. The 
objective of this study was to identify, using a genetic approach, proteins of H. pylori 
that are exported across the cytoplasmic membrane. A genomic H. pylori l ibrary was 
constructed i n  " the plasmid vector pJEM 1 1 , designed to identify exported proteins by 
use of alkaline phosphatase (AP) gene fusions. The pJEM 1 1  H. pylori l ibrary was 
transformed into E. coli and recombinant clones expressing enzymatically active AP 
(AP+) were identified as blue colonies when plated on the colorimetric substrate 5-
bromo-chloro-indoyl-phosphate (BCIP) . Approximately 2 .3% of transformants 
contained insert H. pylori DNA sequences that expressed active AP. Two hundred and 
eighty of these were selected and stored for further analysis .  Sequence analysis of 
twenty-eight E. coli pJEMl l  H. pylori inserts confirmed that the majority contained 
partial putative H. pylori genes encoding exported proteins (secreted or membrane 
proteins) in frame with AP. In other experiments, lysate proteins prepared from a 
number of E. coli AP+ clones were screened in  Western blots using a polyclonal 
antibody raised against alkaline phosphatase. The antibody was able to detect each 
fusion protein as well as the AP positive control .  No AP activity was detected in 
protein prepared from a white (AP-) clone, a non-recombinant pJEM l l  clone and a 
non-transformed E. coli control. The use of the pJEM l 1 vector and AP fusion 
technology proved to be a fast and rel iable method to identify genes encoding novel 
exported proteins from H. pylori . 
4.2 Introduction 
The interaction of bacterial pathogens with host cells often involves factors that are 
located on the bacterial surface or proteins that are secreted i nto the extracel lular 
environment (Hueck, 1 998 ) . B acterial surfaces are thus ric h  sources of 
immunodominant proteins,  which represent potential vaccine antigens (Vyas and 
S ihorker, 1 999). Indeed, outer membrane preparations of H. feUs were shown to 
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contain proteins capable of inducing protection against H. fe/is infection (Keenan et al. , 
1 997) (see also Chapter 3). However, only a small number of H. pylori proteins have 
been experimentally determined to be unambiguously localised within the periplasm or 
outer membrane of H. pylori. This is partly due to the presence of high copy assemblies 
of cytoplasmic proteins such as urease and GroEL, which copurify with cell envelopes 
and complicate analysis of the membrane components (Cao et al. , 1 998 ;  Vanet and 
Labigne, 1 998) .  Some well-characterised exported proteins include the vacuolating 
cytotoxin (VacA) (Cover, 1 996),  flagell in components (Suerbaum et al . , 1 993 ) ,  
adhesins (Wadstrom et al . ,  1 996) and proteins associated with the cag pathogencity 
i sland (Covacci et al., 1 997). There are many immunogenic surface-located or secreted 
H. pylori products that have yet to be identified. Progress i n  this field has been 
hampered by the difficulties associated with screening large numbers of proteins and 
assessing their role in the immune response to infection. One potential strategy to 
overcome these difficulties is to first identify the genes that code for these exported 
proteins, and then determine if they are recognised by the host ' s  immune cells . 
Approximately 20% of the polypeptides synthesized by bacteria are located partially or 
completely outside of the cytoplasm (Pugsley, 1 993) .  Most reach their final destination 
via the general secretory pathway (GSP), the first step of which is their insertion i nto 
and trans location across the cytoplasmic membrane. Escherichia coli alkal ine 
phosphatase (encoded by the phoA gene) is an enzyme that normally resides i n  the 
periplasm and is exported by the GSP. The enzyme is synthesized as a precursor 
monomer with a signal peptide at the amino-terminal end. If retained in the cytoplasm, 
AP is enzymatically inactive. This inactivity is due to the inability of the intramolecular 
disulfide bonds to be formed in the cytoplasm. Disulfide bond formation in E. coli 
occurs during or fol lowing translocation of AP across the cytoplasmic membrane where 
Dsb proteins facil itate bond formation (Derman and Beckwith, 1 995) .  Using this 
feature as a marker of export, alkaline phosphatase (AP) fusion systems have become a 
powerful tool for the analysis of protein secretion (Manoil et al . ,  1 990) . The 
colorimetric detection of AP with the substrate 5 -bromo-4-chloro-3-indolyl phosphate 
(SeIP) makes it useful in gene fusion reporter systems. 
Several genetic methodologies based on AP fusions have been developed for 
characterising proteins exported by pathogenic bacteria. TnphoA is a transposon that 
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can be used to directly select for transposon inserts in  genes coding for secreted proteins 
(Manoil and Beckwith, 1 985) .  TnphoA mutagenesis has been used to identify virulence 
factors from several pathogens (San M ateo et al. , 1 998)  including Salmonella 
typhimurium (Finlay et a l. ,  1 988) ,  Vibrio cholera (Taylor et a l . ,  1 987)  and 
enterotoxigenic E. coli (Donnenberg et al. , 1 990) . More recently, a similar system of 
reporter gene technology based on TnBlaM transposon mutagenesis using �-lactamase 
as the reporter gene was used to identify gene loci that are involved in virulence­
associated traits such as motility and adherence in H. pylori (Odenbreit et aI. , 1 996). 
Gene fusion methodology based on AP (Hoffman and Wright, 1 985)  has been used in 
our laboratory (Johnson et al . ,  1 995) and by others (Bina et al. , 1 997) to successfully 
identify H. pylori exported proteins. 
This chapter describes the first genetic approach for the identification of H. pylori genes 
encoding exported proteins using phoA gene fusion technology. An H. pylori gene 
l ibrary was constructed in the plasmid vector pJEM1 1  (Figure 4. 1 ) . This vector util ises 
the features of AP by fusing fragments of H. pylori DNA upstream of the E. coli phoA 
pJEM1 1 
vector 
( 1 0857 bp) 
ori-Ecoli 
Figure 4.1 :  Map of the plasmid vector pJEMl 1 showing the major features. pJEMl l  is 
a shuttle vector containing the origins of replication (ori) for both E. coli and 
Mycobacteria. The selectable marker is the kanamycin gene (Km). The truncated E. 
coli alkal ine phosphatase gene is devoid of the promoter, start codon, and signal 
sequence. 
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gene. The phoA gene promoter, ribosomal binding site and the complete s ignal­
sequence encoding region including the translational start codon of the phoA gene have 
been removed in pJEM 1 1 . Therefore, expression and exportation of AP depends on a 
translational fusion with the N -terminus of another exported protein, present in  the 
correct reading frame with the AP moiety (Lim et al. ,  1 995) .  The pJEMl l  H. pylori 
library was transformed into E. coli as the host strain.  Recombinant p lasmids 
expressing enzymatically active AP were sequenced to identify open reading frames 
(ORFs) encoding putative exported proteins. Results obtained in  the preliminary 
screening of this H. pylori exported protein l ibrary indicate that it is a powerful tool to 
selectively identify H. pylori secreted or membrane-associated proteins. 
4.3 Materials and Methods 
4.3.1 Construction of an H. pylori exported protein library 
4.3.  L 1 Preparation of pJEMl l  plasmid DNA 
E. coli DH l OB cell s  were transformed with the plasmid vector, pJEM 1 1 . Large scale 
purification of pJEM 1 1  was carried out by cesium chloride 1 ethidium bromide 
equilibrium centrifugation, based on a method described in  Current Protocols In 
Molecular B iology (Heilig et aI. , 1 994) .  Cultures of E. coli -pJEMI l  were grown 
overnight in LB medium ( 1 50 ml) containing 30 Ilg/ml kanamycin. The cells were 
pelleted by centrifugation at 5 ,000 rpm for 20 mins at 4°C in a GSA rotor (Sorvall RC5 
Centrifuge, Du Pont) . Following washes with TE buffer, the cells were resuspended in 
1 2  m! of 25% sucrose, 50 mM Tris, 40 mM EDTA (pH 8 .0) supplemented with 1 .25  
mg/ml lysozyme and 1 .5 Ilg/ml RNAse and incubated on ice for 1 5  mins .  A 7 .5  ml 
volume of 250 mM EDT A (pH 8 .0) was added and the cel ls were incubated on ice for 
1 5  mins. The cells were lysed by addition of 2 .5  ml of 5%  Triton X- WO, 50 mM Tris,  
0 .2 M EDT A (pH 8 .0) and left on ice for a further 45 mins. Insoluble cel lu lar debris 
was pelleted by centrifugation (Sorvall SS34 rotor, 1 5 ,000 rpm for 90 mins at 4°C) and 
the supernatant incubated at 65°C for 1 5  mins fol lowed by centrifugation at 7,000 rpm 
for 1 5  mins at 4°C .  The supernatants were collected and 1 /3 volume of 40% 
polyethylene glycol 1 2 M NaCl added to precipitate the DNA. The DNA was pelleted, 
resuspended in 1 5  m] TE buffer, and stored at 4°C overnight. After warming the DNA 
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solution to RT, 1 2 .5 g of CsCI was added, with stirring. A blank solution of 1 .2 g/ml 
CsCI in TE was made to top up the DNA solution to the neck of the u ltra-centrifuge 
tube (Nalge Nunc International, New York) . Ethidium bromide was added to each tube 
at a concentration of 0.67 mg/ml . Equilibrium centrifugation was carried out using a 
Type Ti70 fixed angle in a Beckman LS-70 Ultracentrifuge at 62,000 rpm for 22 hrs 1 5  
mins. The speed of the u ltracentrifuge was reduced to 40,000 rpm one hour before 
stopping. Under UV i l lumination, the u ltracentrifuge tube was punctured with a 2 1  
gauge needle just below the concentrated plasmid DNA band and the plasmid DNA 
col lected. The plasmid DNA was washed with an equal volume of TE-saturated 
i sopropanol, and the isopropanol layer containing the ethidium bromide discarded. 
After four washes, 3 ml TE buffer and 4 ml isopropanol were added to 1 ml of plasmid 
DNA and the sample frozen at -20°C for 75 mins. The DNA was pelleted at 1 4,000 
rpm for 20 mins at 4°C in a microfuge (Centrifuge 5402, Eppendorf). The DNA pellet 
was washed twice with 70% ethanol and resuspended in 200 III TE buffer. 
4 .3 . 1 .2 Preparation of the H. pylori pJEMl 1 library 
For construction of the l ibrary, approximately 1 Ilg of CsCI-purified pJEMl l  vector 
was l inearised with the restriction enzyme Bam HI and dephosphorylated using E. coli 
alkaline phosphatase (Pharmacia B iotech, Sweden) according to the manufacturer's 
instructions. Genomic DNA was isolated from H. pylori NZCH 1 and partially digested 
with Sau 3A (� 1 U per 2 .5  Ilg DNA) for 2 mins at 37°C. Following electrophoresis, 
DNA fragments between 200 and 2000 base pairs were excised from a 1 % low melting 
point agarose gel and purified using GELase (Epicentre Technologies, Wisconsin) 
according to the manufacturer's instructions .  The H. pylori DNA fragments were 
ligated into the compatible Bam HI site of pJEM l l  with T4 DNA ligase for 1 6  hrs at 
4°C. Following the ligation, 2 III of the dialysed ligation mix was transformed into 
electrocompetent E. coli DH l OB cells (Life Technologies). The transformation mix ( l  
ml) was then plated onto four LB media plates containing kanamycin and B CIP and 
incubated overnight at 37°C. Colonies from these four plates were harvested into 4 ml 
of TE buffer and the total plasmid DNA extracted using alkaline lysis method (see 
Chapter 2 .3)  and stored at -20°C. 
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4.3.2 Screening of the pJEMll library for known H. pylori gene sequences 
4 .3 .2 . 1 Polymerase chain reaction 
4 
Oligonucleotide primers were designed to amplify two H. pylori genes encoding 
previously identified proteins whose sequences were available in the databases. These 
genes were the vacuolating cyototoxin (vacA) and a flagellin subunit (jlaA) for which 
the detail s  of the primer sequences and amplification conditions have been previously 
described (see Chapter 3 . 3 . 3 ) .  PCR amplification was performed under standard 
conditions using Taq polymerase and an annealing temperature of 55°C (Chapter 2.6).  
PCR products were purified from agarose gels using B resatec gel purification kit 
(BRESATEC, Aus) .  
4.3 .2.2 Southern blotting 
Colony hybridisation was carried out using nylon membrane discs (Hybond-N+ Nucleic 
Acid Transfer Membrane Discs, 0 .45 /lm removal rating,  Amersham, England) .  
Recombinant blue E. coli colonies were patched from glycerol stocks onto LB agar 
plates containing 30 /lg/ml kanamycin. Following overnight incubation at 37°C, nylon 
membrane discs were placed on top of the agar for 1 minute and the E. coli 
recombinants transferred to the membrane were lysed by floating the discs on a solution 
containing 0.5 M NaOH and l . 5  M NaCl. Membrane discs were then neutralised in 1 
M Tris,  1 .5 M NaCI , pH 7 .5  and the DNA fixed by placing the discs in  a microwave 
oven for 1 minute. The purified PCR products generated as described above (section 
4 . 3 .2 . 1 )  were l abelled with 32p[dCTP] and the membranes screened with each  
radiolabelled probe a s  previously described for Southern blots (Chapter 2.8 .2) .  
4.3.3 Analysis of H. pylori alkaline phosphatase fusions 
4 .3 .3 . 1 Sequencing of the H. pylori DNA inserts 
The DNA inserts from the pJEM l l plasmid constructs were partially or completely 
sequenced using the Perkin Elmer AmpliCycle ™ Sequencing Kit according to the 
manufacturer's instructions, using [a-33P]-dCTP as described in Chapter 2 .7 . 1 .  The 
different oligonucleotide primers trialed in the optimisation of the sequencing protocol 
are l isted in Table 4. 1 .  
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Table 4.1 : Oligonucleotide primers designed to the pJEM 1 1  vector 
Sequencing Primer Primer Sequence (5'-3 ' )  Reference 
(reverse primer) (forward priner) 
pJEM3* TCG CCC TGA GCA GCC CGG IT Lim et al. ( 1 995) 
pJEM4# TTG GGG ACC CTA GAG GTC CC Lim et al. ( 1 995) 
pJEM6* GCA GT A AT A TCG CCC TGA GCA GC This study 
pJEM7# TTA ATT GGG GAC CCT AGA GGT CC This study 
�. ; .. 
JEM2* TCGCCCTGAGCAGCCCGGIT Pasteur Institute 
JEM l# CGAGCTGCAGTGGGATGACC Pasteur Institute 
* - sequencing primer designed to the complimentary sequence of the E. coli phoA gene 
coding for alkaline phosphatase (Acc#O 1 659) .  
# sequencing primer designed to the coding strand of  the transcriptional terminator 
sequence from pJEM l l .  The sequence is derived from the bacteriophage T4 gene 
(Acc#X066 1 9). 
Both published and custom designed primers were tested in the cycle sequencing 
reaction. Oligonucleotide primers were designed to both the non-coding strand of the 
phoA gene and to the coding strand of the terminator sequence on the pJEM l l vector. 
Primers were designed as previously described and used at a final concentration of 1 0  
IJ.M i n  the cycling mix, a long with approximately 2 IJ.g o f  pJEM l l plasmid DNA. 
Sequencing contigs were bu i lt up using the Gene Works Sequencing Project document. 
A loop structure in the region of the forward primer design was later described (M. 
Jackson ,  Mycobacteria l  Geneti c s  Uni t ,  Pasteur Institute, Pari s ;  personal 
communication) and a new primer (JEM l )  designed upstream of this region eliminated 
previous PCR and sequencing technical problems (see Figure 4.2 ) .  Primers JEM l and 
JEM2 were later used to PCR amplify the pJEM l 1 inserts, which were then sequenced 
directly by direct automated sequencing (see Chapter 2.7.2) .  
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(a) pJEM l l  sequencing prirrers 
pJ '111. 6 
____ MCS H. fly/cri in!ert ....... _A_lkaI_i re--'-ph_osp..;,-.halase_---'- pJEM 1 1  
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(b) Tenninator sequenre A 
T G  
C A 
C-G 
C-G 
A-T 
G-C 
G-C 
5' G -C  
TCGAGCTGCAGTGGGATGACCTTTTGAATGACCTTTAATAGATTATATTACTAATTAATTGCTTTT 
3' 
Figure 4.2:  Ca) Schematic representation of the location of the ol igonucleotide primers 
designed to sequence the H. pylori insert within the pJEM l l vector. Primers were 
designed to the coding strand of the terminator sequence and the non-coding strand of 
phoA. Sequences of the individual primer pairs are li sted in Table 4. 1 .  (b) The 
sequence of the loop terminator region in pJEM 1 1 showing the location of and 
sequence of the loop structure. 
4.3 .3 .2  Western blot analysis of fusion proteins 
In the Western blot experiments to detect the AP fusion proteins , lysate protein from 
recombinant E. coli was prepared as described prev iously (Chapter 2 . 9 . 1 ) . 
Approximately 20 I-lg of lysate protein was separated on a 1 2% SDS-polyacrylamide gel 
and transferred onto PVDF membrane as prev iously described (Chapter 2 . 1 0.3 ) .  
Fol lowing blocking, the membranes were incubated with rabbit anti-E. coli alkaline 
phosphatase IgG (Rockland, Gi lbertsvi l le ,  USA) diluted 1 : 20,000 at RT for 1 hour. 
After washing with PBS-T, membranes were incubated with goat anti-mouse IgG­
alkaline phosphatase conjugate CSigma, St Louis) di luted 1 : 2 ,500 at RT for 1 hr. 
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Protein bands detected by the antibody were visualised by the addition 50 J..lg / ml BCIP 
and 0. 1 % NBT as substrates .  
4.4 Results 
4.4.1 Construction and screening of an H. pylori library of AP fusions 
In order to identify H. pylori gene sequences encoding exported proteins, a library of H. 
pylori AP-fusions was constructed in the vector, pJEM l l and expressed in E. coli. The 
design and construction of the plasmid vector has been described el sewhere (Lim et al. ,  
1 995) .  The construction and screening of  the l ibrary is diagrammatically represented in 
Figure 4.3 .  Plasmid DNA was purified from twenty randomly selected transformants 
pJEM l 1  
MCS 
• 
, , 
" 
, , 
promoter signal sequenct\ H. pylori gene 
, , , , , , , 
\ 
'. 
TRANSLATON \ \ H. pylori protein 
_ H. pylori derived 
pJEM I I derived 
'w.1"ff�41 
PhoA 
I 
I 
, 
, 
I 
I 
I 
" 
, 
I 
I 
I 
, 
, 
I 
I 
DNA 
, PROTEIN 
Figure 4.3 :  Schematic representation of the pJEM l l AP fusion library. H. pylori Sau 
3A fragments were c loned into the Barn HI site of the pJEM l l vector. H. pylori 
sequences containing a promoter and signal sequence in frame with the pho A gene, and 
transcribed and translated by E. coli, will produce an AP fusion protein. The AP fusion 
protein, once exported across the cytoplasmic membrane, wil l  turn the recombinant 
colony blue on the substrate BClP. 
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and digested with Pst I and Kpn I to estimate the percentage of the l ibrary that contained 
DNA inserts . Al l  of the plasmids were found to contain inserts and the DNA insert 
sizes ranged from 200 to 2000 base pairs (bp) with an average insert of 1 000 bp (data 
not shown) . The pJEM 1 1  H. pylori l ibrary was screened for recombinants encoding 
exported AP fusion proteins by plating 1 2,000 of the E. coli transforrnants onto medium 
containing kanamyc in  and the chromogenic substrate BCIP. Recombinant c lones 
producing enzymatical ly active AP turn blue in the presence of this substrate. Two 
hundred and eighty of these transformants (designated p lasmids pJHp l -280) turned a 
detectable blue after overnight incubation, representing 2 .3% of the total number of 
transforrnants (see Figure 4.4) . Each of these blue recombinant colonies were selected 
and stored as glycerol stocks at -70°C for future analysis . 
(a) 
(b) 
Figure 4.4 :  (a) Recombinant E. coli pJEM l l H. pylori recombinant colonies. AP+ 
clones turn blue in the presence of the colorimetric substrate, BCIP. (b) S ingle colony 
streaks of pJEM l l  recombinant colonies. 1 ,  pJEM l l no insert; 2, pJEM l l white 
recombinant c lone; 3 ,  pJEM l l blue recombinant clone. 
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4.4.2 Screening of the H. pylori AP fusion l ibrary for known H. pylori gene 
sequences 
In other studies, all H. pylori strains have been found to contain a gene encoding the 
vacuolating cytotoxin (VacA), responsible for vacuolating of epithelial cells,  and 
expressed by approximately 50% of H. pylori strains. The clinical strain used in this 
study was previously shown to be VacA+ (see Chapter 3 .4 .2) and so the presence of the 
gene in the exported protein library was investigated. Sequences of the flagellin subunit 
A gene (jlaA) were also used as a probe to test for its presence in the l ibrary . A PCR 
product was amplified from H. pylori 1 7874 genomic DNA using the primers designed 
to the vac A and flaA genes, radiolabelled and used as a probe to screen the blue 
colonies. Two positive clones (pJHp234 and pJHp248) were identified using the vacA 
probe (see Figure 4.5) and one clone was positive forjlaA (pJHp5 1 ) . The recombinant 
PJHp234 
PJHp248 
Figure 4.5 : Autoradiograph of Southern blot screening of the pJEM1 1  H. pylori library 
with the vacA gene probe. Approximately 300 blue recombinant colonies were patched 
onto LB medium and transferred to membranes (one plate of fifty is presented in this 
figure). The vacA gene was radiolabelled and used to screen the library as described in 
the materials and methods (section 4.3 .2) .  Plasmids pJHp234 and pJHp248 contained 
H. pylori insert DNA that hybridised to the vacA gene probe. 
plasmids from the two vacA positive clones and the single flaA positive clone were 
isolated. Restriction endonuclease analysis showed the DNA insert sizes to be 1 1 80, 
4 1 5  and 620 bp respectively (data not shown). Sequencing of these inserts revealed that 
each contained H. pylori sequence with homology to the known vacA or flaA H. pylori 
sequence. However, none of these sequences were in-frame with the phoA gene. 
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4.4.3 Sequencing of the H. pylori DNA inserts encoding exported proteins 
PCR amplification of the pJEM 1 1  inserts from thirty-six of these blue E. coli 
recombinants using primers JEM! and JEM2, revealed that the insert size ranged from 
approximately 280 to 2200 bp in length (Figure 4.6) with a mean size of 767 bp. The 
DNA inserts from twenty- eight recombinant AP+ clones were sequenced to identify the 
ORFs responsible for expression of the phoA gene fusions. DNA and protein databases 
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Figure 4.6: PCR amplification of thirty-five blue E. coli pJEMl l  H. pylori recombinant 
p lasmids . Primers JEMl and JEM2 were used to amplify the H. pylori i nsert by PCR 
(see section 4 .3 .2 . 1 ) . PCR products were separated on ethidium bromide stained 1 % 
agarose gels and visualised under UV light. Insert sizes were deduced from a direct 
comparison with size markers labeled on the left. 
were searched to identify similarities between the insert DNA and deduced amino acids 
sequence with sequences in the databases .  Following the release of the H. pylori 
genome sequence (Tomb et al. , 1 997), the insert sequences were re-submitted to the H. 
pylori database and the ORFs they encoded identified (see Tables 4 .2 and 4 .3) .  The 
results of these findings are presented in the following sections. 
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4.4. 3 . 1 Identification of H. pylori ORFs with the start codon in frame with pho A 
Twenty-three percent of the open reading frames CORFs) identified in the H. pylori 
genome were predicted to contain a s ignal peptide (Tomb et aI., 1 997) . Table 4 .2 l ists 
the H. pylori ORFs identified that contained expression sequences and a start codon in­
frame with the pho A gene. The majority of the ORFs identified encoded hypothetical 
secreted or membrane proteins of unknown function. Sequence analysis (Chapter 2 .7 .3)  
revealed that the mcUority of ORFs listed in Table 4.2 were predicted to encode inner 
membrane proteins (9 out of 1 6) ,  while four encoded periplasmic proteins and two, 
outer membrane proteins. Three of the identified genes (HPO I 44, HP0375 and 
H P0758)  were not previously assigned a signal peptide in the publ ished genome 
sequence (Tomb et al . ,  1 997) .  Analyses of  the predicted N-terminal amino acid (aa) 
sequence revealed features characteristic of bacterial signal sequences. The hydropathy 
plots of two of these proteins (HPO 1 44 and HP0758) were compared to a typical 
integral membrane protein (HP l 1 85)  and are presented in Figure 4.7 .  
HP0144 Hro7S8 
HP118S 
Figure 4.7 : Kyte-Doolittle (KD) plot of three integral membrane proteins. The ORF 
was translated from the start codon and the hydropathy of the individual amino acids 
plotted using WEB ANGIS software. Hydrophobic amino acids lie above the centre 
line, while hydrophillic amino acids fall below. 
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Table 4.2: Open reading frames (ORFs) with start codon in-frame with phoA, identified 
by sequencing of pJEM l l H. pylori insert DNA from recombinant blue colonies. 
HP/JHPv#;· 
0021 *1001 9  22 N/A H.pylori specific hypothetical protein 
0 1 44/0 1 32 27 Rhizobium 43.9 69.4 Cytochrome C oxidase sub unit (fixN) 
meliloti 
0247/0232 32, 1 09 Haemophillus 37.7 6 1. 0  ATP-dependent RNA helicase (deaD) 
inJluenzae 
037511 006 42, 85 N/A H. pylori specific hypothetical protein 
041 5*10969 26 Escherichia 44.4 67.6 Conserved hypothetical integral membrane 
coli protein 
0567*/05 1 4  1 08 Streptococcus 25.4 50.3 Cell envelope protein 
pneumoniae 
0726*10663 1 6  N/A Hypothetical protein (OMP) 
0758/0695 37 Haemophillus 47.6 68.8 Conserved hypothetical integral membrane 
inJluenzae protein 
0780*/071 7  34 N/A H. pylori specific hypothetical protein 
0896*/1 164 1 , 47 Helicobacter 1 00 100 Outer membrane protein (OMP1 9)(babB) 
pylori 
1 085 *10340 20 N/A H. pylori specific hypothetical protein 
1 1 17*11045 3, 4 Escherichia 32.3 53.2 Conserve hypothetical secreted protein 
coli 
1 1 36*/1064 38  Synechocystis 28.3 57.2 ATP synthase FO, subunit b (atpF) 
1 1 85*/ 1 1 1 1  2, 1 5, 30 Haemophillus 55.5 77.4 Conserved hypothetical integral membrane 
inJluenzae protein 
1 5 1 1 */1404 248 N/A H. pylori specific hypothetical protein 
1 568*/1476 33 N/A H. pylori specific hypothetical protein 
#The ORFs are listed according to the nomenclature and descriptions designated in the 
published genome sequence [3] .  * signal peptide designated to this gene product. N/A ­
not applicable (no significant homology was found to any other species in the database) . 
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Each protein contains regions of hydrophobicity throughout the protein consistent with 
an integral membrane protein. Indeed, PSORT II predicted each to be inner membrane 
proteins with several potential transmembrane domains. Neither HP0 1 44 or HP0726 
appear to contain a peptidase cleavage recognition sequence in their predicted aa signal 
sequence, suggesting that the signal sequence in this instance is acting as a signal 
anchor. HP 0 1 44 has 43 .9% aa sequence homology (% identities) to the cytochrome c 
oxidase, heme b and copper-binding subunit (fixN) of Rhizobium meliloti which is  
membrane-bound, while HP0375 and HP0758 remain hypothetical proteins. 
Figure 4.8 compares the hydropathy plots of a known secreted (or periplasmic) protein 
(HP 1 1 1 7) with a characterised outer membrane protein (HP0896) . In comparison to the 
inner membrane proteins shown in Figure 4.7,  the hydropathy plots of these proteins 
demonstrate the absence of the large stretches of hydrophobic segments characteristic of 
cytoplasmic membrane proteins .  The sorting signals which discriminate between 
periplasmic and outer membrane proteins in gram-negative bacteria are not well 
characterised, but features of their amino acid sequence can reflect differences in the 
sorting process of these two proteins. The hydropathy plots of the H. pylori membrane 
or secreted proteins  in Figures 4.7 and 4 . 8  illustrate the typical hydropathy plot 
observed in the N terminal region of an exported protein, and is representative of each 
of the H. pylori proteins listed in Table 4.2. 
HP111 7  HPffi96 
" r" �������,,),,�����-J. 
Ra,!diQ Pod t ! o �  
Figure 4.8: Kyte-Doolittle plot of HP 1 1 1 7 ,  an H. pylori periplasmic protein, and 
HP0896, an outer membrane protein (omp 1 9) identified by sequencing of the H. pylori 
inserts in recombinant blue pJEM l l clones. The ORF was translated from the ATG 
and hydropathy of the amino acids plotted using WEB ANGIS software. Hydrophobic 
amino acids lie above the centre line, while hydrophilIic amino acids fall below. 
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4.4 .3 .2 H. pylori ORFs that encode for proteins lacking recognisable signal peptides or 
start codons in frame with the pho A gene 
In addition to those H. pylori ORFs in-frame with the phoA gene, a number of unusual 
sequences were obtained for some blue recombinant clones. These are l isted in Table 
4.3 and have been divided into three groups. Group (a) lists those c lones that contained 
Table 4.3: Open reading frames (ORFs) with part of a gene fused to phoA, identified 
by sequencing of pJEM l 1 H. pylori insert DNA from recombinant blue colonies. 
HP/JHl'#r PJEMli 
clcjn,e # 
(a) 
02 1 4*10200 5 , 9 
0487*10439 29 
091 010846 7, 2 1  
0946/0880 1 0, 28 
1 4091 1 301  1 8  
Homo Sapien 36.6 
N/A 
Haemophillus 33.4 
injluenzae 
Haemophillus 35.9 
injluenzae 
N/A 
JHP0928 
(b) 
23, 3 1 , 42 N/A 
0243/0228 13 
0805/0741 17 
0823/0762 6 
1 579*/1486 25 
(c) 
1 350*11 269 1 2  
1491 */1 384 1 9, 24 
Helicobacter 
pylori 
Haemophillus 36.9 
injluenzae 
N/A 
N/A 
Bartonella 
bacillifo rmis 
40.6 
Haemophillus 35.0 
injluenzae 
60.3 
52.2 
60.8 
53.4 
64. 1 
58 .0  
Sodium-dependent transporter (huN aDC-I) 
Hypothetical outer membrane protein 
Adenine specific DNA methyltransferase 
(HINDIIM) 
Conserved hypothetical integral membrane 
protein 
H. pylori specific hypothetical protein 
Putative outer membrane protein 
Lipooligosacchatide ·biosy�th�si{Pf(}tejn 
(lex2B) 
Consefved.hypotheW.:alprQ� hl 
H, pYl()ri.§��i�C .li�ppth�tf9al���t�;�, , '.·· 
Carboxyl-terminal protease 
Putative phosphate permease 
#The ORFs are listed according to the nomenclature and descriptions designated in the 
published genome sequence [3] . * signal peptide designated to this gene product N/A= 
not applicable (no significant homology to any species i n  the database). 
1 05 
- --- - --
4 
part of an H. pylori gene fused to the phoA that did not include the start codon or N 
terminal region. These sequences generally included only the middle region of the ORF 
listed. Group (b) lists the ORFs that had their start codon and N terminal sequence in­
frame with phoA, but included an intervening sau 3A fragment preceding the phoA 
gene . Although it i s  possible that there is transcriptional read-through of these 
intervening sequences, the addition of extra sequences could complicate the 
interpretation of these results. The third group, group (c), includes two H. pylori inserts 
that appeared to contain homology to proteins encoded on the non-coding strand 
relative to the phoA gene. 
For each of the pJI-Ip clones listed in Table 4 .3  (a), the H. pylori insert sequence was 
analysed for the presence of any start codons in-frame with phoA preceded by possible 
promoter sequences .  In all cases, at least one A TG start codon was found to be in­
frame with the phoA gene and sequences resembling E. coli consensus promoter 
sequences were found upstream of the putative start codon . Sequences were also 
translated from these potential start codons to ensure read-through was possible to the 
phoA gene. In most cases, the translated sequence was identical to the protein sequence 
of the identified ORF. In addition, the translated sequences were assessed for regions of 
hydrophobicity that may be recognised as signal sequences (see Discussion) .  
The results obtained for each of these was similar and so the results of only one H. 
pylori insert (pJHp5 and pJHp9) in this category are presented. Plasmids pJHp5 and 
pJHp9 were found to contain identical insert sequences. Database searches revealed 
that the H. pylori insert sequence contained homology to HP02 1 4, encoding a sodium­
dependent transporter, however the homology was restricted to the region between 
nucleotides at position 343 to 1 1 1 9 (see Figure 4.9) .  The promoter sequences and start 
codon of this ORF were not included in the insert and therefore not responsible for 
expression and export of AP. Several potential start codons (A TG) were found to be in­
frame with the phoA gene and upstream of one of these was an E. coli consensus 
promoter sequence and ribosomal binding site. In addition, promoter prediction by 
neural network (Reese et al. , 1 996) predicted a + 1 of transcription site following the 
-10 and -35 consensus regions with a promoter score of 1 .0 (Figure 4.9) .  A hydropathy 
plot was drawn from the amino acid sequence translated from the predicted start codon 
(Figure 4 . 1 0) .  The N-terminal region showed the characteristics of a signal peptide 
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Q u e r y  GATCATCTTTCTTTTTATGGGAGGGTTTAT 
x :  : : : : : :  : : : : : :  : :  : : :  : : : : : :  : : : : : 
H P 0 2 1 4  CGCTAGCGTCAGCTCTTCTTACGCATCGCCGATCATCTTTCTTTTTATGGGAGGGTTTAT 
3 2 0  3 3 0  3 4 0  -35 3 5 0  3 6 0  - 1 0 7 0  
Query TTTAGCCCTAAGCATGCAAAAATGGAAT TGCACA( GCGCATCGCTTTAAGCP TTATTT� 
H P 0 2 1 4 
Query 
H P 0 2 1 4  
Query 
· . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .  . 
· . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .  . 
TTTAGCCCTAAGCATGCAAAAATGGAAT rTGCACAC GCGCATCGCTTTAAGCPTTATTT� 
� 8 0  3 9 r  4 0 0  4 1 0  4 2 0  4 3 0  + 1 R R S  :rr:![t!!�:�:::���r::!:!:' r!:rr:r:!!:::�tr!lr!!�r:�:!!�:r:�: 
4 4 0  4 5 0 4 6 0  4 7 0  4 8 0 4 9 0  
GTCTATGTGGGTGAGCAATACCGCAACGGCGGTGATGATGCTCCCTGTTGGCATGAGCGT/ 
: : : : : : : : : : : : : : : : : : : : : : : : : : : : : : : : : : : : : :  : : : : : : : : : : : : : : : : : : : : : : / 
H P 0 2 1 4  GTCTATGTGGGTGAGCAATACCGCAACGGCGGTGATGATGCTCCCTGTTGGCATGAGCGT/ 
5 0 0  5 1 0 5 2 0  5 3 0  5 4 0  5 5 0  
Query GCTCACTTATGTGATTTTCCCTTTAAAGATTAAAGAAATCCCAGGGGGTAAGGAAGTCAT 
· . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .  . 
· . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .  . 
H P 0 2 1 4  GCTCACTTATGTGATTTTCCCTTTAAAGATTAAAGAAATCCCAGGGGGTAAGGAAGTCAT 
9 2 0  9 3 0  9 4 0  9 5 0  9 6 0  9 7 0  
Query TAGGGTAGAGTTAAAAAAATTAGGCCGTTTGAGTCAGGCGGAAATCTCTGTGGGGATTAT 
· . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .  . 
· . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .  . 
H P 0 2 1 4  TAGGGTAGAGTTAAAAAAATTAGGCCGTTTGAGTCAGGCGGAAATCTCTGTGGGGATT AT 
9 8 0  9 9 0  1 0 0 0  1 0 1 0  1 0 2 0  1 0 3 0  
Query TTTTATTTTAGCGTCTTTAGGGTGGATTTTTTTAGGCGTAATGTTAAAATCTTGGGGCGT 
· . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .  . · . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .  . 
H P 0 2 1 4  TTTTATTTTAGCGTCTTTAGGGTGGATTTTTTTAGGCGTAATGTTAAAATCTTGGGGCGT 
1 0 4 0  1 0 5 0  1 0 6 0  1 0 7 0  1 0 8 0  1 0 9 0  
7 6 0  7 7 0  phoA s equence � 
Query TAAGATAGATAAAATTGATTCAGTGATCCGGATACGTACGGTACCTGACTCTTATA CA CA 
: : : : : : : : : : : : : : : : : : : : : : : : : :  : X  
H P 0 2 1 4  TAAGATAGATAAAATTGATTCAGTGATCGCTATGGGGGTTTCTGCGCTTTTATTCATTTT 
1 1 0 0  1 1 1 0  1 1 2 0  1 1 3 0  1 1 4 0 1 1 5 0  
Figure 4.9: DNA sequence al ignment between pJHp5/9 and the HP02 1 4  open reading 
frame showing the region of homology_ The Sau 3A sites (GATC) flanking the H .  
pylori insert i n  the pJEM 1 1  vector are shown shaded in  grey. The putative promoter 
sequences and start codon (A TG) are shown boxed along with the predicted + 1 of 
transcription. The sequences flanking the fusion point to phoA and the fol lowing phoA 
sequence (blue) is shown. The pJHp insert sequence was 95 . 3% homologous over the 
8 1 3  nt overlap (nudeotides 550-9 1 0  are not shown for diagrammatical presentation) .  
with a large stretch of hydrophobic amino acids and potential transmembrane domains, 
consistent with the report that this protein is an integral membrane protein. 
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Figure 4.10 :  (a) KD hydropathy plot of HP02 1 4  translated from the potential start 
codon fused in-frame with the phoA gene. (b) The first fifty amino acids translated 
from the start codon, showing the potential domains and cleavage site that may 
substitute for a signal peptide. 
4 .4 .3 .3 H. pylori promoters are functional in E. coli 
Sequencing of the pJEM 1 1  H. pylori inserts revealed that a number of H. pylori ORFs 
expressing putative exported proteins could be identified on the basis of active alkaline 
phosphatase. Little data is available on the promoter sequences of H. pylori. With this 
in mind, the H. pylori ORFs expressing functional AP were investigated for the 
presence of consensus E. coli promoter regions. This was done both manually and with 
the aid of Promoter Predictions by Neural Network (Reese et al . , 1 996) .  A 
representative group of these promoter sequences are presented in Figure 4 . 1 1 . The 
predicted potential - l O  and -35 promoter regions are shaded in grey, and the ribosomal 
binding domains (Shine-Dalgarno consensus) and the start codon (ATG or GTG) of 
each were labeled in red. The results demonstrated that a number of H. pylori genes 
contained promoter sequences that conformed to the consensus sequences of E. coli (570 
promoters . In one ORF (HP I 1 1 7) ,  the region upstream of  the start codon in the 
pJEM I l vector was only long enough to include a potential - 1 0  region, with a -35 
region absent, indicating that this region may not be critical for functional transcription. 
108 
ORF'. �Q UENCE UIBTREAM OP TIlE PUfAllYE Sf ART CODON 
0144 ATT AAGCTTTI'TGAAAAAGAT AAAA TTTT AT AATT AATGTTTATCTTTGTTGAA TTT ACTACAAAT AGG AGT ATTGCATG 
( 1 .0) 
0375 GCTTTTCATTGATTAAATCCATTGG TGCATG CTAAAATAAAACG ATTAATAAAAA CAAAT CGTTAGAAAGAAAGAAG TTAATG 
(0 .94) 
0567 ATTATAAGTT AAAAGAGGTTTTTT ATCCTI' AAAAGAGCGTTI'TT TAGCT AACATTTGAT AATT TI'TGG TTCGTTT AA! GGGGAT AATTTCATG 
(0 .99) 
0758 AGG TGTAATTTI'TT GCGCTAAACAAGCACAAAAATTCT AT CA TTTI'TG CGCGGT ATI'TT CATTTT AACAAGGAGCAAAAA TG 
(0 .8 1) 
0780 GGG CCCCGGATCCCTTTTTT ATTT AAT,TATGGCTGAGCGTTGAGAG AAA T AAAAA GGAGAGTG ATG 
(0 .97) 
0896 GATCTTATTCTTTTAAAAGACTTATCTAACCATTTTAATTTCAAGG AGAAAC ATG 
( 1 . 00) 
1085 TTTGGCAT AAAACCO:CTI'TTAG TT AT AATATAGATTTTATTTT AGCTAAAAATGGTAGGG GTTT T AGCAAGGAATG 
( 1 .00) 
1 1 1 7 TT TT AAGATTGGT AGCCATTG GCATT ATG TTTGATCTTATT AAAGCAGAGT AACAAATG 
(0 . 98) 
1 185 TT MM TTTTGTCrr AT AATTCAAGCTTTCAAATTGAATAAAATTT AAC CC TT AAGATTT AAATG 
(0 .9 1) 
1 5 1 1 CTCTGAGCTTT ATTT AAA AAT CAG CAAG TT AGAAATTTCTCCCAATTCTCAAGTGG GAGCG AGCGTG AAA TO:GCT ATG 
(0 .9 1) 
Pigure 4 . 1 1 :  Predicted putative promoter sequences for H .p.m.'UiORFs identified in the pJEM l l library. The start cod on for each 
ORF was fused in-frame with the jWI.7A gene . The - 1 0  and -35 E. cub'consensus promoter regions and predicted + 1  transcription are 
shaded in grey. The predicted ribosomal binding site (RB S) and start codon (A TG) are hlghlighted in red . The promoter and + 1 
transcription sites (underlined) were predicted using Neural Network Promoter Prediction (see text) .  The ORF number corresponds to 
that designated in the published genome (Tomb �r i'lf) 1 997) and the promoter score (0 . 1 - 1 . 0) is shown in brackets for each promoter 
sequence. 
4.4.4 Detection of AP fusion proteins from recombinant E.coli 
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The molecular weights of the AP fusion proteins were determined by reacting lysate 
samples of recombinant E. coli with rabbit antibody raised to AP antigen .  Lysate 
protein was prepared from twenty randomly selected E. coli AP+ transformants and a 
non-recombinant control from 40 ml cultures as described in the Materials and Methods 
(4. 3 . 3 .2) .  In each recombinant lysate sample, more than one band was observed on the 
Western blots (Figure 4 . 1 2) .  Commercially purified alkaline phosphatase was run on 
the gel as a positive control and had an apparent molecular mass of 54 kDa, A protein 
band of 54 kDa was also observed in the lysate preparations, in addition to higher 
molecular weight bands ranging from approximately 56 to 80 kDa. The predicted and 
observed molecular weights of a number of these were calculated and these compared 
favourably when the molecular weight of the highest band was taken as the observed 
molecular weight. The observation of multiple forms of each AP fusion suggests that 
they may have been post-translation ally modified, possibly by proteolytic degradation. 
No protein bands were observed less than 54 kDa, suggesting that proteolysis appeared 
to be limited to the H. pylori encoded peptide. 
(a) 2 3 4 5 6 7 8 9 AP 
(mw) 
84 _ 
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Figure 4.12:  Western blot analysis of lysate protein from various blue recombinant 
pJEM l l  H. pylori clones screened with a polyclonal antibody raised against alkaline 
phosphatase. Lysate proteins were separated on a 1 2 . 5% SDS-PAGE gel and 
transferred to PVDF membrane for Western blotting. Lanes 1 & 1 1 ; Kaleidoscope 
marker' ; lane 2-9; pJHp33,pJHp9, pJHp37, pJHp42, pJHp50, pJHp32, pJHp5, pJHp5 1 ;  
lanes 1 2- 1 9; pJHp45 , pJHp4, pJHp35, pJHp2, pJHp34, pJHp46, pJHp43, pJHp49. AP = 
commercial alkaline phosphatase control. 
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4.5 Discussion 
This study has described the identification of H. pylori ORFs that contain sequences in 
their N-terminal region that code for signals able to express and export alkaline 
phosphatase in an E. coli background. A number of sequences containing export 
s ignals identified in the pJEM 1 1 l ibrary corresponded to the N-terminus of a ORF 
designated as a signal peptide in the published genome (Tomb et al. , 1 997), while 
others appeared to contain random sequences capable of acting as signal peptides. 
Signal peptides appear to have highly variable structures with only a minimal amount of 
sequence conservation (Nielsen et al. , 1 999;  Edman et al. , 1 999) .  This was 
dramatical ly demonstrated in two studies in which random DNA sequences were c loned 
in front of an SP-Iacking p-Iactamase gene in E. coli (Zhang and Broome-Smith. ,  1 989) 
and a SP-Iacking invertase gene in yeast (Kaiser et al. , 1 987).  In both cases, a large 
fraction ( 1 5-20%) of random sequences permitted export. These "functional" sequences 
were reminiscent of degenerate SPs, with an enrichment of positively over negatively 
charged residues and stretches of hydrophobic or uncharged residues. Their results 
supported the notion that there is no sequence specificity to the hydrophobic core of the 
signal sequence and that any hydrophobic sequence of the appropriate length can act as 
a signal (Schatz and Beckwith, 1 990). In most cases, the SP was found to be 
noncleaved, most l ikely due to the more highly constrained pattern of amino acid 
normally present in the region surrounding the signal peptidase cleavage site . 
The alkaline phosphatase fusion system used in this study also identified a number of 
middle hydrophobic regions of H. pylori proteins capable of exporting AP in E. coli. 
These were predicted or identified as being cytoplasmic membrane proteins . Poly topic 
cytoplasmic membrane proteins span the membrane at least twice via segments of 
mainly hydrophobic amino acids and each of these segments is potentially capable of 
targeting the nascent polypeptide to the cytoplasmic membrane and of initiating its 
insertion by interacting with membrane l ipids in the same way as signal peptides 
(Pugsley, 1 993).  One model envisages poly topic membrane proteins being built up by 
the independent, sequential action of a series of signal sequences and stop transfer 
signals. Since transmembrane segments of poly topic membrane proteins are generally 
highly hydrophobic, it is not surprising that many of them can function as signal 
sequences when fused to a suitable reporter protein (Cheah et al. , 1 994) . The earlier 
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work on AP fusions provides evidence that alkaline phosphatase export can be 
promoted not only by signal sequences of periplasrnic proteins but also by signal 
sequences within complex cytoplasmic membrane proteins (Manoil  and Beckwith, 
1 985) .  
In  Gram-negative bacteria, proteins can be exported to several different compartments 
or structures. The majority of ORFs identified in this study encoded putative inner 
membrane proteins. Hikita and Mitzushimu ( 1 992) have extensively investigated the 
secretion efficiencies of a large number of signal peptide mutants of E. coli AP. Their 
data indicate the importance of threshold hydrophobicity and certain length l imitations 
for the central, hydrophobic part of the signal peptide . Differences in amino acid 
sequence properties of the foreign protein can also affect secretion efficiences by 
influencing the ability of the signal peptide to fold into certain conformations, and/or to 
interact with various proteins during the secretion process. The initial results presented 
in this study indicate that SPs derived from cytoplasmic membrane proteins appear to 
be highly efficient at exporting AP. However, further sequencing of the pJEM 1 1 clones 
may eliminate this bias by identifying more periplasmic or outer membrane proteins. 
Without doing local isation studies, the possibil ity that some outer membrane proteins 
have been incorrectly predicted as inner membrane proteins also exists. 
The Western blot experiments using anti-alkaline phosphatase detected multiple bands 
which may represent breakdown products of the full-length fusion proteins. Attaching a 
foreign protein to alkaline phosphatase is likely to result in the accumulation of 
incorrectly folded AP or AP with an additional peptide sequence that may be more 
readily accessible to proteolytic cleavage. A number of studies have demonstrated that 
many secreted fusion proteins are highly sensitive to proteolytic degradation in the 
periplasrnic space (Manoi! and Beckwith, 1 985 ;  Hoffman and Wright, 1 985) .  A fusion 
protein containing the N-terrninal moiety from an inner membrane protein and a C­
terminal derived from AP was shown to be proteolytic ally unstable and was degraded 
into a smaller product with the approximate molecular weight of the AP portion 
(Strauch and Beckwith, 1988) .  The size of the foreign protein attached to the reporter 
protein can also effect the amount of degradation in the periplasm (Guigueno et al. , 
1 997) .  Smaller H. pylori proteins fused to AP may lack regions containing amino acid 
1 1 2 
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residues that are important for folding of the foreign protein into a proteolysis-resistant 
conformation. 
In E. coli, over twenty different intracellular proteases have been identified (WaIler and 
Sauer, 1 996). However, relatively little is known about the biochemical or structural 
properties of proteases which may be responsible for degradation of misfolded or 
abnormal proteins in the periplasrnic compartment of bacterial cel ls .  Such a function 
has been attributed to the periplasmic serine proteases, DegP, which is also known as 
HtrA (or protease Do) and DegQ (WaIler and Sauer, 1 996). DegP is required for E. coli 
growth at elevated temperatures and is involved in the degradation of abnormal 
periplasmic proteins such as unfolded proteins which accumulate in the periplasmic 
space fol lowing heat shock or other stress conditions (Kolmar et al. , 1 996). Mutations 
in the degP gene result in decreased degradation of chimeric membrane and periplasmic 
proteins (Kolmar et al. ,  1 996). A degP mutant may therefore be useful in reducing 
breakdown of such fusion proteins in the periplasm of E . coli. Mutations in degP have 
been shown to prevent the degradation of certain periplasmic fusion proteins and mutant 
forms of maltose-binding protein in addition to stabil ising a number of other ordinarily 
unstable cell envelope proteins (Strauch and Beckwith, 1 988 ;  Baneynx and Georgiou, 
1 990). A particularly dramatic increase in expression of fusion proteins is also 
observed in strains of E. coli with mutations in rpoH ( RNA polymerase sigma factor 
responsible for heat shock protein synthesis) ar..d with rpoH degP double mutants 
(Meerman and Georgiou 1994) .  The use of strains that are deficient in known cell 
envelope pro teases such as DegP can therefore permit the selection of a suitable host 
based on reduced protease activity for these types of studies. 
In addition to the necessary function of the signal sequence in directing export of AP in 
this system, the presence of a promoter region that is recognised by the E. coli 
transcription and translational machinery is also essential .  Spec ific recognition of 
prokaryotic promoter sites by E. coli RNA polymerase is largely mediated by associated 
sigma factor 70 (J70) .  In many bacterial species , most promoter sequences are 
recognized by (J70 -l ike factors at two hexameric sequences centered around positions 
- 1 0  and -35 from the tran criptional start site in E. coli (Kumar et aI . ,  1 993) .  This 
study identified a number of potential H. pylori promoters with consensus sequences to 
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E. coli promoter regions .  Sequencing of the H. pylori genome has revealed a very 
restricted number of transcriptional regulators (Tomb et aI. ,  1 997) . A recent study 
comparing the promoter sequences from eleven different H. pylori genes for which 
primer extension data was avai lable identified a consensus - 10  hexamer (TA TaaT) 
which c losely resembled the - 10  consensus sequence in E. coli (TATAAT) (Forsyth et 
al. ,  1 999). However, they were unable to identify an obvious -35 consensus sequence, 
leading them to bel ieve that there may be structural differences between the H. pylori 
RpoD and orthologous proteins in other bacterial species . The highest degree of 
degeneracy found in domain 4 of H. pylori RpoD (encoding signal factor 80, 0'80) (Beier 
et al. ,  1 998) is consistent with the presence of -35 promoter elements in H. pylori that 
are quite different from those found in E. coli. Alignment of the vacA gene from twelve 
different H. pylori strains also revealed a TAAAAA consensus sequence at - 10  which 
matched the consensus E. coli - 1 0  hexamer (T AT AA T) at four of six positions . 
Alignment of the vacA -35 regions revealed a consensus sequence (TTT ATG) that 
matched the E. coli consensus at 3 of 6 positions (Forsyth et al . ,  1 999). This was 
consistent with the promoter regions investigated in this study where, according to the 
predicted + 1 transcription, a - 1 0  consensus region was present, while the -35 region 
was often more ambiguous (Figure 4. 1 1 ) . 
Detailed nucleotide sequence analysis of the DNA region upstream of the transcription 
start points of the H. pylori cagA and cagB genes also revealed similarities to the - 10  
consensus sequence recognised by Ecr70, but with poorly conserved -35 regions (Spohn 
et aI. , 1997).  Promoters with highly conserved - 1 0  regions but poorly conserved or 
missing -35 regions have been reported for other pathogens such as Mycobacteria 
species (Bashyam et al., 1 996) . Interestingly, sequences upstream of the - 1 0  region of 
one promoter (cag A P I )  revealed the presence of a TGn motif. This motif has been 
described previously as an extended - 10  region, n�cessary to promote transcription by 
Ecr70 (Kumar et al. ,  1 993). Thus, it is possible that, in the promoters of H. pylori in the 
Cag PAl, these 'extended' - 10  motifs compensate for the lack or poorly matching -35 
region. Because al l three promoters could be activated in E. coli and by Ecr70 in vitro, it 
indicates that their nucleotide sequences bear the information necessary for recogntion 
by the major RNA polymerases from both H. pylori and E. coli. This is consistent with 
the finding that a number of exported proteins identified in this study contained 
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sequences encoding expression sequences recogn ised by E. coli and presumably H. 
pylori. Beier et al. , ( 1 998) recently demonstrated that transcription in  H. pylori i s  
regulated by  an RNA polymerase that shares functional similarities with the EO'70 RNA 
polymerase from E. coli. An EO'7°- like promoter also appears to regulate transcription 
of FlgR and other genes coding for structural components of the flagel lar export 
apparatus (Spohn and Scarlato, 1 999). Other studies have shown that a separate operon 
in H. pylori coding for both fJageUin and house-keeping genes contains a promoter that 
shows s imi larities to the E. coli 0'70 consensus ( - 1 0 TAAAAT, -35 TGGAT A. )  by 
primer extension analysis (Porwoll ik et al., 1 999). 
Therefore, H. pylori RpoD may uti l ise an extended - 1 0  promoter, perhaps analogous to 
a set of E. coli 0'70 promoters that contain a TGn motif immediately upstream of the - 1 0  
hexamer (Spohn et al. , 1 997 and Kumar et al. , 1 993) On examination of the predicted 
promoter sequences upstream of the ORFs identified in this study, no evidence was 
found of extended - 1 0  promoters. However, H. pylori appears to use both extended 
- 1 0  and -35 binding sites since mutations in the - 1 4  position dramatical ly  reduce 
transcription with the cagA P I  promoter and, despite a lack of -35 consensus, mutation 
of this region also resulted in decreased levels of transcript. The lack of conservation 
among H. pylori promoters outside the - 1 0  hexamer in this study and others described 
above, suggests that there may be considerable variation in the avidity of RpoD binding 
to different promoters. This may represent a mechanism for determining the levels at 
which individual genes are constitutively transcribed by H. pylori (Forsyth et al. , 1 999). 
A genetic approach using transposon shuttle mutagenesis, was recently used to identify 
adhesin genes by disruption of their function (Odenbreit et al. ,  1 999) . From a collection 
of H. pylori mutants in secreted proteins, two clones were isolated with reduced binding 
abi l ity and both were found to encode integral outer membrane proteins (HP09 1 2  
(omp20) & H P09 1 3  (omp2 1 )) .  Interestingly, no consensus promoter sequences were 
identi fied upstream of the + 1 transcription start s ite of the operon. The study also fai led 
to express functional protein from these genes in E. coli, indicating that the inner 
membrane processing and/or outer membrane insertion of the proteins interfered with 
the survival of E. coli. A similar phenomenon has been found for expression of th,e 
recombinant H. pylori vacA gene (Schmitt and Haas, 1 993) .  The amino acid sequence 
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of these proteins carried a C-terminal autotransporter motif, also identified in  VacA. 
Thus, it may be possible that this type of transport mechanism can be lethal in  a foreign, 
but heterologous host. Proteins containing N-terminal sequences processed across the 
outer membrane by this pathway may therefore not be detected using this system. In 
addition there are several other l imitations to the presented strategy for identifying 
exported and secreted proteins .  Only expressed and translocated proteins wi l l  be 
detected and thi s  relies on a gene fusion occurrine in a region containing a recognised 
signal and promoter sequences. In addition, AP fusions to significant stretches of 
hydrophobic amino acids that are present in cytoplasmic proteins can result in alkaline 
phosphatase activity. Spontaneous lysis of bacteria could also potentially generate false 
AP+ clones . However, experiments where phoA was fused to the blaF start codon 
without a signal sequence and grown in Mycobacteria smegmatis on BCIP medium 
produced colonies that remained white. Evidence that AP was being produced in the 
cytoplasm was demonstrated by Western blots , indicating that a AP+ phenotype i s  
generally associated with a true exported protein (Lim et  al. , 1 995). 
Despite these limitations, the results described in this study demonstrate that the phoA 
technology for genetic identification of exported proteins can be successfu l ly adapted to 
H. pylori and that an E coli environment can al low expression of these genes . The 
biochemical purification of surface-associated proteins from H. pylori is difficult and 
time-consuming because of the strong tendency for autolysis of the bacteria. The use of 
gene-fus ion methodology al lows for the s imple and rapid identification of genes 
encoding for surface-associated proteins, without the complications associated with 
biochemical purification methods and has allowed the identification of a number of 
exported proteins that can now be assessed for their role in  the host response to H. 
pylori infection . 
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Chapter 5 Biochemical and Immunological Analysis of 
E.coli Alkaline Phosphatase Fusion Proteins 
5.1 Abstract 
An H. pylori genomic l ibrary was constructed in the plasmid vector pJEM l l to create a 
pool of fusion proteins containing H. pylori gene sequences encoding exported proteins 
fused to alkaline phosphatase (AP). The subcellular location of these fusion proteins in 
E. coli was determined in order to faci litate purification of AP fusion proteins. Cultures 
of cells from twenty pJEM l l AP+ transformants were fractionated into intracel lular, 
periplasmic space and extracel lular protein fractions. Western blot analysis was carried 
out with the cel lular fractions using commercial antibodies raised against alkaline 
phosphatase to detect the fusion proteins, and also with antibodies raised against �­
galactosidase (�-gal) to monitor its distribution as an intracellular protein marker. In 
addition, the cell fractions were assayed for both AP and � -gal activity. These 
experiments demonstrated that the majority of AP activity was detected in the 
periplasmic space of the E. coli cel l ,  indicating that the fusion proteins were being 
transported across the cytoplasmic membrane. Western blot analysis was carried out, 
using patient sera as probe, against ten partially purified periplasmic space AP fusion 
proteins. The initial screen identified one fusion protein (pJHp20) that was recognised 
by sera from H. pylori infected patients. In other experiments, the periplasmic space 
protein fractions were assayed for their abil i ty to stimulate proliferation of peripheral 
blood mononuclear cells (PBMC) from H. pylori infected patients. None of the protein 
preparations stimulated proliferation of PBMC above background levels. The study 
presented in this chapter describes the identification of a novel exported protein  
involved in the humoral host response to H. pylori infection. 
5.2 Introduction 
In the previous chapter, the construction of a genomic l ibrary was described in which a 
pool of alkaline phosphatase (AP) fusion proteins was used to identify H. pylori gene 
sequences encoding proteins exported by the general secretory pathway (GSP). In 
Gram-negative bacteria, such as E. coli, proteins secreted via the GSP are located in the 
periplasmic space or as components of the inner or outer bacterial cel l membrane 
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(Pugsley, 1 993) .  In contrast, H. pylori secretes proteins to the extracel lu lar mileu, 
where many function as viru lence factors and/or targets for the host immune response 
(Mai et ai. , 1 99 1 ;  Huang et al. , 1 995 ;  Munzenmaier et ai. ,  1 997) . Ultrastructural 
studies have shown that the H. pylori bacterial cell consists of a well-defined outer 
membrane separated from the bacterial body by a thin periplasmic space (Fiocca et aI., 
1 999) .  The mechani sms by which H. pylori releases or secretes its viru lence factors 
through these compartments are not wel l  understood. Active secretion (Vanet and 
Labigne, 1 998) and bacterial autolysis (Phadnis et ai. , 1 996; Cao et al., 1 998) have been 
proposed to explain the extracel lular release of cytoplasmic proteins such as heat-shock 
proteins and urease. The H. pylori cag pathogencity is land may also encode a novel 
secretion system for del ivery of bacterial constituents into host cel l s  (Censini  et al. , 
1 996) .  Sequencing analysis of the H. pylori genome (Tomb et al. , 1 997), and of H. 
pylori gene sequences encoding export s ignals (John son et al. , 1 995 ; Odenbreit et al. ,  
1 996; B ina et al. , 1 997) has revealed that H. pylori signal peptides are an average length 
of 25 amino acids and contain features consistent with other Gram-negative bacteria 
such as E. coli (Tomb et al. , 1 997). The export signals from several well characterised 
H. pylori exported proteins (Yoshida et al., 1 999; Chevalier et al. , 1 999) also suggests 
that H. pylori exports some proteins to subcel lular locations in a manner similar to E. 
coli. 
The question then arises as to the fate of H. pylori exported fusion proteins when 
expressed in a heterologous host such as E. coli. As the s ignal peptides are s imi lar i n  
length and the cleavage recognition site conserved (Tomb e t  al., 1 997), one might 
expect such fusion proteins containing a functional signal peptide to be exported across 
the E. coli plasma membrane and cleaved by signal peptidase. However, it is not easy 
to predict what wi l l  happen to these proteins once they are in the periplasmic space. 
One possibil ity is that they wil l  be recognised as foreign proteins and wi l l  be degraded 
by host proteases (Manoil and Beckwith 1 985 ;  see also Chapter 4). Alternatively, if 
targeting information is present in the fusion protein then the protein may end up being 
translocated to the outer membrane. One of the advantages of using colorimetric 
screening of AP activity is that fusion proteins which are present and enzymatically 
active in  the periplasmic space can be readily detected. S ignal peptides from both 
periplasmic and outer membrane proteins fused to alkal ine phosphatase and expressed 
in E. coli have been shown to be efficiently targeted to the periplasm (Hoffman and 
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Wright, 1 985) .  However, i t  is  not known if secretion into the periplasm occurs when 
AP is fused to export signals from a heterologous species such as H. pylori. 
Another question which is raised by expression of fusion polypeptides in heterologous 
hosts is whether the structural and conformational integrity of the polypeptide wi l l  be 
conserved to the extent that epitopes, normal ly recognised in the native protein, can stil l  
act as potent targets for the host immune response. The identification and 
characterisation of individual H. pylori antigen ic proteins may be important for the 
understanding of the mechanisms of infection and the host' s immune response to the 
orgamsm. In addition, this information might be useful for the design of new diagnostic 
tests. 
The principal objectives of the work described in this chapter were to investigate the 
subcel lu lar di stribution of H. pylori fus ion proteins expressed in E. coli. If 
predominantly located in the periplasmic space, it was hoped to take advantage of this 
distribution as a rapid step to partial ly purify the recombinant fusion protein .  The 
periplasmic fractions, enriched for the H. pylori fusion protein,  could then be assayed 
for their immune recognition using patient sera in Western blot assays and also i n  
Iymphocyte proliferation assays using peripheral blood mononuclear cel ls (PBMC' s) 
isolated from H. pylori infected patients. 
5.3 Materials and methods 
5.3. 1 Isolation of periplasmic space proteins 
Recombinant plasmids were transformed into E.coli DE3 (BL2 1 ), a strain carrying an 
induc ible lacZ gene. Plasmid DNA was isolated from E. coli DH l OB AP+ c lones and 
transformed into E. coli strain DE3 using standard procedures .  The periplasmic 
proteins were purified by a procedure based on a method described by Neu and Heppel 
( 1 965) .  The cel ls were grown in M63 minimal media ( l Og (NH4)2S04' 68g KH2P04, 
2 .5mg FeS04.7H20, pH 7) supplemented with 0.4% glucose, 1 mM MgS04 and 0.4% 
casamino acids. The cultures were grown to late-log phase (OD 0.7-0.9) and harvested 
by centrifugation. The supernatant was stored as the extracel lular fraction and the cells 
were washed with 10  ml of 10  mM NaCI,  then agitated gently in  10 ml of sucrose 
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solution (25% sucrose, 1 .5 mM EDT A) at RT for 1 0  mins. After centrifugation, 5 ml of 
ice-cold water was added to shock the cells which were then incubated on ice for 1 0  
mins .  The preparation was filtered through a 0 .2 �m membrane fi l ter (Mil l ipore 
Corporation, MA, USA) to collect the periplasmic fraction. The cells were then washed 
in 1 0  mM Tris-HCI pH 8 , 1 mM EDTA and sonicated to release the intracel lular protein 
after incubating on ice for 30 mins with 0 .5 mg / ml of lysozyme.  The periplasmic 
space (PS) protein was then concentrated using Centricon membrane filters with a 1 0  
kDa cut-off (Amicon Division, Beverly, USA) to a final volume of approximately 0 .5 
ml according to the manufacturer' s instructions. Protein concentrations in each fraction 
were determined using the BCA colorimetric micro assay kit (Pierce, Rockford). 
5.3.2 Enzyme assays 
5 .3 .2 . 1 Alkaline phoshatase assay 
Alkaline phosphatase assays were carried out on protein extracts based on a method 
originally described by Brickman and Beckwith ( 1 975) .  Total protein ( 1 00 �l aliquots) 
or protein fractions (extracellular, periplasmic or intracel lular) were assayed in 900 �l 
of I M  Tri s-HCI (pH 8 .0) and 1 00 �l of 20 mM p-nitrophenylphosphate (Sigma, St .  
Louis) . Tris-HCI was used as a blank. Enzyme reactions were carried out in  triplicate 
at 370C for 40 minutes unless otherwise stated. Assay reactions were stopped by the 
addition of 1 00 �l of 1 M K2HP04, and the optical density was measured at 420 nm. 
As a control ,  0 .05 �g of E. coli alkal ine phosphatase (Pharmacia B iotech, Uppsala, 
Sweden) was assayed along with the protein samples. The protein concentration of 
each sample was measured to al low calculation of the spec ific activity of each 
according to the fol lowing formula: 
Activity (units / min / ml) = ODW) x 1 03 
Vol (mls) x Time (mins) x OD600 
5 .3 .2 .2 Beta-galactosidase assay 
The assay of � -galactosidase activ ity In  proteil i samples was based on a method 
described by Miller ( 1 972). Each sample was diluted as appropriate and assayed in 
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dupl icate in  800 1-11 of distil led water with the addition of 200 1-11 of 5x  Z buffer ( lOO 
mM Na2HP04.7H20, 350 mM NaH2P04.H20, 1 0  mM KC1, 2 mM MgS04, pH 7) .  As a 
blank, 800 1-1  of water was used. After equi libration at 300C for 5 mins, the reaction 
was started by the addition of 200 1-11 of o -nitrophenyl-�-D-galactopyranoside (ONPG) 
(S igma, St. Louis), and the time recorded for sufficient yellow colour to appear. The 
reaction was stopped by adding 500 1-11 of I M  Na2C03 . One unit of �-galactosidase was 
calculated as the amount of enzyme which l iberates 1 I-1mol of o-nitrophenol per min at 
30oC, pH 7 under the above conditions. Al l  assays were done i n  trip l icate with an 
average variation of less than 10% between samples. 
5.3.3 Western blotting 
For detection of alkaline phosphatase in the cel lular protein fractions, Western b lot 
assays were performed using a polyclonal antibody raised against alkaline phosphatase 
as previously described (see Chapter 4 . 3 . 3 .2)  or us ing the chemiluminescence 
developing system as fol lows. Approximately 1 0  I-1g of protein was electrophoresed on 
a 10% SDS-PAGE gel and transferred to PVDF membrane using standard procedures 
(Chapter 2 . 1 0 .2) .  Following i ncubation in the primary antibody, the membrane was 
incubated for 1 hour in a 1 : 2,000 dilution of anti-mouse - POD conjugate (Boehringer 
Mannheim) and developed by chemiluminescence. For detection of �-galactosidase, 
the Western b lot procedure was as described above for chemi luminescence 
development, with the exception that the primary antibody was a monoclonal antibody 
against �-galactosidase (Promega #537 10, Immunoscreening system) di luted 1 : 5 ,000. 
5.3.4 Immunoassays 
5.3 .4. 1 Western blotting 
Cross-reactive antibodies against E. coli removed from patient serum using an affinity 
column as described in Chapter 2 (section 2 . 1 2) .  One hundred microlitres of serum 
from patients PSO I 0, PSO I 4, PS0 1 8 , PS025 and PS027 (see Table 2.4 for patient 
details) was made up to 1 rnl with Tris buffered saline (TBS) and appl ied to the column. 
The eluted fractions containing the purified serum, determined by reading the 
absorbance at 280 nm, were pooled and used as the primary antibody in the Western 
blot. Approximately 40 I-1g of periplasmic space protein from pJHp #4, 5, 6, 7, 9, 1 0, 
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1 3 , 1 6 , 1 9  and 20 was separated by SDS-PAGE alongside periplasrnic protein from a 
pJEM I I control containing no H. pylori insert DNA. Protein was loaded onto a l arge 
1 2% SDS-PAGE gel using BioRad ProteanTM I I  S lab Cell apparatus according to the 
manufacturer' s instructions and run overn ight at 1 0  mA. Protein was transferred to 
PVDF membrane as described (Chapter 2 . 1 0.2) and fol lowing blocking, incubated i n  
the primary antibody overnight at 4oC. After washing, the membrane was incubated i n  
anti-human IgG conjugated to alkaline phosphatase (Sigma) di luted 1 : 20,000 for 1 hour 
at RT and developed colorimetrically .  
5 . 3 .4.2 Lymphocyte prol iferation assay 
B lood samples were col lected from patients (n=4) infected with H. pylori at the 
Wakefield Gastroenterology Centre, Wel l ington. Peripheral blood mononuclear cell s  
(PBMCs) were separated from heparinised blood samples by  density centrifugation over 
lymphoprep (density = 1 .077 g/ml; Nycomed Pharma As. ,  Oslo, Norway). The PBMCs 
were washed by centrifugation three times in PBS and resuspended at a concentration of 
2 x 1 06 / ml in supplemented RPMI- I O  cu lture medium (Gibco BRL, Auckland, New 
Zealand) . The PBMCs were cultured in tripl icate wel ls ( 2 x 1 05 cells/wel l ) of 96-well 
flat-bottomed microti tre plates (Nunc, Roski lde) in the presence of 1 00 III of RPMI - 1 0, 
1 00 III phytohaemagglutinin (PHA) ( l Ollg/ml) (Sigma, St Louis) ,  Staphylococcus 
aureus (SA- I )  or H. pylori protein preparations, in a total volume of 200 Il l .  The cells 
were incubated at 37°C in a humidified atmosphere of 5% C02 for 3 -7 days (3 -5 days 
for PHA and 5 - 7 days for bacterial antigens) .  Proliferation was detected by adding 1 0  
/-l l  3 -(4,5-dimethylthiazol-2-yl)-2,5-diphenyl tetr::.zol ium bromide (MTT)(S igma, St 
Louis) to each well and incubating a further four hours at 37°C. MTT was then 
removed and 200 II I of dimethylsuphoxide added to each wel l .  The absorbance at 570 
nm was determined using an ELISA reader. Results were expressed as mean OD570 x 
1 000 and as stimulation indices (S I) ,  which were determined by calculating the mean 
absorbance of replicate stimulated wel ls divided by the absorbance of non-stimulated 
wells (no antigen). All experimental samples were carried out in triplicate. 
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5.4 Results 
5.4.1 Isolation of periplasmic space proteins enriched for H. pylori AP fusion 
proteins 
To determine the subcel lular distribution of H. pylori AP+ fusion proteins when 
synthesised in E. coli, the cellular fractions were purified from cultures of a panel of the 
AP+ transformants and screened i n  a Western blot using an antibody raised against AP 
(see Figure 5 . 1 ) . With each fusion protein, a strong band was detected either at the 
Alkal i ne 
phosphatase 
A l kaline 
phosphatase 
AP pI D 7 6 5 4 2 W AP M 
AP 1 7  1 9  9 1 0  20 2 4 5 6 D PJ AP 
84 kDa 
44 kDa 
Figure 5.1 :  Western blot analysis of selected H. pylori AP fusion proteins .  
Periplasmic space (PS) protein was isolated from recombinant E. coli and separated by 
SDS-PAGE. The proteins were transferred to PVDF membrane and screened with a 
polyclonal antibody raised to alkal ine phosphatase and developed us ing colorimetric 
detection. PJHp clone # is l isted above the corresponding lane; W = pJHp white c lone; 
pJ = vector control (no insert); D = De3 host strain control ; AP = alkaline phosphatase 
control. 
same molecular weight as the alkaline phosphatase control or migrating at a h igher 
molecular weight. In some i nstances, the fu:; ion proteins showed a ladder of 
degradation products as observed previously (see Chapter 4) .  These results suggested 
that the fusion proteins were being degraded by proteolytic digestion e ither during or 
after translocation to the periplasmic space. In an attempt to reduce the degradation, the 
pJEM 1 1  colonies were grown at a lower temperature of 30oC . However, fol lowing 
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analysis by Western blot, the results indicated no change in the levels of degradation 
(data not shown). 
In other experiments, nine perip lasmic space protein preparations containing the AP+ 
fusion proteins were assayed for alka line phosphatase activity and the levels compared 
to the activity in the controls which inc luded a non-recombinant E. coli c lone, a 
recombinant clone containing pJEM l l with no insert DNA and a recombinant clone 
containing a pJEM 1 1  H. pylori insert that remained white when grown on the AP 
substrate BCIP (Figure 5 .2) .  Each of the periplasmic fractions from AP+ c lones 
displayed high levels of AP activ ity ranging from 42 .0 units/ml  to 286.7 units/ml. 
Negligible levels of AP activity were detected in each of the controls. 
PhoA Activity in  Periplasmic Fractions 
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Figure 5.2: Alkaline phosphatase activity in periplasmic space protein fractions isolated 
from H. pylori pJEM l l recombinant clones and controls .  # on x ax is refer to the pJHp 
c lone number; pJ = pJEM l l control (no insert); De3 = host strain control (no plasmid); 
W = pJHp white control .  
5.4.2 Determination of the purity of the periplasmic space proteins by Western 
blot analysis 
To determine the level of intracel lular protein contamination in the periplasmic protein 
preparations, the intracellu lar and peripl asmic space protein s  were isolated from a 
culture of a number of AP+ transformant c lones. Fol lowing separation by SOS-PAGE, 
the proteins from each fraction were stained using Coomassie Bril l iant B lue R-2S0 
(B ioRad). The protein profiles between the two cel l  fractions demonstrated distinct 
differences (Figure S .3 (a» . The fractions were then analysed by Western blot using the 
a lkal ine phosphatase antibody as a probe . Strong antibody binding to a lkaline 
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phosphatase was observed in the periplasmic space proteins and i n  the control AP 
(Figure 5 .3(b» . A small amount of fusion protein was observed in  the intracel lular 
2p 3p 4p Sp 2i 3 i  AP M 
(a) 
2p 3p 4p 5p 2i 3i AP M 
Cb) 
Alkal ine 
phosphatase 
A lkal ine 
� phosphatase 
Figure 5.3: (a) Coomassie stain of intracellular and periplasmic space proteins from 
pJHp blue colonies and alkaline phosphatase control . (b) Autoradiograph of Western 
blot of intracel lular and periplasmic space proteins screened with a polyclonal antibody 
raised against alkaline phosphatase and developed using chemiluminescence detection. 
Numbers above the l anes refer to pJHp c lone number; AP = alkaline phosphatase; p = 
periplasmic space protein fraction; i = intracellular protein fraction. 
fraction (faint bands), indicating that the major fraction of the fusion protein was 
recovered in the periplasmic space. The �-galactosidase (�-gal) enzyme, a cytoplasmic 
protein, was chosen as an intracellular marker to monitor for leakage of cytoplasmic 
proteins into the periplasmic space. The perip lasmic and intracel lular proteins from 
AP+ c lones and a pJEM l l vector control were separated on SDS-PAGE and transferred 
to membrane for Western blot analysis using an antibody raised against �-galactosidase 
(data not shown) .  Beta-galactosidase was detected only in the intracellu lar fraction 
indicating that there was negligible contamination of the periplasmic space protein 
fraction with intracellular proteins. 
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5.4.3 Alkaline phosphatase and �-galactosidase enzyme activity in E. coli 
cellular fractions 
The intracel lular, periplasmic space and extracel lu lar proteins were then prepared from 
a number of AP+ c lones. The �-gal and AP enzyme activity in each of these fractions 
was measured. The levels of activity in each fraction was recorded and calculated as a 
percentage of total activity in each of the fractions (Figure 5 .4). In each sample, the 
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Figure 5.4: Alkal ine phosphatase and Beta-galactosidase enzyme assays for cel lular 
fractions derived from E. coli pJHp clones and controls . Numbers along the x axis refer 
to pJHp clone number; pJ = pJEM l l control (no insert) , W = pJHp white control; De3 
= non-recombinant host strain control. 
greatest proportion of the AP activ ity was detected in the periplasmic space protein 
fraction and the majority of �-gal activity detected in the intracellular protein fraction. 
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No enzyme activity from either AP or � -gal could be detected i n  the extracel lu lar 
fraction. 
5.4.4 Antibody recognition of H. pylori AP+ fusion proteins 
To investigate the antibody-mediated immune response to some of the exported proteins 
identified in the pJEM 1 1  l ibrary , ten periplasmic space fractions enriched for the AP+ 
fus ions were analysed in Western blots using pooled patient sera as the primary 
antibody from five patients infected with H. pylori (Figure 5 .5)  . A strong band 
209 
1 37 
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44 -
33 -
4 9 1 3  1 6  20 1 9  pJ 
+- 55 kDa fusion 
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Figure 5.5: Western blot analysis of periplasmic space (PS) protein from E. coli pJHp 
recombinant blue c lones . PS protein  was separated by SDS-PAGE and transferred to 
PVDF membrane. The membrane was screened with pooled sera from H. pylori 
i n fected patients as the primary antibody and developed us ing colorimetric 
development .  Numbers above the lanes refer to the pJHp c lone number; pJ = pJEMl l  
vector control (no insert) . 
corresponding to an observed molecular weight of 55  kDa was detected i n  the 
perip lasmic space proteins prepared from E. coli pJHp20. A similar band was not 
observed at this molecular weight in  the pJEMI l  control . Despite the preadsorption of 
the sera to remove antibodies against E. coli, the presence of other common bands on 
the blot suggested that there was stil l  residual E. coli antibodies i n  the sera. The s ize of 
H. pylori i nsert in each of the clones from which periplasmic space proteins  was 
prepared suggested that there was theoretical ly enough H. pylori protein  sequence 
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(ranging from 40 to 286 amino acids) present in the fusion proteins to detect any l inear 
epitopes . 
To confirm that the 5 5  kDa protein corresponded to the AP fusion protein, the 
periplasmic protein from pJHp20 was electrophoresed in duplicate and transferred to 
membrane for further Western blot analysis . The blots were screened with an antibody 
raised against AP and with the pooled sera from infected patients used in the initia l  
screen. An AP fusion protein was detected at the same location as the band reacting 
with the patient serum, indicating the patient sera contained antibodies to the H. pylori 
protein fused to AP (Figure 5 .6). The Western blot protocol was repeated using the 
(a) M W 20 pJ 
1 37 -
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33 -
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protei n  
(b) M VI 2.0 pJ 
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Figure 5.6: Western blot analysis of pJHp20 and controls . (a) Screened with pooled 
sera from H. pylori infected patients (b) Screened with a polyclonal antibody raised 
against alkaline phosphatase. PS protein and the AP control were separated by SDS­
PAGE and transferred to PVDF membrane before screening with the appropriate 
antibody . B lots were developed using colorimetric detection. M= Kaleidoscope size 
marker; 20 = pJHp20 clone; W = pJHp white clone; pJ=pJEMl l  control (no insert) . 
separated individual sera to determine whether some or all of the patient sera i nc luded 
in the original pool had antibodies that recognised this protein .  For each of the 
individual patient sera, an immunoreactive band at 55 kDa was observed (Figure 5 .7) .  
Thus, the epitopes present on this partial H. pylori protein appear to be recognised by all 
of the infected patients from this pool of sera. 
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Figure 5.7 : Western blot analysis of pJHp20. Periplasmic space protein from pJHp20 
was separated on SDS-PAGE and transferred to PVDF membrane. The blot was 
screened with individual sera from five H. pylori infected patients that were used in the 
original pool. (a) PS025 (b) PS027 (c) PSO 1 8  (d) PSO 1 4  (e) PSOO 1 
5.4.5 Sequence analysis of the plasmid pJHp20 
The plasmid encoded by pJHp20 was purified for sequence analysis using primers 
pJEM6 and pJEM7. The 1 . 1  kb H. pylori insert was found to contain two adjacent 
ORFs with 98% homology to HP I 084 and HP I 085 described in the published genome 
(Tomb et al. , 1 997) (Figure 5 .8) .  Extensive searches of the current databases fai led to 
find any significant homology with any other sequences available, suggesting that these 
genes may be unique to H. pylori. 
HP 1 084 HP 1 085 Truncated 
TG phoA gene Bam HI ........ C> 
-d---....---�---t-.... -
T,4  termmator Barn HI 
I I 
1 . 1  kb Helicobacter pylori 
DNA insert 
Figure 5.8 : Schematic diagram of pJHp20. The plasmid pJEM 1 1 contains a 1 . 1  kb H. 
pylori insert (blue) fused to the truncated phoA gene (yel low) . Thick black l ine 
represents vector DNA. 
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5.4.6 Enzyme activity in cellular fractions from cultures of E. coli pJHp20 
The cel lular protein fractions were isolated from E. coli contain ing pJHp20 and the 
alkaline phosphatase and �-galactosidase activity determined. Cells were harvested at 
either OD600 1 .0 or OD600 1 .2 to determine the maximum amount of periplasmic space 
protein that could be harvested without intracel lu lar contamination. The results are 
plotted in Figure 5 .9  and show that the increase from 00600 1 .0 to 00600 1 .2 resulted in 
elevated levels of �-gal activity in the periplasmic space. Thus ,  for the large scale 
preparation of further periplasmic space protein from E. coli, cells were harvested 
before reaching an OD of 1 .0 (usually  in the range 0.7-0.9) .  
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Figure 5.9 : Alkal ine phosphatase and Beta-galactosidase activity in pJHp20 cel lular 
fractions. Intracel l ular and periplasmic space proteins were isolated from E. coli 
harbouring plasmid pJHp20 at an cu lture OD600 reading of 1 .0 and 1 .2 .  The fractions 
were then assayed from AP and �-gal enzyme activity and p lotted as a precentage of 
total activity. 
5.4.7 Peripheral blood lymphocyte response to H. pylori AP+ fusion proteins 
To investigate the cellular immune response to individual H. pylori proteins ,  the 
periplasmic space protein preparations from six H. pylori AP+ fusion proteins were 
incubated with peripheral blood mononuclear cel ls (PBMC) prepared from four H. 
pylori infected patients. The prol iferat ive responses of PBMCs from infected 
individuals to the periplasmic space proteins were measured from one patient in the first 
study (Table 5 . 1 ) , and from three H. pylori infected patients in a separate study (Table 
5 .2). The avai lability of the patients dictated the design of this protocol. As positive 
controls, PBMCs from infected patients were stimulated with the mitogens ,  SA- 1 and 
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PHA at a predetermined optimal concentration of 1 Ilg/well .  Lymphocytes were 
cultured along with a broad concentration range of the H. pylori fusion preparations 
(0 .5 Ilg/wel l  to 27.7 Ilg/well) and cell proliferation measured by colormetric detection. 
Standard deviations (SD) are shown for the data in Table 5 . 1 ,  and are representative of 
the range of SDs observed in each experiment. Each of the perip lasrnic space protein 
preparations were concentrated using membrane filtration (Centricon) and standardised 
for concentration on the basis of measured AP activity . Following incubation w ith 
PBMCs, the stimulation index (SI) recorded for the experimental samples showed no 
significant differences when compared to controls .  Therefore, no  signific ant  T cell 
reactivity was detected with any individual patient. In addition, alkaline phosphatase 
alone did not stimulate proliferation of the lymphocytes . The S I  observed with PHA 
and SA- l controls indicated that the cells were viable and proliferating. 
Table 5.1 :  Lymphocyte proliferation assays A 
H. pylori infected patient 
Sample flglwell 
(specific activity*) Mean OD SD SI 
Medium N/A 536 22 1.00 
PHA 1 .00 1 330 20 2.48 
AP 1 .56 492 2 1  0.918 
( 148.6) 3 . 1 3  495 7 0.924 
6.25 459 8 0.856 
0.78 483 3 0.902 
PJEMl l  1 .56 477 1 7  0.890 
(0.2) 3 . 1 3  490 5 0.915 6.25 467 1 0  0.871 
0.78 439 3 1  0.820 
PJHp4 1 .56 493 8 0.919 
(4.4) 3. 1 3  477 0.890 6.25 439 2 0.819 
1 2. 5  459 0.857 
0.78 477 6 
PJHp9 1 .56 494 32 0.921 
(6.0) 3. 1 3  5 1 8  1 9  0.967 
6.25 489 0.913 
1 2.5 469 
0.78 49 1 1 1 
PJHp20 1 .56 5 1 0  3 1  0.952 
( 1 .0) 3. 1 3  5 1 6  6 0.963 6.25 5 10 4 0.952 
1 2.5 50 1  0.934 
N/A : Not applicable; Mean OD: average ODS70 reading from triplicate wells x 1 000; S D: 
observed standard deviation; SI: stimulation index; *Specific Activity (units/min/mg/mI) 
1 3 1 
Chapter 5 
Table 5.2: Lymphocyte proliferation assays B 
Sample H. pylori infected 1 H. pylori infected 2 H. pylori infected 3 
(specific /lgJwell 
activity*) 
Mean OD SI Mean OD SI Mean OD SI 
Medium N/A 632 1.00 570 1.00 287 1.00 
PHA 1 .00 1 1 63 1.84 947 1.66 991 3.46 
0.88 1 4 1 4  2.24 1 80 1  3.16 
SA·l 0.44 984 1.56 808 1.42 928 3.23 
0.22 77 1 1.22 500 0.88 ( I  Ilg/well) 
0. 1 1  1 064 1.68 
0.83 16 0.03 22 
AP 0.42 28 0.04 1 26 0.22 45 0.16 0.2 1  362 0.57 446 0.78 (0. 1 unit/well) ( 1 48 .6) 0. 1 0  
22.90 
pJEMll 1 1 .45 5 14 0.81 0.92 5.73 539 0.85 0.99 ND N D  (0.3) 2.86 556 0.92 567 0.99 
1 5 .70 503 0.80 5 1 4  0.90 252 0.88 
PJEMll 7.85 5 1 1 0.81 546 0.96 3 1 3  1.09 3.93 534 0.84 569 1.00 4 1 5  1.45 white 1 .96 552 0.87 573 1.00 440 1.53 (0.4) 0.98 ND N D  N D  Nj) 439 1.53 
ND 
14.80 44 1 
PJHp6 7.40 466 0.74 502 0.88 
(7 .9) 3.70 5 1 1 0.81 545 0.96 N D  N D  
1 .85 548 0.87 556 0.98 
27.70 509 0.81 5 19 0.91 236 0.82 
PJHp7 1 3 .85 520 0.82 550 0.96 324 1.13 6.93 543 0.86 562 0.99 388 1 .35 ( 1 .9) 3.46 556 0.88 549 0.96 397 1.38 
1 .73 ND ND N D  N D  4 1 0  1.43 
ND 
50 1 
4.00 538 0.85 1.03 
2.00 592 0.94 1.04 NU ND 
250 
PJHplO 
1.00 338 
1.03 386 (3 .8) 1.03 4 1 4  
N D  ND N D  
1 7.4 
PJHp4 8.7 305 1 .06 4.35 N D  N D  N D  ,'\ D  400 1.40 (3.5) 2. 1 8  429 1.50 
1 .09 39 1 1.36 
0.54 378 1.32 
N/A : not applicable; ND: not done; mean OD: average OD570 reading from triplicate wells x 
1 000; SI; stimulation index; *Specific Activity (units/min/mg/ml) 
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The study reported here describes a pre l iminary immunological characterisation of 
exported proteins of H. pylori, identified and partially  purified as alkaline phosphatase 
gene fusions. The results obtained from the enzyme activ ity analyses in conjunction 
with Western blotting, demonstrated that signal peptides of H. pylori are functional and 
recognised by the export machinery of E. coli, and that the AP fusion proteins were 
transported to the periplasmic space in E. coli. The periplasmic space protein, enriched 
for the H. pylori AP+ fusion proteins were therefore screened with patient antibody in 
Western blot assays and tested against peripheral b lood mononuclear cel l s  for T ce l l  
recognition . The individual AP+ fusion proteins i n  the periplasmic space protein 
preparations were initia ll y  identified in Western blot assays using an antibody raised 
against AP. These size of the bands on these blots confirmed that there was sufficient 
H. pylori amino acid sequence present in each AP+ fus ion protein to detect potential 
protein epitopes that may be present. 
Sequence analysis, in conjunction with the release of the completed H. pylori genome 
sequence, fac il i tated characterisation of the c loned inserts. Each of the AP+ fusion 
proteins tested contained H. pylori amino acid (aa) sequence fused to AP, ranging from 
40 aa to 286 aa. Plasmid pJHp20 was chosen for further investigation because it 
contained i nserts expressing polypeptide epitopes recognised by patient antibody. 
Amongst the other AP+ fusion proteins screened, two (pJHp5/9 and pJHp 1 0) contained 
a region of coding sequence lacking the amino terminus and start codon of the 
respective genes. Therefore, the size of the H. pylori protein fused to AP (2 1 6  aa and 
94 aa respectively) was deduced from the predicted internal start site (see Chapter 4 of 
pJHp5/9) .  In addition, two of the H. pylori i nserts contained the start regions of 
HP0823 (pJHp6) and HP0243 (pJHp 1 3) fused to an intervening Sau3A fragment from 
another gene. Three other c lones, pJHp3/4, pJHp7 and pJHp 1 6  contained 70, 55  and 
286 predicted amino acids respectively, fused to AP. However, because of suspected 
proteolytic degradation, the amount of predicted peptide sequence may not have been 
equivalent to that tested in the immunoassays. 
Al though alkaline phosphatase gene fusions have been successfu l ly  screened for 
immunoreactive T cell epitopes (Moran et al . ,  1 999; Borich, 1 997), there are several 
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potential disadvantages to using fusion proteins for screening with antibodies. One 
possibility is that the structural and conformational integrity of the fused polypeptide 
may differ considerably  from the same polypeptide in the native protein . This could  
have consequences for presentation of  epitopes recognised by  antibody . This may 
explain why only one H. pylori AP fusion protl':in was found to react with patient 
antibody . The majority of antibodies recognise epitopes that depend upon the 
conformation of the native protein (Blundel l  et al. ,  1 987) .  This may vary depending 
upon the nature of the antigen, as some cell surface proteins for example are l ikely to be 
formed by discontinuous surface sequences (Horsfal et al. , 1 99 1 ) .  The detection of B 
ce l l  epitopes using SDS-PAGE is  therefore l imited to the identification of l inear 
epitopes that are not dependent on native conformation. An alternative explanation for 
the l ack of recognition of the fusion porteins is that the proportion of antibodies in the 
serum, specific for l imited number of epitopes ,  may have been outside the detection 
limit of the Western blot assay . 
Recogntion of antigen by T helper cell s  requires processing by antigen presenting cells 
and subsequent presentation of short l inear peptides to the appropriate T cell .  There is 
evidence that peptidestof less than 1 2  amino acids can bind to T -ce l l  receptors when 
z 
presented in the context of the appropriate major histocompatablity complex (MHC) 
(Horsfa l l  et al. , 1 99 1 ) .  Thus, it is conceivable that even short H. pylori sequences 
attached to a reporter protein could be recognised by lymphocytes previously exposed 
to the antigen. Considering the smallest amount of H. pylori protein fused to AP was 20 
amino acids, each of the fusion proteins tested had the potential to contain T cell 
epitopes. In spite of this, none of the six H. pylori AP+ fusions stimulated proliferation 
of PBMCs from four H. pylori infected patients. PBMC ' S  from a l arger population of 
H. pylori infected and non-infected patients would need to be tested to reach any 
conclusions. It is possible, however, that the H. pylori polypeptides, expressed as 
fusion proteins, were not immunodominant and recognised by the PBMC from the 
infected patients. Alternativel y, they could be antigenic but the PBMC from the 
infected patients contained only a very small proportion of antigen specific T cel ls 
primed to recognise the particular polypeptide epitopes. The proliferation of these cell s  
may consequently have been outside the detection l imit of the assay. 
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The suppression of T cel l  responses by H. pylori antigens has been observed previous 
studies ( Knipp et al., 1 993;  B irkholz et al . ,  1 993) .  The design of the assays did not 
allow us to specifical l y  address the phenomenon of suppressed T cell responses in  these 
patients, however, it is a possibility that cannot be ruled out. A study has shown that a 
recombinant fusion protein carrying an immunodominant region of CagA affected the 
prol iferation of human cells . This fusion protein  not only inhibited PHA-driven T cell 
prol i feration, but also inhibited growth of macrophages and epithe l ial cell s  from 
metaplastic gastric carcinoma. CagA therefore has anti-proliferative activity that i s  not 
restricted to T cells (Rudnicka et al., 1 998). The present study also used a popul ation of 
lymphocytes i solated from peripheral blood. It could be that gastric l ymphocytes, at the 
focus of infection, would consti tute a more appropriate popul ation for prol iferation 
assays .  It may be that T cel ls  that respond to H. pylori in infected persons are 
compartmentalised in the GI tract, while  peripheral T cell s  reflect prior systemic 
exposure. However, i t  has been demonstrated that there is no difference between 
peripheral b lood lymphocytes and gastric lymphocytes when comparing prol iferative 
responses to H. pylori between H. pylori seropositive and seronegative patient derived T 
cells (Fan et al. , 1 994) .  Varying distribution of HLA class II phenotypes i n  people from 
different populations can also influence peptide reactivity (Roche et  al. , 1 996) and may 
account for the lack of a T cell response to these antigens i n  the four subjects from 
which PBMC were taken. 
Although the putative outer membrane protein  idenlified in thi s  study appears to contain 
B cel l  epitopes, it did not induce proliferation of T cell s  from H. pylori infected patients. 
Dichotomy in the B cell and T cell responsiveness to the same antigen i n  H. pylori 
infected patients has been observed (Sharma et al. ,  1 994). However, since only a small 
proportion of the entire protein  was fused to AP, there i s  a possibil i ty that other 
immunodominant epitopes are present i n  other regions of the protein capable of 
st imul at ing B and T cell s .  In evaluat ing the u sefulness of immunoscreening 
recombinant fusion proteins from E. coli with patient antibody , i t  appears that the 
methodology described in this study has proved a rapid way of detecting antigens that 
might be involved i n  the immune response against H. pylori, or could be usefu l  as 
immuno-diagnostic reagants. 
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Chapter 6 Cloning and Heterologous Expression of an 
Immunogenic Protein from H. pylori 
6.1 Abstract 
The application of alkaline phosphatase (AP) fus ion methodology was used to identify 
Helicobacter pylori exported proteins .  Serological screening of these AP+ fusion 
proteins identified a gene with a partial open reading frame (ORF) encoding a highly 
i mmunogenlc , putative exported protein. The predicted amino acid sequence of this 
gene displays a characteri stic N-terminal signal peptide and also contains regions of C­
terminal hydrophobicity consistent with a membrane-associated protein. Southern blot 
analysis revealed that the gene was absent in  other Helicobacter species tested. In 
addition, by use of a combination of PCR and sequence analysis of the amp lified gene 
product, it was shown to be highly conserved amongst H. pylori i solates . In order to 
obtain pure recombinant  protein, the gene encoding the protei n  was c loned and 
expressed in Escherichia coli as a Beta-galactosidase (�-gal) fusion and the protein was 
then purified by affinity chromatography and proteolytic c leavage of the �-gal moiety. 
In Western blot assays ,  the purified protein (with an apparent molecular weight of 1 8  
kDa) was recognized by 7 1  % of sera taken from patients infected with H. pylori, but by 
only 1 6% of sera taken from patients with unrelated or no gastroi ntestinal disease . 
These results indicated that the 1 8  kDa protein from H. pylori was expressed in vivo and 
was immunogenic. The purified antigen was also tested in a murine model of H. pylori 
infecti on to determine its abi l ity to generate a protective immune response. Oral 
administration of this antigen with a cholera toxin adjuvant did not protect mice against 
infection fol lowing challenge with H. pylori. 
6.2 Introduction 
Helicobacter pylori infection in humans i s responsible for a number of c linically 
significant d i seases including peptic u l cer di sease and gastric adenocarcinoma. 
Although there are effective treatments currently avai l able to cure H. pylori infection 
(Axon, 1 998) ,  the l ack of a s imple, cheap antibiotic regime and the emergence of 
antibiotic resistant strains (Megraud, 1 998) makes the deve lopment of a vaccine a 
desirable goal . 
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The data obtained from prevIous  vaccination studies using animal mode ls  of 
Helicobacter infection have provided evidence that many of the protective antigens are 
found among the secreted or surface proteins of H. pylori (reviewed in  Vyas and 
Sihorkar, 1 999). Oral immunisation of mice with H. pylori bacterial sonicates, or 
recombinant antigens, along with cholera toxin as an adjuvant, results in the induction 
of specific IgG-secreting cell s  that correlate with protection against H. felis infection 
(Ferrero et al., 1 995 ; Ferrero et al. , 1 997) .  Some examples of surface-exposed H. pylori 
proteins considered to be protective antigens include the urease enzyme (Michetti et al., 
1 994; Ferrero et aI . ,  1 994; Pappo et al., 1 995) ,  heat shock proteins (Ferrero et  al. , 
1 995),  and the vacuolating cytotoxin, VacA (Marchetti et al . ,  1 995) .  A recent study 
(Hocking et al . ,  1 999) has identified other potential vaccine candidates, including the 
l ipoprotein Lpp20 (Kostrzynska et al . ,  1 994). This lipoprotein has been identified as a 
component of outer membrane vesicles (OMVs) released from H. pylori under certain 
growth conditions.  In mouse vaccination trials, OMVs containing Lpp20 i nduce 
protection against infectious H. pylori challenge ( Keenan et al .  submitted for 
publication). 
The H. feli.s mouse model has been widely used to evaluate vaccine candidates. H. felis 
was original ly isolated from the stomach of a cat ,  and in some strains of mice, causes 
disease pathology similar to that seen in humans with H. pylori infection (Lee et al. , 
1 990, 1 993) .  One advantage of using this model to screen candidate H. pylori vaccine 
antigens is that many antigens are conserved between the two Helicobacter species .  
However, a l imitation of this model is that H. felis does not produce VacA and CagA, 
two important H. pylori virulence factors. Therefore, the validity of using H. felis as a 
surrogate for H. pylori is open to question. 
A more relevant mouse model has been described for testing the safety and efficacy of 
potential vaccine candidates against challenge with H. pylori (Lee et al. , 1 997). This 
mouse adapted H. pylori strain, known as the Sydney strain (SSI) ,  colonises the mouse 
to high levels of infection, exhibits specific adhesion to gastric epithelial cells and also 
causes pathology resembling that seen in humans mfected with H. pylori. In addition, 
the use of the standardised H. pylori "Sydney Strain" (Lee et al. , 1 997) in chal lenge 
experiments allows for direct comparisons with other immunisation protocols. 
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In Chapter 4 the use of alkaline phosphatase gene fusions to identify H. pylori genes 
encoding secreted or membrane-associated proteins was described. The fol low-up 
study (chapter 5)  described the immunological screening of these partial surface and 
secreted H. pylori proteins fused to AP, and led to the identified of a previously 
uncharacterized H. pylori exported protein that was recognised by sera from H. pylori 
infected patients .  The present study describes further investigations i nto this 
immunogenic protein, to determine its potential as a candidate for inclusion in a subunit 
vaccine against H. pylori infection . The gene encoding the protein (HP 1 085) was 
investigated for its distribution among H. pylori clinical isolates and other Helicobacter 
species. The entire protein, with a predicted molecular weight of 1 8  kDa, was 
expressed and purified from E. coli. The recombinant protein was then tested for its 
immunogenicity against a panel of sera taken from patients positive or negative for H. 
pylori infection and for its protective efficacy in a H. pylori mouse model of infection. 
6.3 Materials and Methods 
6.3.1 Polymerase chain reaction 
Genomic DNA prepared from eight H. pylori clinical isolates, H. pylori CCUG 1 7874, 
H. mustelae 4298 and H. felis (see Chapter 2 . 3 . 3 )  was used as the template in the 
polymerase chain reaction. Oligoncucleotide primers were designed to amplify the 
ORF (HP 1 085) encoding the 1 8  kDa protein, based on the ful l  sequence from the H. 
pylori 26695 genome (Tomb et al . ,  1 997). The primers were designed to produce a 
truncated HP 1 085 sequence beginning 5 residues from the putative c leavage point of 
the signal sequence with an Eco RI site incorporated into the 5 '  end and a Kpn I site at 
the 3' end. The sequence of the primers were as fol lows: 
Primer 20/ 1 :  5 '  TAATGAATTCACTTACACGCTAGAC 3' 
Primer 2012 : 5 '  TTGAGGTACCGGGACTTGATAAGC 3' 
High fidelity Pwo DNA polymerase was used in the PCR with approximately 20 ng of 
genomic DNA as template. PCR amplification consisted of an initial denaturation step 
(95°C, 5 mins) fol lowed by 30 cycles of amplification consisting of denaturation (95°C, 
30 sec) ,  annealing (SO°C, 30 sec) and primer extension (72°C, 1 min) . The PCR 
products generated were separated on a 1 % agarose gel and purified using a Qiagen gel 
purification kit (QIAGEN) for sequencing. The purified PCR products (approximately 
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400 ng) were sequenced by automated sequencing using primer 201 1  at a concentration 
of 8 pmol . 
6.3.2 Southern blot analysis 
For Southern blotting, approximately 5 /-1g of genomic DNA from Helicobacter sp. was 
digested with Hind IH and separated by electrophoresis on a 1 % agarose gel and the 
DNA transferred to positively-charged membrane (Amersham, UK) by capillary action 
(Chapter 2 .8 .2) .  The PCR amplification product generated from H. pylori CCUG 1 7874 
was purified from an agarose gel fol lowed by phenol/chloroform extraction for use as a 
probe in Southern blots. The probe was labeled with DIG and quantitated according to 
the manufacturer's instructions (Chapter 2 .8 . 1 ) . Following prehybridization at 42°C for 
four hours, the blot was hybridized with 25 ng probe/m I of hybridization solution (DIG 
Easy Hyb, Boehringer Mannheim) overnight at 42°C. The blot was washed under 
moderate stringency using I x  SSC at 60°C and developed with anti-DIG antibody 
conjugated to alkaline phosphatase. After 30 mins incubation in substrate, the blot was 
developed by autoradiography . 
6.3.3 Expression and purification of the 18 kDa protein 
6 .3 .3 . 1  Cloning of the HP 1 085 ORF into expression vectors 
The pXa series of plasmids (Boehringer Mannheim) were used for initial expression of 
the HP 1 085 ORF. These plasmids contain the lac promoter and a multiple cloning site 
in all translational frames of the lacZ gene to create �-galactosidase fusion proteins. A 
PCR product was generated from CCUG 1 7874 using primers 20/ 1 and 20/2 (section 
6.3 . 1 )  and purified from an agarose gel . The PCR product and expression vector were 
digested with the restriction enzymes Eco RI and Kpn I and purified from a 1 % agarose 
gel .  The digested PCR product and plasmid were ligated using 1 unit of T4 l igase for 1 
hour at 22°C and transformed into the E. coli strain XLI-blue by heat shock at 42°C for 
90 seconds. Recombinant colonies were grown on selective media containing 1 00 /-1g / 
ml of ampicil l in from which eight were selected and resuspended in 1 00 /-11 of water. 
Total DNA was prepared by boil ing the suspension for 1 0  minutes, fol lowed by 
centrifugation to remove cell debri. Five microIitres of the supernatant was removed 
and used in the PCR with primers 20/ 1 and 20/2 to confirm the presence of the insert. 
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Beta-galactosidase derived polypeptides can be isolated on the basis of their affinity for 
the lactose analogue APTG. In practice, this method yields material of excellent purity, 
but is not very efficient and is ineffective for purification of proteins of low abundance. 
To obtain large amount of recombinant protein for the mouse immunisation trials, the 
1 8  kDa protein was also prepared as a His-tagged recombinant protein. The Eco RI and 
Kpn I fragment was cloned into the compatible sites of the expression vector pPROEX 
Htb (Life Technologies) as described above. 
6 .3 .3 .2  Expression and purification of the 1 8  kDa protein 
Positive colonies were selected and grown in LB broth containing 1 00 �g / ml  
ampicillin a t  37°C . Expioession of  the fusion protein was induced by the addition of 
isopropyl-p-3-thiogalactopyranoside (IPTG) into the culture medium when an OD600 0.8 
was reached. Varying amounts of IPTG (0.5 mM - 2.0 mM) was added to the culture to 
determine the optimal levels of induction, over periods ranging from 1 hour to 
overnight. The cel ls were then harvested by centrifugation at 6 ,000 rpm and 
resuspended in loading/washing buffer (20 mM Tris-HCI, 1 0  mM MgC12, 1 . 6 M NaCl, 
1 0mM 2ME, pH 7 .4) .  The fusion protein was released by sonication, and the 
supernatant applied to an APTG (4-aminophenyl-p-3-thiogalactopyranoside) affinity 
chromatography column according to the manufacturer's instructions (Boehringer 
Mannheim). The fusion protein was eluted with 0. 1 M borate, 1 0  mM 2ME, pH 1 0  and 
the fractions containing the highest amount of protein, as determined by SDS-P AGE, 
were pooled. The p-gal portion of the fusion was removed by proteolytic c leavage with 
Factor Xa (biotin-labeled) at different concentration ratios of enzyme: substrate (l: 1 0, 
1 :  1 50 and 1 :  1 00) over t ime at 25°C. The enzyme was subsequently removed by 
incubating with streptavidin gel for 30 mins at RT. The gel was removed by 
centrifugation at 1 4,000 rpm and the cleaved p-gal portion removed by a second APTG 
affinity chromatography step yielding pure recombi!1ant protein. 
For purification of the his-tagged recombinant protein, 0.2 mM IPTG was added to the 
culture medium and the cells harvested after 6 hours induction and resuspended in start 
buffer (20 mM Na2HP04, 0 .5 M NaCI, pH 7.4) with the addition of 20 mM imidazole. 
The resuspended cells were sonicated, cell debri removed by centrifugation at 1 4,000 
rpm and the soluble fraction removed. Purification of the recombinan t  protein was 
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achieved using a nickel chelating affin ity column as described in  Chapter 3 .3 . 6 .  
Following the application of the sample ,  contaminants binding to  the column were 
eluted by washing with Start buffer containing 40 mM imidazole, fol lowed by a 60 mM 
imidazole wash. The recombinant protein was eluted using 200 mM imidazole and the 
purity of the protein determined by SDS-PAGE. Protein concentration was estimated 
by reading the absorbance at 280 nm taking into account the extinction coefficient of 
the truncated HP 1 085  amino acid sequence along with the histidine hexamer tag. 
6 .3 . 3 . 3  N-terminal sequencing of the recombinant 1 8  kDa protein 
Twenty microlitres of the pure recombinant protein  c leaved from � -gal was 
electrophoresed on a 1 2 .5% SDS-PAGE gel and blotted onto PVDF membrane as 
previously described (Chapter 2 . 1 0.2) . The membrane was subsequently stained with 
0.25% Coomassie brilliant blue and excised for N-terminal sequencing. The N-terminal 
amino acid sequence analysis was performed with a pulse liquid phase sequenator 
(Model 477 A, Applied B iosystems) by the Amino Acid Analysis and Protein 
Sequencing Service, Massey University, NZ. 
6.3.4 Western blot analysis 
Electrophoresis of proteins was routinely performed on SDS-polyacrylamide gels using 
standard methods using B ioRad Mini  Protean II  apparatus according to the 
manufacturer' s  instructions and as previously described (Chapter 2. 1 0.2) .  For Western 
blotting, approximately 20 J..lg of purified protein/laile was run on a 1 2% SDS-PAGE gel 
and transferred to PVDF membrane using a TransBlot semi-dry transfer cell (BIORAD) 
according to the manufacturer's instructions. After blocking, the blots were incubated in 
patient sera diluted 1 : 200 in PBS for two hours at RT using Biorad mini-protean II 
multi-screen apparatus. Following washing, the membranes were incubated at RT for 2 
hours in anti-human IgG alkaline phosphatase conjugated secondary antibody (Sigma, 
St. Louis) diluted 1 : 20,000 in PBS.  The color reaction was performed by developing 
with 0 .05  mg/ml of B CIP and 0.0 1  % nitroblue tetrazolium (NBT) . Protein  
concentrations were determined using the BCA Protein Assay (Pierce, Rockford) . 
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6.3.5 Patient samples 
Sera was collected from thirty-two individuals at the Wakefield Gastroenterology 
Centre, Wellington (summarised in Table 2 .4) .  Of the total thirty-two individuals from 
whom samples were collected, twenty-one were determined to be infected with H. 
pylori. Infection was diagnosed by either CLOtest, urease breath test (UBT) and/or by 
testing for anti-Ho pylori antibodies in serum (Quikview Kit). Control sera were 
obtained from eleven asymptomatic volunteers who were determined to be H. pylori 
negative by Quikview and CLOtest (three) or by Quikview only (eight) . Serum samples 
were stored at -70°C until immunoblotting was performed. 
6.3.6 Mouse immunisation protocol 
C57B 1 I6J mice were purchased from the Animal Breeding Station, University of Otago, 
and housed at the Wakefield Gastroenterology Research Centre, Wellington. All mice 
were maintained under conventional conditions in an i solation unit and were 8- 1 0  
weeks of age at the time of the experiment. Experimental mice (n= 6 )  were immunised 
orogastrically four times at fortnightly intervals with recombinant protein plus cholera 
toxin ( lOjlg)(Sigma, St. Louis) .  Each mouse was initially immunised with 750 jlg of 
recombinant ] 8 kDa antigen, followed by 500 jlg, 500jlg and 250 jlg doses for the next 
three immunisations respectively. As controls,  mice (n=6) were immunised with 1 mg/ 
mouselimmunisation of H. pylori sonicate extract (HPSE) plus CT ( 1 0  jlg) or PBS plus 
CT ( 1 0  jlg) .  The mouse-adapted H. pylori Sydney strain 1 (SS 1 ) , established by Lee et  
al . ,  ( 1 997) was used for challenge. Mice were inoculated orally with 1 x 1 08 colony­
forming units (CFU) of freshly harvested H. pylori in 500 jll B HI broth by using a 1 9-
gauge feeding needle as described previously (Chen et al. ,  1 993) .  Mice were sacrificed 
by overdose of carbon dioxide at 6 weeks post-challenge, and the serum and stomachs 
of the animals were collected for analysis. 
The presence of H. pylori infection in the individual mice was determined by biopsy 
urease test and quantitative bacterial culture. After removing the contents , the stomach 
was washed in sterile physiological saline and placed on a nat filter paper with mucosal 
side up. They were then dissected longitudinally along the greater curvature into three 
tissue fragments so that each fragment contained gastric cardia, body and antrum. For 
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each stomach ,  one fragment was used for determination of the presence of urease 
activity . The tissue was placed in urea-containing medium and incubated at RT for 5 
hours. A red-pink colour was recorded as positive and the sensitivity of the test was 
approximately log Io 5 .0  CFU/g stomach tissue. The second set of tissue fragments was 
used for quantitative bacterial cultures .  The tissue was homogenised in brain heart 
infusion (BHI) broth, serially diluted and plated onto agar plates containing Glaxo 
Selective Supplement A (Lee et al. , 1 997). The plates were incubated for 72-96 hours 
under microaerophillic conditions and the number of colonies counted and expressed as 
CFU per gram of tissue . With thi s method, log 10 2 .6 CFU per gram of stomach 
represented the limit of detection. 
Antibodies specific for H. pylori were measured by an enzyme-linked immunosorbent 
assay modified from a previously described procedure (Chen et al. ,  1 993) .  B riefly, 96-
well Immunolon 4 plates (Dynex Technologies, V A) were coated with 20 J.lg/ml;  50 
J.ll/wel l ,  of recombinant HP 1 085-His protein or whole cell extracts of H. pylori SSI in 
carbonate-bicarbonate buffer (pH 9.5)  at  4°C overnight. The plates were blocked by 
incubation with 1 % Gelatin in PBS at RT for 1 hour and then rinsed four times with 
PBS with 0.05% Tween 20. 1 00 III of pre-diluted serum samples ( 1 : 50) were added to 
the wells  and the plates were incubated at RT for 3 hours. An alkaline phosphatase 
conjugated secondary antibody specific for mouse IgA and IgG (Sigma, St. Louis) was 
added for 2 hours at RT. Colour reactions were developed by addition of p-nitrophenyl 
phosphate (pNPP) or 2 ,2 '  -azinobis (3 -ethylbenxthiazolinesulfonic acid) substrates 
(Sigma) and the optical density measured at 405 nm with an automated ELlS A plate 
reader. 
6.3.7 Statistical Analysis 
Data are presented as means ± standard deviations (SD) for parametric data and median 
ranges for non-parametric data. Differences in the bacterial colony counts between 
groups of animals and proliferation assay results were determined by Student t test. 
Differences in antibody titres were determined by the Mann-Whitney U test. 
Differences were considered significant for a P value of .s; 0.05. 
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6.4 Results 
6.4.1 Distribution of the HPI085 gene among Helicobacter species 
Chapter 6 
A panel of independent H. pylori isolates representing Type I and II H. pylori strains 
were tested for the presence of the HPl O85 gene encoding the 1 8  kDa protein by PCR 
amplification. The HP l O85 gene was detected as a 444 bp product in all ten H. pylori 
isolates tested (see Table 2. 1 for details on H. pylori strains).  Neither Helicobacter felis 
nor Helicobacter mustelae, the Helicobacter species naturally colonising the stomach of 
the cat and ferret respectively, produced a PCR product (Figure 6 . 1 ) . Southern blot 
experiments were also carried out to test for the presence of the HP 1 085 gene in 
chromosomal DNA from other Helicobacter species using the 444 bp PCR 
M 1 2 3 4 5 6 7 8 9 lO 1 1  1 2  
� 444 bp 
Figure 6.1 : PCR amplification of the HP 1 085 gene from Helicobacter species. Primers 
201 1 and 20/2 were used in the PCR with genomic DNA prepared from H. pylori 
strains ,  H. mustelae and H. felis. Lane l ,  H. pylori MU005 ; lane 2, H. pylori MU007; 
lane 3 ,  H. pylori MU008 ; lane 4, H. felis; lane 5, H. pylori MU0 1 5, lane 6 ,  H. pylori 
MU0 1 6, lane 7, H. mustelae; lane 8, H. pylori MU038; lane 9, no DNA control;  lane l O, 
H. pylori MU064; lane 11 ,  H. pylori MU09 1 ;  lane 1 2, CCUG 1 7874. Products were 
separated on a 1 % ethidium bromide agarose gel and visualised under UV light. M, l kb 
marker. 
amplification product amplified from H. pylori CCUG 1 7874 as a probe. The results of 
the PCR were consistent with the absence of the HP I 085  gene sequence in the 
chromosome of these species. No hybridization was observed with chromosomal DNA 
from H. felis or H. mustelae, however, a strong signal was detected with H. pylori 
1 7874 (Figure 6 .2) .  The results of this screen suggest that the HP I 085 gene is present 
in H. pylori, but absent in other Helicobacter species .  Searches of DNA and protein 
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databases to identify similarities with HP 1 085 revealed no homologies in the current 
databases, suggesting that this gene may be unique to H. pylori. 
(a) 2 3 M (b) 2 3 M 
Figure 6.2: Southern blot of genomic DNA from Helicobacter species, using the 
HP 1 085 gene PCR product as a probe. (a) Agarose gel .  Genomic DNA was isolated 
from Helicobacter sp. ,  digested with the restriction enzyme Hind III and separated on a 
1 % agarose gel. (b) Autoradiograph of Southern blot. Transferred DNA was probed 
with radiolabelled HP I 085 as described in section 6 .3 .2 .  Lane 1 ,  H. mustelae; lane 2, 
H. felis; lane 3 ,  H. pylori 1 7874; M, Lambda DNA marker (Life Technologies) . 
6.4.2 Conservation of the HPI085 gene among H. pylori strains 
The PCR product from five H. pylori clinical isolates and the H. pylori CCUG type 
strain 1 7 874 was sequenced. The resulting sequences from these five c linical strains, 
the type strain and the two H. pylori strains (strain 26695 and 199) for which the 
genome sequence is available (Tomb et al . ,  1 997 ; AIm et al. , 1 998)  were compared. 
Pair-wise and multiple sequence alignments were preformed using ClustalW version 1 .7 
(data not shown). Preliminary examination of the multiple alignments showed a high 
level of identity and similarity at the nucleotide and amino acid level respectively. 
DNA identity scores for pair-wise alignments ranged from 93-99% and from 94- 1 00% 
using the corresponding similarity scores for amino acid data. Nucleotide and amino 
acid substitutions occurred at very few sites, indicating that the gene is conserved at the 
nucleotide level . 
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6.4.3 Sequence analysis of the HPI085 gene 
Chapter 6 
The HP 1 085 gene was examined for features associated wi th a gene encoding an 
exported protein. Based on a Kyte-Doolittle plot, a hypothetical organisation of the 
gene product can be deduced (Figure 6.3a) .  In addition to the N-terminal region 
corresponding to the predicted signal peptide, there is a region of hydrophobicity at the 
C-terminal which may be involved in anchoring the protein into a bacterial cel l 
membrane. The signal peptide consists of a positively-charged N domain fol lowed by a 
hydrophobic stretch (H  domain) of 1 0  residues at the N terminus (Figure 6 .3b) .  The 
(b) 
In itiation 
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320- Predicted 
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��r---------.� � --------------------� • 
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-3 -2 - It+ 1 
Predicted 
Cleavage Si te 
Figure 6.3: (a) Kyte-Doolittle plot of the 1 8  kDa protein .  Hydrophobic regions are 
shown above the l ine and hydrophil l ic below. (b) S ignal sequence features of the N­
terminal region of the 1 8  kDa protein showing the predicted domains and cleavage site. 
hydrophobic polar D basic (positively charged) D 
c leavage site is similar to that of a l ipoprotein signal peptidase I I  (Lsp) c leavage site 
(CLG-CV) with a cysteine residue at the + 1 site (von Heijne, 1 990) . The predicted 
signal peptide sequence also has features consistent with l ipoprotein signal peptides .  
The presence of one or more positively charged residues in the N region is universal 
among bacterial signal peptides, but the length ( 1 0  residues) and highly hydrophobic H 
region is more consistent with l ipoprotein signal peptides. In addition, the s ignal 
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peptide appears to lack the G or P residue typically found in or around position -6 in 
signal peptides c leaved by signal peptidase I (LepB) (Pugsley, 1 993). The lack of a 
consensus signal peptidase I cleavage site, commonly A-X-A, also indicates that the 
signal peptide of this protein is cleaved by a different peptidase. The presence of an 
aromatic residue at the C terminal is consistent with an outer membrane location. 
6.4.4. Expression and purification of the 18 kDa protein 
In order to produce the entire 1 8  kDa protein to high levels, the HP 1 085 gene was 
expressed as a B-galactosidase fusion. Upon IPTG induction of E. coli XLI-blue cells 
harboring the pXa- 1 085 plasmid, a 1 35 kDa B-gal fusion protein was produced (Figure 
6.4). The B-gal-HP 1 085 fusion protein was purified from the crude lysate by affinity 
chromatography and the eluted fractions containing the largest proportion of fusion 
protein, as determined by SDS-PAGE (data not shown) were pooled. A portion of the 
M 1 2 
1 35 kDa 
... . t-- fusi on 
protein 
Figure 6.4: Expression of the Beta­
galactos idase HP } 085 fu sion protein .  
Coomassie stain of lysate protein from an 
un induced and induced sample of E. coli 
De3 harbouring pXa 1 - 1  085. Cel ls  were 
induced with 0.2mM IPTG and harvested 
after 6 hours induction. M, Kaleidoscope 
marker (Biorad); lane 1 ,  uninduced sample 
lane 2, induced samples. 
purified B-gal fusion protein was cleaved with varying amounts of the protease Factor 
Xa to determine the optimal conditions to cleave the B-gal portion from the H. pyLori 1 8  
kDa protein (Figure 6.5 (a» . The B-gaJ portion of the fusion protein from the entire 
sample was then removed by proteolytic cleavage with factor Xa (biotin-labelled) at 
25°C overnight and was subsequently removed using streptavidin gel . The cleaved B­
gal portion was then removed by a second APTG affinity chromatography step yielding 
pure recombinant protein (Figure 6.5 (b» . The size of the recombinant protein is in 
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agreement with the calcu lated molecular mass of the polypeptide deduced from the 
DNA sequence (approximately 1 8  kDa) . To confirm its identity, the purified 1 8  kDa 
recombinant protein was subjected to N-terminal sequencing. The resulting amino ac id 
sequence, GA TMEFFfYT, was consi stent with the predicted amino acid sequence from 
the HP1 085 ORF. 
(a) M 2 3 4 
1+- �-gal 
1 8  kDa 
- � protein 
(b) 
M 1 2 3 
Figure 6.5: Cleavage and purification of the 1 8  kDa antigen from Beta-galactosidase 
(�-gal) (a) Cleavage of the fusion protein with Factor Xa to release the 1 8  kDa protein. 
Lane 1 ,  lysate protein from induced pXa- l 085 ; lane 2,3 and 4, cleavage of the H. pylori 
1 8  kDa antigen from �-gal using different ratios of substrate:enzyme Cb) Pure 1 8  kDa 
protein fol lowing a second affin ity chromatography to remove the cleaved �-gal. Lane 
] , H. pylori-�-gal fusion protein before cleavage, lanes 2 and 3, released pure 1 8  kDa 
antgien. M= Kaleidoscope protein marker (B ioRad) . Protein was separated on 1 5% 
SDS-PAGE gels and stained with Coomassie blue to visualise the protein. 
6.4.5 Humoral immune response to the purified 18 kDa antigen 
The immunogenicity of the 1 8  kDa antigen was determined by immunoblotting. 
Twenty-one serum samples from H. pylori-infected patients and eleven non-infected 
contro ls  were col lected and used in indiv idual immunoblot assays to determine the 
frequency of recognition of the purified protein by antibodies from infected patients 
(Figure 6.6). Of the 2 1  H. pylori positive samples, the 1 8  kDa antigen was recognized 
by 1 5  sera in Western blots (7 1 %) demonstrating that the protein is immunogenic 
during the infectious process. Only two of the eleven control patients ( 1 8%) recognized 
the H. pylori 1 8  kDa protein (p = 0.008). 
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Figure 6.6: Western b lot of purified recombinant 1 8  kDa protein screened with sera 
from H. pylori infected and non-infected individual s .  Patient numbers are marked 
above the corresponding lane. Arrow refers to the position of the 1 8  kDa anti gen. For 
patient details refer to Table 2 .3 .  
6.4.6 Oral immunisation using recombinant 18 kDa antigen in a mouse model 
A mouse model of H. pylori infection was used to determine if oral administration of 
the pure recombinant 1 8  kDa antigen would induce protective immunity.  S ham 
immunised (PES + CT) mice (n=6) were used as controls in addition to non­
immunisedlinfected controls (n=4) . As a positive control, mice (n=6) were immunised 
with a H. pylori sonicate extract, a regime previously established to protect mice against 
challenge with H. pylori and H. jelis . Experimental mice (n=6) were immunised with 
the 1 8  kDa antigen plus CT as described in section 6 .3 .7 .  For each mouse, infection 
was assessed by determining the number of CFU/g stomach tissue (Figure 6 .7)  and 
gastric tissue urease test (Figure 6 .8) .  Mice immunised with the 1 8  kDa antigen plus 
cholera toxin showed similar levels of colonisation to both non-immunised (control) 
and sham immunised mice (PBS) .  Each mouse in the experimental group ( 1 8  kDa) was 
positive by gastric tissue urease test and showed no significant decrease in CFU/g tissue 
compared to the control and PBs groups. On the other hand, mice immunised with H. 
pylori sonicate extract (sonicate) showed signifIcantly lower levels of colonisation (p = 
0.009 1 )  compared to the control and PBS groups, with only l out of the 6 mice positive 
by urease test in this group. 
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Figure 6.7: Mean log CFU/g stomach of stomach tissue for each group of mice. Mice 
were either non-immunised (controls) or immunised with PBS, H. pylori sonicate or the 
1 8  kDa antigen. Cholera toxin ( l 0  )lg) was added as an adjuvant in each immunisation 
protocol . 
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Figure 6.8: Gastric tissue urease test for each group of mice. Stomach tissue was 
determined as positive or negative as described in section 6.3.6 .  The number of mice 
positive for urease acitivty were plotted as a percentage of total number for each group 
of mice immunised with either PBS ,  H. pylori son icate or the 1 8  kDa antigen, in 
addition to non-immunised controls. 
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In addition, ELISA results (Table 6 . 1 )  for each group i l lustrated high IgG and IgA 
antibody titres to both HSPE and cholera toxin (CT) but low antibody titres to the 1 8  
kDa antigen i n  all groups of mice. 
Table 6.1 :  Antibody titres in mice post-immunisation 
Faecal Serum Serum IgG to 
Immunised With No. mice I g A  t o  I g A  t o  
HPSE HPSE HPSE 1 8 kDa 
PBS + CT 6 0.0620 0.0638 0.7735 0.0333 
HPSE + CT 6 0.5943 0.4079 1.3745 0.0309 
1 8  kDa + eT 6 0.0842 0. l 1 90 0.4824 0.27 1 6  
Controls 4 0.0954 0 . 1 288 0.6 1 1 3  ND 
PBS = phosphate buffered saline; CT = cholera toxin;  HPSE = H. pylori sonicate 
extract. 
The results of this preliminary vaccine trial indicated that administration of the 1 8  kDa 
protein to mice did not induce protective immunity against infection, under the 
conditions employed. 
6.5 Discussion 
One of the challenges to understanding the immune response to H. pylori infection is to 
identify those H. pylori protein s  that are recognised by the immune cells regulating the 
host 's  immune response. Many H. pylori surface and secreted proteins are recognised 
by antibody derived from sera taken from H. pylori infected patients (Karczewska et ai, 
1 996). In the previous study (chapter 5 ) ,  screening of H. pylori-AP fusion proteins with 
sera from H. pylori infected patients led to the identification of a recombinant fusion 
protein recognized by patient antibody. Sequencing revealed that the gene encoded an 
1 8  kDa putative outer membrane protein (Tomb et al., 1 997) .  The organization of the 
gene encoding the protein is consistent with an exported protein with regions of 
hydrophobicity in the C terminal domain that could be involved in membrane anchorage 
of the protein (Pugsley, 1 993) .  The 1 8  kDa antigen was designated as a hypothetical 
1 5 1  
6 
outer membrane protein in  the publi shed H. pylori genome sequence (Tomb et al. , 
1 997).  Support for this comes from the observation that the 1 8  kDa antigen contains a 
C-terminal phenylalanine residue, shown to be critical for the efficient sorting to the 
outer membrane (Struyve et al. , 1 99 1 ) . The presence of a potential lipoprotein  signal 
peptide suggests that the 1 8  kDa antigen may potentially function as a peptidoglycan­
assoc iated l ipoprotein (PAL) . S imi lar 1 8  kDa PALs have been foun d  to be 
immunogenic during infection with other gram-negative bacteria (Spinola et  al . ,  1 996; 
Lim et al. ,  1 997) .  
Using a combination of Southern blot analysis and PCR, the gene was not  detected in  
H. felis or  H. mustelae. However, since only one strain of  each species was screened, 
the possibility cannot be excluded that the gene may be present in different strains or 
detected under less stringent conditions u sed in the Southern blot technique.  
Nevertheless ,  these results, and the absence of any homology to sequences i n  the 
databases, suggest that the gene may be specific to H. pylori. The gene is present in  
different New Zealand clinical isolates and the geographical diverse types strain s  
CCUG 1 7874, 26695 (Tomb e t  al . ,  1 997) and J99 (AIm e t  al. ,  1 999) . A comparison of 
the DNA sequence of HP 1 085 from five H. pylori isolates and the three type strains 
showed a variation of up to 3 . 5% in the DNA sequence suggesting that the gene is 
highly conserved. This is consistent with the 2 - 5% variation frequently observed 
when nucleotide sequences of conserved genes from different H. pylori isolates are 
compared. This was observed in the case of the urease genes and the heat-shock protein 
gene hspB (Suerbaum et al . ,  1 996). 
Serology has been used extensively as the basis for diagnostic tests of H. pylori 
infection, and is particularly useful as an initial non-invasive diagnostic tool .  
Sensitivities of ELISA based methods are generally high, but  these assays can be 
plagued by low specificities due to cross-reactivity (Nilsson e t  al. , 1 997) .  The 
advantage of the immunoblot technique in serological assays is its accurate detection of 
antibodies that react with defined antigens  from an infectious agent .  Immunoblot 
analysis has therefore been investigated as a more reliable alternative for serodiagnosis 
in H. pylori (Karvar et  al. , 1 997) .  To investigate the role of the 1 8  kDa protein in  the 
host ' s  humoral immune response, the purified recombinant protein was used in Western 
blot assays against a panel of sera from H. pylori infected and non-infected individuals .  
1 52 
Chapter 6 
The majority of infected patients (7 1 % )  recognized the protein compared to 1 6% of 
non-infected controls .  
Although a number of secreted or surface-associated proteins  are recognised by infected 
individuals ( Karczewska et al. , 1 996) , there appears to be no correlation between the 
relative abundance of a particular antigen and its potency as a target for an 
i mmunological response (Worst et a l . ,  1 996) . In addit ion ,  recognit ion of 
immunodominant antigens during H. pylori infection does not often correlate well with 
disease outcome (Macchia et al., 1 993,  lenks et al. , 1 998).  H. pylori infected patients 
produce antibodies against H. pylori immunodominant antigens such as the urease B 
subunit (Worst et al. ,  1 996), LPS (Yokota et al. , 1 998) and heat shock protein A and B 
(Suerbaum et al. , 1 994; Ng et al. ,  1 999), however, recognition of these antigens  by 
antibody from H. pylori infected individuals varies from 35% (HspA) to 75% (UreB) .  
T o  explain this, i t  has been suggested that genetic restriction in antigen recognition by 
the host results in  individual recognition of some antigens but not others (Worst et al., 
1 996). Alternatively, the proportion of antibodies in  the serum specific for the epitopes 
in some patients may have been outside the detection l imit of the Western blot assay. 
The lack of a detectable antibody response to the 1 8  kDa antigen in  some patients may 
reflect differences in immune response to infection. An alternative explanation is that 
changing patterns in antigen recognition post infection may have influenced the 
recognition of the 1 8  kDa antigen .  In previous studies, it was found that 
immunodominance of individual antigens such as HspA (Perez-Perez et al. ,  1 996) and 
CagA (Mitchell  et al., 1 996) changed over the course of infection. The screening 
criteria employed in  this study was designed to detect H. pylori antigen consi stently 
recognised by antibody as only one blood sample was taken at one particular point in  
time. Thus,  the lack of an antibody response may reflect the patient' s immune status to 
this antigen at the time the blood was taken .  It is also possible that the detection of 
antibody in only 7 1  % of patients in our study is  reflected by an absence of the 1 8  kDa 
antigen in  some strains of H. pylori, as demonstrated with the immunodominan t  CagA 
antigen (Cover et al . ,  1 995). However, the evidence presented in our study suggests 
that the 1 8  kDa antigen is  present in all isolates, irrespective of VacA and CagA status .  
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One patient diagnosed as negative for H. pylori infection ,  but positive on Western blot, 
had been diagnosed with an active duodenal ulcer 1 8  years previously. This result may 
indicate therefore i ndicate a long-lasting memory response to a previous infection or 
exposure to H. pylori. However, we cannot exclude the possibili ty that the initial 
diagnostic tests used were unable to detect a sub-clinical i nfection, in  the two negative 
patients containing antibody to the 1 8  kDa antigen. 
The study described in this chapter demonstrated that the 1 8  kDa H. pylori protein i s  
recognized by patient serum IgG antibodies and is  therefore expressed in  vivo. Further 
investigations were therefore carried out to assess the potential of the 1 8  kDa antigen to 
induce a strong IgG response in mice by oral immunization and protect them against H. 
pylori infection . Immunisation with purified recombinant His-tagged 1 8  kDa antigen 
did not protect mice against challenge with H. pylori. The levels of colonisation, as 
assessed by CFU counts/g tissue and urease test, were similar for both test mice and 
controls. Immunisation with a sonicate of H. pylori SSI, however, achieved protection 
levels (80%) comparable to what others have found (Fen'ero et al., 1 994; Hocking et al., 
1 999). Although two of the mice in  the test group contained low levels of serum IgG 
antibody to the 1 8  kDa antigen, this did not correlate with any decrease in colonisation 
in these animals (data not shown) .  
A recent s tudy has been carried out (Hocking e t  al., 1 999) in  which a number of H. 
pylori recombinant H is-tagged antigens administered to mice achieved up to 80% 
protection from infection following challenge with H. pylori. Two antigens, Lpp20 and 
a 29 kDa protein, were demonstrated to be the most effective protective antigens. Their 
study used a similar immunisation protocol to that used in the present study, with two 
notable exceptions .  Firstly, Hocking et al. , ( 1 999) used specific-pathogen free (SPF) 
BALB/c mice for the immunisation protocol whereas the mice used in  the present study 
were C57B 1 I6J, mice that are known to display a stronger cellular infi ltrate in the 
stomach when compared to B ALB/c mice (Mohammadi et al. ,  1 996; Ferrero et al. , 
1 998) .  In addition, the mice were sacrificed only two weeks following challenge. The 
mice used in this study were challenged with an equal dose of H. pylori SSI ,  but 
sacrificed 6 weeks following challenge. Despite these differences, it  is  possible that the 
fai lure of the mice to raise a strong antibody response to the 1 8  kDa antigen contributed 
to the inability of this antigen to protect against subsequent challenge with H. pylori. 
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The lack of an antibody response in the mice was not due to failure of the immunisation 
protocol,  as it was demonstrated that the mice in each group raised significant antibody 
to eT. Moreover, the control mice immunised with H. pylori sonicate extract were 
effectively protected against colonisation following challenge with H. pylori. This 
result suggests that the protocol described in this study is  an appropriate model for 
studying antigens that may serve as a basis for the development of a H. pylori vaccine 
and can be used to test other potential candidates. 
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Chapter 7 Concluding Comments 
Chapter 7 
The aims of the work presented in this thesis were to identify H. pylori secreted or 
surface-associated proteins that might be involved in the immunopathogenesis of 
disease and to investigate their potential as vaccine candidates. The development of 
heterologous expression systems has facilitated studies involving the manipulation and 
analysis of genes from Helicobacter species. Expression of genes from a pathogenic 
bacterium such as H. pylori in a non-pathogenic, fast-growing host such as E. coli, 
relies on gene expression signals being recognised in the heterologous gram-negative 
bacterium. In addition to the structural integrity of the recombinant protein remaining 
similar, if not identical ,  to the native form, processing and post-translational 
modification pathways may also need to be conserved for valid immunological studies. 
Several immunodominant H. pylori proteins have now been expressed in E. coli and 
purified as recombinant proteins. Among these are the urease enzyme (Harris et a!., 
1 998),  urease subunits (Ferrero et al. , 1 994), heat shock proteins (Suerbaum et al. , 
1 994) and the cytotoxin-associated gene product (CagA) (Tummuru et aI. , 1 993).  
These recombinant proteins display similar antigenicity to the native form of the 
proteins, with only one exception to date (Manetti et aI., 1 995). 
The development, in  our laboratory, of alkaline phosphatase (AP) fusion technology for 
use with Helicobacter pylori has provided a rapid technique to identify H. pylori 
exported proteins (Johnson et aI., 1 995). Analysis of the deduced amino acid sequences 
revealed that s ixteen fusion proteins producing active AP contained moti fs 
characteristic of bacterial signal peptides. This suggested that the AP-fusion technology 
was identifying proteins exported by the general secretory pathway (GSP). A number 
of recombinant plasmids contained cryptic signal peptides that were capable of 
directing export in E. coli, while others contained hybrid genes resulting from non­
contiguous DNA fragments cloned into the same plasmid. These latter results 
demonstrated a limitation associated with this technology. In addition, the difficulty in 
obtaining full  length stable fusion products in E. coli was exacerbated by the 
degradation observed in the majority of the fusion proteins analysed by Western blot. 
Another limitation is that the strategy identifies only partial gene sequences, which then 
require locating the full length gene for further characterisation. The bacteriophage 
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Lambda l ibrary was primarily constructed to assist in obtaining full  genes for this 
purpose, however, the release of the H. pylori genome sequence in 1 997 enabled direct 
PCR amplification of genes based on the published sequences. 
The sequences of the H. pylori DNA inserts from twenty-eight recombinant plasmids 
expressing enzymatically active AP fusion proteins were determined and used to search 
databases for similarities to known genes. Database searches revealed genes encoding 
H. pylori surface or secreted proteins which had been previously described, including 
the outer membrane protein (OMPI9) gene (babB) ,  which encodes an adhesin involved 
in binding of H. pylori to the human gastric epithelium (Ilver et aI., 1 998) .  Homology 
was also found to the gene encoding a neutrophil activating protein (napA),  implicated 
in the induction of the inflammatory response to H. pylori by promoting neutrophil 
adhesion to the endothelium (Evans et aI. , 1 995) .  One other clone was shown to 
contain sequence homology to a H. pylori 29 kDa secreted protein (sequence submitted 
to the gene database) . This secreted protein corresponds to the 29 kDa protein which 
has been shown to induce protective immunity in mice following chal lenge with H. 
pylori (Hocking et al . , 1 999). The 29 kDa antigen is  currently the focus of a separate 
study being carried out in our l aboratory in collaboration with the Wakefield 
Gastroenterology Centre, Wellington. Many other sequences represented potentially 
novel exported protein genes. Further sequencing of clones isolated from the pJEMl l  
library is  likely to identify other putative adhesins or outer membrane components that 
may contribute to the development of improved diagnosis and control of H. pylori 
infection. 
The identification of candidate H. pylori antigens for use in recombinant vaccines is a 
prelude to developing new strategies for combating this infectious disease. Preliminary 
immunological screening of ten H. pylori enzymatically active AP fusion proteins 
resulted in the identification of a partial 1 8  kDa protein recognised by sera taken from 
patients infected with H. pylori. On the basis of motifs found within the deduced amino 
acid structure, the 1 8  kDa antigen was predicted to be located in the outer membrane. 
The N-terminal sequence fused to alkaline phosphatase resulted in this fusion protein, 
and others, being exported to the periplasmic space in E. coli. This demonstrated 
functional recognition of H. pylori signal peptides in E. coli. However, a conclusion 
cannot be drawn as to the subcellular location of the 1 8  kDa protein in H. pylori and 
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future localisation studies would need to be carried out in its natural host. The function 
of the 1 8  kDa protein in H. pylori is also currently unknown .  The creation of null 
mutants in conjunction with complementation studies would contribute to an 
understanding of the role this antigen plays in the organism' s survival in vitro and 
perhaps in vivo. 
The gene encoding the 1 8  kDa protein was cloned and expressed as a recombinant 
fusion protein for large scale purification of the entire protein. Additional serological 
screening of the recombinant 1 8  kDa protein revealed that 7 1  % of H. pylori infected 
individuals contained antibody to this protein, in contrast to only 1 6% of non-infected 
individuals (Oliaro et al. , in press). Oral administration of the recombinant 1 8  kDa 
antigen did not protect mice from infection following challenge with H. pylori. In 
addition, antibody responses in mice directed to this antigen were low or absent in mice, 
indicating that the antigen did not elicit a strong humoral immune response to the 1 8  
kDa protein. There i s  evidence to suggest that IgG may play a role in protective 
immunity against Helicobacter infection (Ferrero et al., 1 997 ; Keenan et al. , submitted 
for publication) and therefore, the lack of protection observed in this study may reflect 
an absence of protective antibody in these mice. It would be interesting to establish if 
mice chronically infected with H. pylori develop an natural antibody response to the 1 8  
kDa antigen. In order to develop strategies for generating the appropriate immune 
response necessary to induce protective immunity, future research into Helicobacter 
will require a c learer understanding of the immune response that correlates with 
protection. Other future developments in Helicobacter vaccination protocols are likely 
to include the generation of new mucosal adjuvants without gastrointestinal toxicity and 
testing of combinations of different cocktail antigens to direct immune responses 
against different stages of the disease. Alternatively, different routes of administrations 
and vaccine protocols that do not require a mucosal adjuvant, for example, antigen 
expression by live carriers, may also be desirable. 
In preliminary studies ,  the work presented in Chapter 3 described an initial 
characteristion of the human serological response to H. pylori antigens and the 
construction of an H. pylori expression l ibrary in bacteriophage Lambda. A 
collaborative project was initiated in which the expression l ibrary was used to identify 
the gene encoding a potential H. pylori vaccine candidate (identified as part of an 
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independent study) .  The expression library was screened with a monoclonal antibody 
raised against an immunogenic component of H. pylori outer membrane vesicles 
(OMVs) (Keenan et al. , 1 998). Subsequent expression of the gene product, detected by 
this antibody, resulted in the identification of Lpp20 (Kostrzynska et al. , 1 994). When 
used in vaccine trials, the H. pylori OMV preparation was shown to protect mice against 
infection following challenge with H. pylori (Keenan et al. submitted for publication) .  
Moreover, this protection correlated with serum IgG antibody reactivity to the OMV 
antigen identified as Lpp20. In other studies, outer membrane vesicles have been 
shown to play a role in pathogenesis (Keenan et al. , in press) and it has been suggested 
that they may function as a delivery system for virulence factors of H. pylori (Fiocca et 
al. , 1 999). H. pylori OMVs are strongly antigenic, and contain proteins, such as Lpp20, 
with protective properties. Since OMVs from a number of gram negative pathogens can 
be integrated into the outer membrane of common vaccine strains such as Salmonella 
typhimurium aroA (Kadurugamuwa and Beveridge, 1 999), it may be possible to use 
oral , attenuated vaccine strains containing incorporated H. pylori OMVs as multiple 
epitope vaccine candidates against H. pylori. 
The study presented in this thesis has contributed to the general body of information 
concerning the expression and export of H. pylori proteins. The number of clones 
found to express active alkaline phosphatase in E. coli indicates that a large number of 
H. pylori exported proteins still remain to be evaluated for their anti genic activity and 
assessed for their potential as candidates in future vaccine studies. 
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APPENDIX A: Raw Data for Enzyme Assays in Chapter 5 
Sample 
pJH}2 1 
pJHp2( a) 
EJHE2 (b) 
_EJHE4 
EJHE5 
pJHp6 (a) 
pJH}26 (b) 
pJHp7 (a) 
_..P.:!!!E 7 (b) 
.-eJHE9 
pJHp l O  (a) 
EJHE l O  (b) 
pJEM 
_EJEM 
De3 
De3 
pJHp W 
pJHp W 
AI:  Alkaline Phosphatase Enzyme Assays (Table 5 . 1 )  
Culture Assay Volume Mean 
Volume 00600 Time assayed 00420 
(ml) (min) (m I) 
40 0.82 40 0. 1 0.263 
40 0.85 40 0. 1 0.572 
40 0.9 1 40 0. 1 0.63 1 
40 0.80 40 0. 1 0.795 
40 0.85 40 0. 1 0.662 
40 0.86 40 0. 1 0.530 
40 0.90 40 0. 1 0.400 
40 0.85 40 0. 1 0. 1 70 
40 0.80 40 0. 1 0. 1 10 
40 0.75 40 0. 1 0.860 
40 0.73 40 0. 1 0.430 
40 0.82 40 0. 1 0.306 
40 0.94 40 0. 1 0.023 
40 0.80 40 0. 1 0.01 3  
40 0.9 1  40 0. 1 0.020 
40 0.80 40 0. 1 0.020 
40 0.90 40 0. 1 0.043 
40 0.80 40 0. 1 0.01 9  
Activity 
(U/minlml) 
80.2 
1 68.2 
1 73.4 
248.4 
206.9 
1 54 . 1  
1 1 1 . 1  
50.0 
34.4 
286.7 
1 47.2 
93.3 
6. 1 
4. 1 
5.5 
6.2 
1 1 .9 
5.9 
Mean OD420 = mean absorbance at 4 20 nm for triplicate wells. Alkaline phosphatase 
activity was measured as described in Chapter 5 .3 .2 .  The results from two separate 
preparations (a + b) are shown for some samples. pJEM = vector control (no insert); 
De3 = host strain control (no plasmid); pJHp W = white recombinant pJHp clone. 
A2: Enzyme Assays on Cellular Fractions from pJHp20 (Table 5 .3) 
00420 Specific % Total  
Sample OD600 mglml Assayed Activity* Activity 
�-gal AP �-gal 
(lOllg) 
AP �-gal AP 
periplasrnic 1 .0 0.7 1 4.2 III 0. 1 36 1 .056 2.74 2.65 20 99.9 
intracellular 1 .0 1 .4 7. 1 III 0.543 0.008 10.92 0.02 80 0.01 
periplasrnic 1 .2 1 .0 l O  III 0.286 0.736 14.72 1 .84 50 99.9 
intracellular 1 .2 2.4 4.0 III 0.700 0.002 14.58 0.01 50 om 
*Specific Activity = units/ml/min/mg; �-gal = beta-galactosidase; AP = alkaline 
phosphatase 
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A3: Enzyme Assays on Cellular Fraction from pJHp clones (Table 5.2) 
Alkaline Phosphatase �-galactosidase 
Sample 
(cell fraction) OD420 % Total OD420 % Total 
average Activity Activity average Activity Activity 
(min) 
pJHp l (per) 0.63 1 1 57.8 99.3 
pJHp l (int) 0.004 1 .0 0.7 
-E:!!:!�t) 0.0 1 6(0/n) < 1  < 1  
pJHp2 (per) 0.572 143.0 90.8 
pJHp2 (int) 0.058 1 4.5 89.2 
EJHE2 (ext) 0.0 14(0/n) < 1  < 1  
pJHp4 (per) 0.795 1 98.8 94. 1 
pJHp4 (int) 0.050 1 2.5 5.9 
. . .EJHE4 (ext) 0.01 2(0/n) < 1  < 1  
pJHp5 (per) 0.362 90.5 90.0 
pJHp5 (int) 0.042 1 0.5 1 0.0 
...EJHp5 (ext) 0.0 14(0/n) < 1  < 1  
pJHp6 (per) 0.53 1 32.5 96.4 0. 1 24 (30) 20.6 1 .9 
pJHp6 (int) 0.02 5.0 3.6 0.236 (5) 1 048.9 98. 1 
pJHp7 (per) 0. 1 7  42.5 89.5 0.207 ( 1 5) 6 1 .3 5.7 
...£.!!!p.7 (int) 0.02 5.0 1 0.5 0.274 (6) 1 0 1 4.8  94.35 
pJHp9 (per) 0.860 1 65.0 95.7 0. 1 60 (40) 1 7. 8  3.4 
-.P.!!!e9 (int) 0.030 7.5 4.3 0.230 ( 1 0) 5 1 1 . 1  96.6 
pJHp 10 (per) 0.42 1 05.0 89.4 0. 1 80 (40) 20.0 3.3 
EJHE 1 0 (int) 0.05 1 2.5 1 0.6 0.260 ( H)) 577.8 96.7 
pJEM (per) 0.023 5.75 N/A 0. 1 88 ( 1 5 )  55.7 1 2.8  
pJem (int) 0.0 1 0  2.50 N/A 0. 1 70 ( 1 0) 377.8 87.2 
pJem (ext) 0.008(0/n) < 1  N/A ND ND ND 
pJHp W (per) 0.043 1 0.75 N/A 0. 1 70 ( 1 5) 50.4 1 2.3 
pJHp W (int) 0.024 6.0 N/A 0. 1 62 (6) 360.0 87.7 
pJHp W (ext) O.Ol O(o/n) < 1  N/A ND ND ND 
De3 (per) 0.020 5.0 N/A 0.22 (40) 24.4 1 . 1  
De3 (int) 0.0 1 1 2.75 N/A 0.491 (5) 2 1 77.8 98.9 
De3 (ext) 0.008(0/n) < 1  N/A ND ND ND 
Per = periplasmic space protein fraction; int = intracellular protein fraction; ext = 
extracellular protein fraction; NI A = not applicable; ND = not done. 
For the �-galactosidase assay, the assay time varied with different samples and is 
therefore recorded in brackets. One hundred microlitres of each sample was assayed for 
alkaline phosphatase under standard conditions for 40 mins. For the �-galactosidase 
assay, 50 ul of periplasmic and 1 0  JlI of intracellular protein fractions were assayed. 
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APPENDIX B :  Raw Data for Mouse Immunisation Trial in Chapter 6 
Mouse Sex Imm. Serum Serum Serum Serum Serum CFU/g 
No. with IgA to IgG to IgA to IgG to IgG to UT tissue 
HPSE HPSE CT CT 18kDa 
1 9  F PBS 0.0440 0.6980 0.38 10 1 .4 1 00 0.0265 + 5.32E+06 
20 F PBS 0.0300 0. 1 9 1 5  0.201 5  1 .2070 0.0470 1 .37E+05 
2 1  F PBS 0.2260 1 .6660 1 .6480 1 . 1 380 0.0525 + 1 .54E+07 
22 F PBS 0.0225 0.5775 0.95 1 5  1 .4830 0.0345 + 1 .  1 3E+07 
23 F PBS 0.0345 1 . 1 1 90 0.7420 1 .5740 0.0 1 75 + 1 .0IE+07 
24 M PBS 0.0255 0.3890 0.8 105 1 .3400 0.0220 + 7.  92E+06 
25 F HPSE 0.0635 1 .8920 0.5435 1 .4 1 20 0.0280 1 .46E+05 
26 F HPSE 0.0795 1 .7740 0.4705 1 .5940 0.0 1 80 6 .00E+04 
27 F HPSE 0.5850 1 .5800 0.9 1 80 1 .4720 0.01 50 9.30E+04 
28 M HPSE 0. 1 650 1 .5000 0.4330 1 .3860 0.0525 1 .02E+06 
29 M HPSE 0.0625 0.3070 0.8565 1 .4590 0.0345 + 1 .28E+06 
30 M HPSE 1 .4920 1 . 1 940 2.3950 1 .7480 0.0375 3 .66E+05 
3 1  F 1 8kD 0. 1 275 1 .3660 1 .0900 1 .8800 0.2495 + 6.34E+06 
32 F 1 8kD 0.2 1 85 0.5980 0.7590 1 .83 1 0  1 . 1 85 + 6.33E+07 
33 F 1 8kD 0.2 1 75 0.3060 0.6300 1 .9890 0.0405 + 2.5 1 E+07 
34 F 1 8kD 0.0850 0.3400 0.3630 1 .3260 0.0550 + 1 .66E+07 
35 F 1 8kD 0.0255 0.0880 0.49 1 5  1 .5670 0.0660 + 2. 1 7E+07 
36 F 1 8kD 0.0400 0. 1 965 0.5330 1 .25 1 0  0.0335 + 1 .6 1 E+07 
HPSE = H. pylori sonicate extract; CT = cholera toxin; UT = urease test; CFU/g tissue 
= colony forming units per gram of stomach tissue 
APPENDIX C: One letter codes for amino acids and 
deoxyribonucleosides 
amino acids: G, A, V, L, I, P, F, Y, W, S, T, C, M, N, Q, D, E, K, R, H for glycine, 
alanine, valine, leucine, isoleucine, proline, phenylalanine, tyrosine, tryptophan, serine, 
threonine, cystein, methionine, asparagine, glutamine, aspartate, glutamate, lysine, 
arginine and histidine, respectively. 
deoxyribonucleos ide s : A, C, G,  T for deoxyadenylate, deoxycytidylate, 
deoxyguanylate and deoxythymidylate, respectively. 
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APPENDIX D: List of Publications related to this thesis 
J Keenan, J. Oliaro, N. Domigan, H .  Potter, G. Aitken and R. Allardyce Immune 
respons iveness to an 1 8  kDA outer membrane antigen identifies Lpp20 as an 
Helicobacter pylori vaccine candidate. Submitted for publication. 
J. Oliaro, RD. Johnson, W. Chen, V. Chadwick and A. Murray Identification of an 
immunogenic 1 8  kDa protein of Helicobacter pylori using alkaline phosphatase gene 
fusions. Journal of Medical Microbiology (In Press) 
*RD.Johnson, J.Oliaro, W Chen, V.S.  Chadwick and A. Murray ( 1 997) Formyl Met­
Leu-Phe peptides and Helicobacter pylori. Biomedical Letters 56 1 05 - 1 10  
J.  Oliaro, RD. Johnson, W. Chen, V .S .  Chad wick and A. Murray ( 1 997) Identification 
of Helicobacter pylori genes encoding exported proteins . Abstract. In Proceedings of 
the Australian Society for B iochemistry and Molecular B iology Vol 29 B2- 1 05 
RD. Johnson, J. Oliaro and A. Murray. ( 1 995) Identification of Helicobacter pylori 
genes encoding exported proteins. Biomedical Letters 51 267-269 
* This publication arose from a separate study which did not form part of this PhD 
project. 
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